Section 55

EurekaMag Full Text Articles Chapter 54,023


He, L.; Wang, Y. 2014: Iterative support detection-based split Bregman method for wavelet frame-based image inpainting. IEEE Transactions on Image Processing: a Publication of the IEEE Signal Processing Society 23(12): 5470-5485
Scaringi, S.; Nesi, G.; Bargellini, T.; Batignani, G.; Tonelli, F. 2010: Iterative surgical resection of a recurrent gallbladder carcinoma with long-term survival: report of a case. In Vivo 24(2): 215-217
Togashi, K.; Hosaka, Y.; Okada, A.; Sato, S. 2010: Iterative surgical resections for second primary and local recurrent lung cancer; comparison of lobectomy and limited resection. Kyobu Geka. Japanese Journal of Thoracic Surgery 63(11): 963-968
Brand, G.J.; Studte, C.; Breit, B. 2009: Iterative synthesis of (oligo)deoxypropionates via zinc-catalyzed enantiospecific sp3-sp3 cross-coupling. Organic Letters 11(20): 4668-4670
Finke, A.D.; Moore, J.S. 2008: Iterative synthesis of 1,3,5-polyphenylene dendrons via C-H activation. Organic Letters 10(21): 4851-4854
Lin, C.-H.; Lin, K.-H.; Pal, B.; Tsou, L.-D. 2009: Iterative synthesis of acenes via homo-elongation. Chemical Communications 7: 803-805
Norris, B.N.; Pan, T.; Meyer, T.Y. 2010: Iterative synthesis of heterotelechelic oligo(phenylene-vinylene)s by olefin cross-metathesis. Organic Letters 12(23): 5514-5517
Cremosnik, G.S.; Hofer, A.; Jessen, H.J. 2014: Iterative synthesis of nucleoside oligophosphates with phosphoramidites. Angewandte Chemie 53(1): 286-289
Heidecke, C.D.; Lindhorst, T.K. 2007: Iterative synthesis of spacered glycodendrons as oligomannoside mimetics and evaluation of their antiadhesive properties. Chemistry 13(32): 9056-9067
Van As, B.A.C.; van Buijtenen, J.; Mes, T.; Palmans, A.R.A.; Meijer, E.W. 2007: Iterative tandem catalysis of secondary diols and diesters to chiral polyesters. Chemistry 13(29): 8325-8332
Valuev, I.; Deinega, A.; Belousov, S. 2008: Iterative technique for analysis of periodic structures at oblique incidence in the finite-difference time-domain method. Optics Letters 33(13): 1491-1493
Schils, G.F.; Sweeney, D.W. 1987: Iterative technique for the synthesis of distortion-invariant optical correlation filters. Optics Letters 12(5): 307-309
Bernhardt, M.; Wyrowski, F.; Bryngdahl, O. 1991: Iterative techniques to integrate different optical functions in a diffractive phase element. Applied Optics 30(32): 4629-4635
Loss, L.A.; Bebis, G.; Parvin, B. 2011: Iterative tensor voting for perceptual grouping of ill-defined curvilinear structures. IEEE Transactions on Medical Imaging 30(8): 1503-1513
Letheulle, J.; Tattevin, P.; Saunders, L.; Kerjouan, M.; Léna, H.é; Desrues, B.; Le Tulzo, Y.; Jouneau, S.ép. 2014: Iterative thoracentesis as first-line treatment of complicated parapneumonic effusion. Plos one 9(1): E84788
Drever, L.; Roa, W.; McEwan, A.; Robinson, D. 2007: Iterative threshold segmentation for PET target volume delineation. Medical Physics 34(4): 1253-1265
Urbańczyk, M.; Bernin, D.; Koźmiński, W.; Kazimierczuk, K. 2013: Iterative thresholding algorithm for multiexponential decay applied to PGSE NMR data. Analytical Chemistry 85(3): 1828-1833
Puchal Añé, R. 2008: Iterative tomographic reconstruction. Revista Espanola de Medicina Nuclear 27(6): 460-467
Zeng, G.L.; Li, Y.; Zamyatin, A. 2013: Iterative total-variation reconstruction versus weighted filtered-backprojection reconstruction with edge-preserving filtering. Physics in medicine and biology 58(10): 3413-3431
Ghosh, A.; Seeley, S.K.; Seeley, J.V. 2014: Iterative trapping of gaseous volatile organic compounds in a capillary column. Analytical Chemistry 86(14): 6993-7000
Jiang, X. 2012: Iterative truncated arithmetic mean filter and its properties. IEEE Transactions on Image Processing: a Publication of the IEEE Signal Processing Society 21(4): 1537-1547
Sinoquet, C. 2009: Iterative two-pass algorithm for missing data imputation in SNP arrays. Journal of Bioinformatics and Computational Biology 7(5): 833-852
Horsman, G.P.; Van Lanen, S.G.; Shen, B. 2009: Iterative type i polyketide synthases for enediyne core biosynthesis. Methods in Enzymology 459: 97-112
Chen, X.; Ji, R.; Jiang, X.; Yang, R.; Liu, F.; Xin, Y. 2014: Iterative type i polyketide synthases involved in enediyne natural product biosynthesis. Iubmb Life 66(9): 587-595
Parvin, B.; Yang, Q.; Han, J.; Chang, H.; Rydberg, B.; Barcellos-Hoff, M.Helen. 2007: Iterative voting for inference of structural saliency and characterization of subcellular events. IEEE Transactions on Image Processing: a Publication of the IEEE Signal Processing Society 16(3): 615-623
Deledalle, C.-A.; Denis, L.ïc.; Tupin, F. 2009: Iterative weighted maximum likelihood denoising with probabilistic patch-based weights. IEEE Transactions on Image Processing: a Publication of the IEEE Signal Processing Society 18(12): 2661-2672
Boccard, J.; Rutledge, D.N. 2014: Iterative weighting of multiblock data in the orthogonal partial least squares framework. Analytica Chimica Acta 813: 25-34
Jin, C.; Nadakuditi, R.R.; Michielssen, E.; Rand, S.C. 2013: Iterative, backscatter-analysis algorithms for increasing transmission and focusing light through highly scattering random media. Journal of the Optical Society of America. a Optics Image Science and Vision 30(8): 1592-1602
Lupu, O.; Madaschi, M.; Seel, T.; Cologni, A.; Previdi, F.; Schauer, T. 2012: Iteratively Learning Electromyography (EMG)-based Functional Electrical Stimulation (FES) for Stroke Rehabilitation. Biomedizinische Technik. Biomedical Engineering 57 Suppl 1
Zhu, Z.; Janunts, E.; Eppig, T.; Sauer, T.; Langenbucher, A. 2010: Iteratively re-weighted bi-cubic spline representation of corneal topography and its comparison to the standard methods. Zeitschrift für Medizinische Physik 20(4): 287-298
Tóth, A.ár.; Hausknecht, A.; Krisai-Greilhuber, I.; Papp, T.ás.; Vágvölgyi, C.; Nagy, L.ás.ó G. 2013: Iteratively refined guide trees help improving alignment and phylogenetic inference in the mushroom family Bolbitiaceae. Plos one 8(2): E56143
Merli, M.; Sciascia, L. 2011: Iteratively reweighted least squares in crystal structure refinements. Acta Crystallographica. Section a Foundations of Crystallography 67(Part 5): 456-468
Baker, K.L.; Moallem, M.M. 2007: Iteratively weighted centroiding for Shack-Hartmann wave-front sensors. Optics Express 15(8): 5147-5159
Kurihara, N.; Sugiyama, M.; Ogawa, H.; Kitagawa, K.; Suzuki, K. 2010: Iteratively-reweighted local model fitting method for adaptive and accurate single-shot surface profiling. Applied Optics 49(22): 4270-4277
Yu, Q.; Fédière, G.; Abd-Alla, A.; Bergoin, M.; Tijssen, P. 2012: Iteravirus-like genome organization of a densovirus from Sibine fusca Stoll. Journal of Virology 86(16): 8897-8898
Dumon, S.; Walton, D.S.; Volpe, G.; Wilson, N.; Dassé, E.; Del Pozzo, W.; Landry, J.-R.; Turner, B.; O'Neill, L.P.; Göttgens, B.; Frampton, J. 2012: Itga2b regulation at the onset of definitive hematopoiesis and commitment to differentiation. Plos one 7(8): E43300
Kountouris, P.; Lederer, C.W.; Fanis, P.; Feleki, X.; Old, J.; Kleanthous, M. 2014: IthaGenes: an interactive database for haemoglobin variations and epidemiology. Plos one 9(7): E103020
Emerson, H. 1921: Ithaca Again. American Journal of Public Health 11(10): 927
Thurston, R.H. 1903: Ithaca, N. Y., Water-Supplies. Science 17(429): 474
Giraldo, C.E.; Willmott, K.R.; Vila, R.; Uribe, S.I. 2013: Ithomiini butterflies (Lepidoptera: Hymphalidae) of Antioquia, Colombia. Neotropical Entomology 42(2): 146-157
Friedman, E. 1960: Itinerant Anesthesia - A New Problem in Dental Anesthesiology. Journal of the American Dental Society of Anesthesiology 7(8): 16
Knox, J.H. 1926: Itinerant Conferences-Standards of Examination. American Journal of Public Health 16(5): 465-467
Villar Salinas, J. 1953: Itinerant Group for the Study of Public Health in Norway and France. II. France. Revista de Sanidad E Higiene Publica 27(1-2): 100-148
Graham, J.H. 1959: Itinerant Surgery. Canadian Medical Association Journal 80(7): 580
Rabinsky, R.J. 2013: Itinerant deaf educator and general educator perceptions of the D/HH push-in model. American Annals of the Deaf 158(1): 50-62
Kawanaka, H.; Yokoyama, M.; Noguchi, A.; Bando, H.; Nishihara, Y. 2009: Itinerant electron magnetism in CaRu(1-x)Mn(x)O(3) (0 ≤ x ≤ 0.5). Journal of Physics. Condensed Matter: An Institute of Physics Journal 21(29): 296002
Martin, I.; Batista, C.D. 2008: Itinerant electron-driven chiral magnetic ordering and spontaneous quantum Hall effect in triangular lattice models. Physical Review Letters 101(15): 156402
Lakkaraju, A.; Rodriguez-Boulan, E. 2008: Itinerant exosomes: emerging roles in cell and tissue polarity. Trends in Cell Biology 18(5): 199-209
Kamakura, N. 2009: Itinerant ferromagnetism by e(g) and t(2g) states in the two-band Hubbard model. Journal of Physics. Condensed Matter: An Institute of Physics Journal 21(3): 035601
Jo, G.-B.; Lee, Y.-R.; Choi, J.-H.; Christensen, C.A.; Kim, T.H.; Thywissen, J.H.; Pritchard, D.E.; Ketterle, W. 2009: Itinerant ferromagnetism in a Fermi gas of ultracold atoms. Science 325(5947): 1521-1524
Massignan, P.; Yu, Z.; Bruun, G.M. 2013: Itinerant ferromagnetism in a polarized two-component Fermi gas. Physical Review Letters 110(23): 230401
Kurzweil, N.; Kogan, E.; Frydman, A. 2009: Itinerant ferromagnetism in the electronic localization limit. Physical Review Letters 102(9): 096603
Sakai, S.; Arita, R.; Aoki, H. 2007: Itinerant ferromagnetism in the multiorbital Hubbard model: a dynamical mean-field study. Physical Review Letters 99(21): 216402
Pilati, S.; Bertaina, G.; Giorgini, S.; Troyer, M. 2010: Itinerant ferromagnetism of a repulsive atomic Fermi gas: a quantum monte carlo study. Physical Review Letters 105(3): 030405
Yang, X.; Wu, G. 2009: Itinerant flat-band magnetism in hydrogenated carbon nanotubes. Acs Nano 3(7): 1646-1650
Nandkishore, R.; Chern, G.-W.; Chubukov, A.V. 2012: Itinerant half-metal spin-density-wave state on the hexagonal lattice. Physical Review Letters 108(22): 227204
Seo, K.; Yoon, H.; Ryu, S.-W.; Lee, S.; Jo, Y.; Jung, M.-H.; Kim, J.; Choi, Y.-K.; Kim, B. 2010: Itinerant helimagnetic single-crystalline MnSi nanowires. Acs Nano 4(5): 2569-2576
Diallo, S.O.; Antropov, V.P.; Perring, T.G.; Broholm, C.; Pulikkotil, J.J.; Ni, N.; Bud'ko, S.L.; Canfield, P.C.; Kreyssig, A.; Goldman, A.I.; McQueeney, R.J. 2009: Itinerant magnetic excitations in antiferromagnetic CaFe2As2. Physical Review Letters 102(18): 187206
Cricchio, F.; Bultmark, F.; Grånäs, O.; Nordström, L. 2009: Itinerant magnetic multipole moments of rank five as the hidden order in URu(2)Si(2). Physical Review Letters 103(10): 107202
Khajetoorians, A.A.; Lounis, S.; Chilian, B.; Costa, A.T.; Zhou, L.; Mills, D.L.; Wiebe, J.; Wiesendanger, R. 2011: Itinerant nature of atom-magnetization excitation by tunneling electrons. Physical Review Letters 106(3): 037205
Agostoni, C. 2008: Itinerant physicians, the art of healing and doctors in national history (Mexico City, 1877-1911). Ciencia and Saude Coletiva 13(3): 975-984
W, J.R. 1885: Itinerant science-teachers. Science 5(104): 85
Janik, J.A.; Zhou, H.D.; Jo, Y-J.; Balicas, L.; Macdougall, G.J.; Luke, G.M.; Garrett, J.D.; McClellan, K.J.; Bauer, E.D.; Sarrao, J.L.; Qiu, Y.; Copley, J.R.D.; Yamani, Z.; Buyers, W.J.L.; Wiebe, C.R. 2009: Itinerant spin excitations near the hidden order transition in URu(2)Si(2). Journal of Physics. Condensed Matter: An Institute of Physics Journal 21(19): 192202
Luckner, J.L.; Ayantoye, C. 2013: Itinerant teachers of students who are deaf or hard of hearing: practices and preparation. Journal of Deaf Studies and Deaf Education 18(3): 409-423
Yusuff, K.B.; Wassi Sanni, A.' 2011: Itinerant vending of medicines inside buses in Nigeria: vending strategies, dominant themes and medicine-related information provided. Pharmacy Practice 9(3): 128-135
Hoshino, S.; Kuramoto, Y. 2013: Itinerant versus localized heavy-electron magnetism. Physical Review Letters 111(2): 026401
Diniz, D.; Medeiros, M. 2012: Itineraries and methods of illegal abortion in five Brazilian state capitals. Ciencia and Saude Coletiva 17(7): 1671-1681
Seppilli, T. 2012: Itineraries and specificities of Italian medical anthropology. Anthropology and Medicine 19(1): 17-25
Borrat, J.é-A.é 2008: Itinerary after liver transplantation. Soins; la Revue de Reference Infirmiere 727: 39-40
Rousseau, G. 2010: Itinerary of renal insufficiency. Soins; la Revue de Reference Infirmiere 745: 44
Van Praag, H.M. 2003: Itinerary: Concerning the professional and spiritual objectives of my life. Medical Humanities 29(2): 89-96
Singleton, K.L.; Gosh, M.; Dandekar, R.D.; Au-Yeung, B.B.; Ksionda, O.; Tybulewicz, V.L.J.; Altman, A.; Fowell, D.J.; Wülfing, C. 2011: Itk controls the spatiotemporal organization of T cell activation. Science Signaling 4(193): Ra66
Hu, J.; Qi, Q.; August, A. 2010: Itk derived signals regulate the expression of Th-POK and controls the development of CD4 T cells. Plos one 5(1): E8891
Lo, H.Y. 2010: Itk inhibitors: a patent review. Expert Opinion on Therapeutic Patents 20(4): 459-469
Moriarty, K.J.; Winters, M.; Qiao, L.; Ryan, D.; DesJarlis, R.; Robinson, D.; Cook, B.N.; Kashem, M.A.; Kaplita, P.V.; Liu, L.H.; Farrell, T.M.; Khine, H.H.; King, J.; Pullen, S.S.; Roth, G.P.; Magolda, R.; Takahashi, H. 2008: Itk kinase inhibitors: initial efforts to improve the metabolical stability and the cell activity of the benzimidazole lead. Bioorganic and Medicinal Chemistry Letters 18(20): 5537-5540
Min, L.; Joseph, R.E.; Fulton, D.B.; Andreotti, A.H. 2009: Itk tyrosine kinase substrate docking is mediated by a nonclassical SH2 domain surface of PLCgamma1. Proceedings of the National Academy of Sciences of the United States of America 106(50): 21143-21148
Gomez-Rodriguez, J.; Wohlfert, E.A.; Handon, R.; Meylan, F.ço.; Wu, J.Z.; Anderson, S.M.; Kirby, M.R.; Belkaid, Y.; Schwartzberg, P.L. 2014: Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells. Journal of Experimental Medicine 211(3): 529-543
Grasis, J.A.; Tsoukas, C.D. 2011: Itk: the rheostat of the T cell response. Journal of Signal Transduction 2011: 297868
Kihara, M.; Kiyoshima, T.; Nagata, K.; Wada, H.; Fujiwara, H.; Hasegawa, K.; Someya, H.; Takahashi, I.; Sakai, H. 2014: Itm2a expression in the developing mouse first lower molar, and the subcellular localization of Itm2a in mouse dental epithelial cells. Plos one 9(7): E103928
Lagha, M.; Mayeuf-Louchart, A.; Chang, T.; Montarras, D.; Rocancourt, D.; Zalc, A.; Kormish, J.; Zaret, K.S.; Buckingham, M.E.; Relaix, F. 2013: Itm2a is a Pax3 target gene, expressed at sites of skeletal muscle formation in vivo. Plos one 8(5): E63143
Tai, T.-S.; Pai, S.-Y.; Ho, I.-C. 2014: Itm2a, a target gene of GATA-3, plays a minimal role in regulating the development and function of T cells. Plos one 9(5): E96535
Venkatesh, V.; Kulkarni, K.P. 2008: Itopride and pantoprazole outcomes in diabetic gastroparesis trial (IPOD trial). Journal of the Indian Medical Association 106(12): 814-815
Sun, J.; Yuan, Y.-Z.; Holtmann, G. 2011: Itopride in the treatment of functional dyspepsia in Chinese patients: a prospective, multicentre, post-marketing observational study. Clinical Drug Investigation 31(12): 865-875
Huang, X.; Lv, B.; Zhang, S.; Fan, Y.-H.; Meng, L.-N. 2012: Itopride therapy for functional dyspepsia: a meta-analysis. World Journal of Gastroenterology 18(48): 7371-7377
Sakamoto, R.; Hashimoto, Y.; Satoh, M.; Yoshioka, S.; Tomita, A. 2012: Itoshima Medical Association nurse practitioner from the point of view of a surgical resident. Nihon Geka Gakkai zasshi 113(6): 532-535
Chai, X.Y.; Song, Y.L.; Xu, Z.R.; Shi, H.M.; Bai, C.C.; Bi, D.; Wen, J.; Li, F.F.; Tu, P.F. 2008: Itosides J-N from Itoa orientalis and structure - anti-COX-2 activity relationship of phenolic glycosides. Journal of Natural Products 71(5): 814-819
Panda, N.K. 1997: Itraconazole - a potent antifungal drug. Indian Journal of Otolaryngology and Head and Neck Surgery: Official Publication of the Association of Otolaryngologists of India 49(3): 293-294
Andrade M, A.; Puga L, B.; Guerra C, C.; Molina E, J.; Capurro C, M. 2011: Itraconazole 800 mg for the prophylaxis of fungal infections in patients with acute leukemia and severe neutropenia. Revista Medica de Chile 139(9): 1128-1134
Kim, J.; Aftab, B.T.; Tang, J.Y.; Kim, D.; Lee, A.H.; Rezaee, M.; Kim, J.; Chen, B.; King, E.M.; Borodovsky, A.; Riggins, G.J.; Epstein, E.H.; Beachy, P.A.; Rudin, C.M. 2013: Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists. Cancer Cell 23(1): 23-34
Pizzimenti, S.; Bussolino, C.; Badiu, I.; Rolla, G. 2013: Itraconazole as 'bridge therapy' to anti-IgE in a patient with severe asthma with fungal sensitisation. BMJ Case Reports
Pazyar, N.; Feily, A. 2010: Itraconazole as a novel addition to ANCA-associated vasculitides or other neutrophilic dermatosis armamentarium. Minerva Medica 101(6): 458-459
Bennack, E. 2007: Itraconazole as an angiogenesis inhibitor?. Pharmazie in Unserer Zeit 36(6): 420-421
Karadi, R.L.; Gow, D.; Kellett, M.; Denning, D.W.; O'Driscoll, R.B. 2011: Itraconazole associated quadriparesis and edema: a case report. Journal of Medical Case Reports 5: 140
Maeda, M. 2008: Itraconazole concentrations of fingernails and toenails of patients with tinea unguium. Journal of Dermatology 35(5): 314-315
Kobayashi, R.; Suzuki, D.; Yasuda, K.; Kobayashi, K. 2010: Itraconazole for invasive fungal infection with pediatric malignancies. Pediatrics International: Official Journal of the Japan Pediatric Society 52(5): 707-710
Shi, J.-m.; Wang, C.; Zhou, Y.-h.; Yu, K.; Du, X.; Luo, Y.; Cai, Z.; He, J.-s.; Ye, X.-j.; Zhang, J.; Xie, W.-z.; Huang, H. 2013: Itraconazole for secondary prophylaxis of invasive fungal infection in patients undergoing chemotherapy and stem cell transplantation. Zhonghua Xue Ye Xue Za Zhi 34(5): 413-416
Antoniu, S. 2009: Itraconazole for severe asthma with fungal sensitivity. Expert Opinion on PharmacoTherapy 10(7): 1231-1233
Agarwal, R.; Vishwanath, G.; Aggarwal, A.N.; Garg, M.; Gupta, D.; Chakrabarti, A. 2013: Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature. Mycoses 56(5): 559-570
Ohta, K.; Ishida, Y.; Fukui, A.; Nishi, H.; Naruse, T.; Takechi, M.; Kamata, N. 2015: Itraconazole inhibits TNF-α-induced CXCL10 expression in oral fibroblasts. Oral Diseases 21(1): 106-112
Hashimoto, N.; Yokoyama, K.; Sadahira, K.; Ueda, T.; Tsukada, Y.; Okamoto, S. 2012: Itraconazole may increase the risk of early-onset bortezomib-induced peripheral neuropathy. International Journal of Hematology 96(6): 758-763
Nakarani, M.; Misra, A.K.; Patel, J.K.; Vaghani, S.S. 2010: Itraconazole nanosuspension for oral delivery: Formulation, characterization and in vitro comparison with marketed formulation. Daru: Journal of Faculty of Pharmacy Tehran University of Medical Sciences 18(2): 84-90
Kato, K.; Nagao, M.; Nakano, S.; Yunoki, T.; Hotta, G.; Yamamoto, M.; Matsumura, Y.; Ito, Y.; Takakura, S.; Chen, F.; Bando, T.; Matsuda, Y.; Matsubara, K.; Date, H.; Ichiyama, S. 2014: Itraconazole prophylaxis for invasive Aspergillus infection in lung transplantation. Transplant Infectious Disease: An Official Journal of the Transplantation Society 16(2): 340-343
Mishra, M.; Panda, P.; Panda, S.; Mishra, S.; Singh, P.C. 1998: Itraconazole pulse therapy in onychomycosis. Indian Journal of Dermatology Venereology and Leprology 64(3): 123-125
Shi, W.; Nacev, B.A.; Aftab, B.T.; Head, S.; Rudin, C.M.; Liu, J.O. 2011: Itraconazole side chain analogues: structure-activity relationship studies for inhibition of endothelial cell proliferation, vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, and hedgehog signaling. Journal of Medicinal Chemistry 54(20): 7363-7374
Liu, R.; Li, J.; Zhang, T.; Zou, L.; Chen, Y.; Wang, K.; Lei, Y.; Yuan, K.; Li, Y.; Lan, J.; Cheng, L.; Xie, N.; Xiang, R.; Nice, E.C.; Huang, C.; Wei, Y. 2014: Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking. Autophagy 10(7): 1241-1255
Lovacheva, O.V.; Kornienko, I.I.; Kul'ko, A.B.; Slogotskaia, L.V.; Litvinov, V.I. 2008: Itraconazole treatment in the suspension of pathological fungal colonization of the airway in patients with pulmonary tuberculosis. Problemy Tuberkuleza i Boleznei Legkikh 1: 42-46
Acharya, K.M.; Mukhopadhyay, A.; Thakur, R.K.; Mehta, T.; Bhuptani, N.; Patel, R. 1995: Itraconazole versus griseofulvine in the treatment of tinea corporis and tinea cruris. Indian Journal of Dermatology Venereology and Leprology 61(4): 209-211
Chaiwarith, R.; Fakthongyoo, A.; Praparattanapan, J.; Boonmee, D.; Sirisanthana, T.; Supparatpinyo, K. 2011: Itraconazole vs fluconazole as a primary prophylaxis for fungal infections in HIV-infected patients in Thailand. Current HIV Research 9(5): 334-338
Borges, S.R.C.ção.; Silva, G.M.S.d.; Chambela, M.d.C.; Oliveira, R.d.V.C.d.; Costa, R.L.B.; Wanke, B.; Valle, A.C.F.d. 2014: Itraconazole vs. trimethoprim-sulfamethoxazole: a comparative cohort study of 200 patients with paracoccidioidomycosis. Medical Mycology 52(3): 303-310
Tapaninen, T.; Backman, J.T.; Kurkinen, K.J.; Neuvonen, P.J.; Niemi, M. 2011: Itraconazole, a P-glycoprotein and CYP3A4 inhibitor, markedly raises the plasma concentrations and enhances the renin-inhibiting effect of aliskiren. Journal of Clinical Pharmacology 51(3): 359-367
Kim, J.; Tang, J.Y.; Gong, R.; Kim, J.; Lee, J.J.; Clemons, K.V.; Chong, C.R.; Chang, K.S.; Fereshteh, M.; Gardner, D.; Reya, T.; Liu, J.O.; Epstein, E.H.; Stevens, D.A.; Beachy, P.A. 2010: Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth. Cancer Cell 17(4): 388-399
Niño, D.F.; Cauvi, D.M.; De Maio, A. 2014: Itraconazole, a commonly used antifungal, inhibits Fcγ receptor-mediated phagocytosis: alteration of Fcγ receptor glycosylation and gene expression. Shock 42(1): 52-59
Heiskanen, T.; Backman, J.T.; Neuvonen, M.; Kontinen, V.K.; Neuvonen, P.J.; Kalso, E. 2008: Itraconazole, a potent inhibitor of P-glycoprotein, moderately increases plasma concentrations of oral morphine. Acta Anaesthesiologica Scandinavica 52(10): 1319-1326
Santos, A.; Loureiro, G.; Faria, E.; Chieira, C. 2009: Itraconazole, an effective adjunctive treatment for allergic bronchopulmonary aspergillosis. Journal of Investigational Allergology and Clinical Immunology 19(5): 404-408
Chen, S.; Wu, D.; Sun, A.; Qiu, H.; Jin, Z.; Tang, X.; Miao, M.; Fu, Z.; Ma, X.; Han, Y.; Hu, X. 2007: Itraconazole-enhanced vindesine neurotoxicity in adult acute lymphoblastic leukaemia. American Journal of Hematology 82(10): 942
Alomrani, A.H.; Shazly, G.A.; Amara, A.A.; Badran, M.M. 2014: Itraconazole-hydroxypropyl-β-cyclodextrin loaded deformable liposomes: in vitro skin penetration studies and antifungal efficacy using Candida albicans as model. Colloids and Surfaces. B Biointerfaces 121: 74-81
Yoshikado, T.; Takada, T.; Yamamoto, T.; Yamaji, H.; Ito, K.; Santa, T.; Yokota, H.; Yatomi, Y.; Yoshida, H.; Goto, J.; Tsuji, S.; Suzuki, H. 2011: Itraconazole-induced cholestasis: involvement of the inhibition of bile canalicular phospholipid translocator MDR3/ABCB4. Molecular Pharmacology 79(2): 241-250
NoorZurani, M.H.R.; Vicknasingam, B.; Narayanan, S. 2009: Itraconazole-induced torsade de pointes in a patient receiving methadone substitution therapy. Drug and Alcohol Review 28(6): 688-690
Patel, N.R.; Damann, K.; Leonardi, C.; Sabliov, C.M. 2010: Itraconazole-loaded poly(lactic-co-glycolic) acid nanoparticles for improved antifungal activity. Nanomedicine 5(7): 1037-1050
Van Eerdenbrugh, B.; Van Speybroeck, M.; Mols, R.; Houthoofd, K.; Martens, J.A.; Froyen, L.; Van Humbeeck, J.; Augustijns, P.; Van den Mooter, G. 2009: Itraconazole/TPGS/Aerosil200 solid dispersions: characterization, physical stability and in vivo performance. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 38(3): 270-278
Denolle, T.; Azizi, M.; Massart, C.; Zennaro, M.C. 2014: Itraconazole: a new drug-related cause of hypertension. Annales de Cardiologie et d'Angeiologie 63(3): 213-215
Lestner, J.; Hope, W.W. 2013: Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections. Expert Opinion on Drug Metabolism and Toxicology 9(7): 911-926
Shein-Filipowicz, A.; Kaźmierczak, Rław.; Kostkiewicz, Bław.; Sempińska-Szewczyk, J.; Sankowski, A. 2010: Itraorbital organic foreign body - radiological methods in diagnosis - case report. Polish Journal of Radiology 75(3): 55-60
Woodward, T.E. 1949: Clinical use of Chloramphenicol (Chloromycetin) in Certain Bacterial Infections. Bulletin of the new York Academy of Medicine 25(12): 795
Vetrovec, G.W. 2010: Its all about time and talent. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 75(5): 700
Anonymous 1997: Its all starting to add up. Trends in Cognitive Sciences 1(6): 201
Terry, B.R. 2011: Its not a crisis. Hda now 2011: 32-33
Brockmann, C.; Wilhelm, T.; Barth, C.; Hörmann, K.; Schoenberg, S.O.; Fink, C. 2009: Its not always due to mumps!. Der Radiologe 49(4): 340-343
Linton, O. 2007: Its not on my watch. Academic Radiology 14(10): 1284
Goodwin, D.; Johnston, K.; Gustafson, P.; Elliott, M.; Thurmeier, R.; Kuttai, H. 2009: Its okay to be a quad: wheelchair rugby players sense of community. Adapted Physical Activity Quarterly: Apaq 26(2): 102-117
Weisskirch, R.S.; Delevi, R. 2012: Its ovr b/n u n me: technology use, attachment styles, and gender roles in relationship dissolution. Cyberpsychology Behavior and Social Networking 15(9): 486-490
Smith, M. 2010: Itty bitty boxes...and the big headaches they can bring. Ems Magazine 39(7): 20
Crane, J.M.; Gibson, D.M.; Vaughan, R.H.; Bergstrom, G.C. 2013: Iturin levels on wheat spikes linked to biological control of Fusarium head blight by Bacillus amyloliquefaciens. Phytopathology 103(2): 146-155
Jermy, A. 2010: It's not easy being green. Nature reviews. Microbiology 8(7): 467
Manning, J. 2013: It's not just getting your 'bell rung'. Rhode Island Medical Journal 96(11): 16
Cobbina, J.E.; Oselin, S.S. 2011: It's not only for the money: an analysis of adolescent versus adult entry into street prostitution. Sociological Inquiry 81(3): 310-332
Naroo, S.A. 2011: It's that time of year when everything goes crazy for those of us involved in universities – its exam time! Introduction. Contact Lens and Anterior Eye: the Journal of the British Contact Lens Association 34(4): 155-156
Mommaerts, J-Luc.; Devroey, D. 2011: It's too soon to recommend probiotics for colic. Journal of family practice 60(5): 251-2; author reply 252
Iudin, B.G.; Lopukhin, I.M. 2009: Iu. M. Lopukhin and the development of bioethics in Russia. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 10: 49-53
Kraus, C.A. 1933: Iv. Division of Chemistry and Chemical Technology. Science 77(2006): 552-554
Newman, W.V.; Whipple, G.H. 1932: Iv. Hemoglobin Injections and Conservation of Pigment by Kidney, Liver and Spleen : the Influence of Diet and Bleeding. Journal of Experimental Medicine 55(4): 637-652
Jones, R. 1916: Iv. On Malunited and Ununited Fractures. British Medical Journal 1(2893): 809-814
Wolfenden, H.H. 1940: Iv. the Definitions and Features of "health Insurance" and "state Medicine". Canadian Medical Association Journal 42(2): 178-181
Tolic-Nørrelykke, I. 2011: Iva Tolic-Nørrelykke. Current Biology: Cb 21(9): R299-R300
Lancellotti, P. 2008: Ivabradine (Procoralan). Revue Medicale de Liege 63(4): 220-224
Luszczki, J.J.; Prystupa, A.; Andres-Mach, M.; Marzęda, E.; Florek-Łuszczki, M. 2013: Ivabradine (a hyperpolarization activated cyclic nucleotide-gated channel blocker) elevates the threshold for maximal electroshock-induced tonic seizures in mice. Pharmacological Reports: Pr 65(5): 1407-1414
Anzai, T. 2011: Ivabradine (pure heart-rate-lowering agent). Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 9): 412-416
Marcondes, J.; Hansen, E. 2008: Transgenic lettuce seedlings carrying hepatitis B virus antigen HBsAg. Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 12(6): 469-471
Post, F.; Münzel, T. 2009: Ivabradine - a new therapeutic option for cardiogenic shock?. Herz 34(3): 224-229
Khawaja, M.Z.; Walker, D.M. 2009: Ivabradine - the beauty of a slow heart rate. International Journal of Clinical Practice 63(4): 542-546
Iliuta, L.; Rac-Albu, M. 2014: Ivabradine Versus Beta-Blockers in Patients with Conduction Abnormalities or Left Ventricular Dysfunction Undergoing Cardiac Surgery. Cardiology and Therapy 3(1-2): 13-26
Rusconi, A.Maria.; Ceriani, E. 2011: Ivabradine added to guidelines-based therapy in systolic heart failure patients. Internal and Emergency Medicine 6(3): 259-260
Cowie, M.R. 2014: Ivabradine and atrial fibrillation: what should we tell our patients?. Heart 100(19): 1487-1488
Lappegård, K.Tore.; Nordmo, E. 2011: Ivabradine and nightmares: a previously unreported adverse reaction. European Journal of Clinical Pharmacology 67(12): 1313-1314
Gupta, A.; Sharma, Y.Pal. 2011: Ivabradine and outcomes in chronic heart failure. Lancet 376(9758): 2069; author reply 2069-70
Swedberg, K.; Komajda, M.; Böhm, M.; Borer, J.S.; Ford, I.; Dubost-Brama, A.; Lerebours, G.; Tavazzi, L.; Swedberg, K.; Komajda, M.; Tavazzi, L.; Borer, J.S.; Böhm, M.; Ford, I.; Dubost-Brama, A.; Lerebours, G.; Perrone, S.; Krum, H.; Van Mieghem, W.; Bocchi, E.A.; Katova, T.; Liu, P.; Jalil, J.; Hu, D.; Vitovec, J.; Køber, L.; Uuetoa, T.; Niemela, M.; Jondeau, G.; Werdan, K.; Kremastinos, D.; Yu, C.M.; Toth, K.; Rao, D.S.; McDonald, K.; Metra, M.; Oh, B.H.; Jirgenson, J.; Erglis, A.; Kavoluniene, A.; Sim, K.H.; Voors, A.A.; Dickstein, K.; Opolski, G.; Providencia, L.; Ionescu, D.D.; Aroutiounov, G.; Hatala, R.; Sebestjen, M.; Aviles, F.; Willenheimer, R.; Oto, A.; Cowie, M.; Parkhomenko, O.; Lopez-Sendon, J.L.; Dickstein, K.; Ponikowski 2010: Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376(9744): 875-885
Kurpesa, M.łg.; Trzos, E.; Wierzbowska-Drabik, K.; Rechciński, T. 2010: Ivabradine as a heart rate-lowering agent in a patient with end-stage renal failure after heart transplantation. Kardiologia Polska 68(6): 684-686
Retegui, G.; Quintero, M.; Ruiz-Borrell, M.; Revello, A.án. 2009: Ivabradine as a treatment option for inappropriate sinus tachycardia. Revista Espanola de Cardiologia 62(5): 577-579
Schulze, V.; Steiner, S.; Hennersdorf, M.; Strauer, B-Eckehard. 2008: Ivabradine as an alternative therapeutic trial in the therapy of inappropriate sinus tachycardia: a case report. Cardiology 110(3): 206-208
Romero-Rodríguez, N.; Barón-Esquivias, G.; González Vargas-Machuca, M.; Martínez Martínez, A. 2010: Ivabradine as treatment of inappropriate sinus tachycardia. Medicina Clinica 135(9): 428-429
Bonadei, I.; Sciatti, E.; Vizzardi, E.; D'Aloia, A.; Metra, M. 2015: Ivabradine during cardiogenic shock: a clinical case and review of the literature. Heart and Lung: the Journal of Critical Care 44(1): 57-58
Anonymous 2012: Ivabradine for chronic heart failure?. Drug and therapeutics bulletin 50(10): 117-120
Wichterle, D. 2013: Ivabradine for inappropriate sinus tachycardia: another piece of evidence. Europace: European Pacing Arrhythmias and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing Arrhythmias and Cardiac Cellular Electrophysiology of the European Society of Cardiology 15(1): 9-10
Fox, K.; Ford, I.; Steg, P.G.; Tendera, M.; Ferrari, R.; Grancelli, H.; Freedman, B.; Eber, B.; Vanoverschelde, J.L.; Finkov, B.; Yotov, Y.; Tardif, J.C.; Hu, D.; Lau, C.; Hradec, J.; Hildebrandt, P.; Eha, J.; Peuhkurinen, K.; Danchin, N.; Steg, P.G.; Meinertz, T.; Vardas, P.; Borbola, J.; Mulcahy, D.; Maggioni, A.; Erglis, A.; Jirgensons, J.; Kalnins, U.; Laucevicius, A.; Dickstein, K.; Ruzyllo, W.; Tendera, M.; Seabra-Gomes, R.; Capalneanu, R.; Belenkov, Y.; Mareev, Y.; Murin, J.; Rakovec, P.; Macaya, C.; Dellborg, M.; Lüscher, T.U.; van Gilst, W.; Oto, A.; Ford, I.; Fox, K.; Hall, A.; Parkhomenko, A.; Robertson, M.; Weir, C.; Aziz, J.; Kean, S.; Wilson, R.; Thygesen, K.; Frenneaux, M.; Jondeau, G.; Camm, A.J.; Dargie, H.; Kjekshus, J.;, 2008: Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372(9641): 807-816
Anonymous 2008: Ivabradine for stable angina?. Drug and Therapeutics Bulletin 46(11): 84-88
Koester, R.; Kaehler, J.; Meinertz, T. 2011: Ivabradine for the treatment of stable angina pectoris in octogenarians. Clinical Research in Cardiology: Official Journal of the German Cardiac Society 100(2): 121-128
Riccioni, G.; Prencipe, G.; Benvenuto, A.; Masciocco, L.; Ventra, S.; Rizzo, U.; Russi, C.; Speziale, G. 2013: Ivabradine improves all aspects of quality of life assessed with the 36-item short form health survey in subjects with chronic ischemic heart disease compared with beta-blockers. Pharmacology 91(1-2): 35-38
Skalidis, E.I.; Hamilos, M.I.; Chlouverakis, G.; Zacharis, E.A.; Vardas, P.E. 2011: Ivabradine improves coronary flow reserve in patients with stable coronary artery disease. Atherosclerosis 215(1): 160-165
Kurtoglu, E.; Balta, S.; Karakus, Y.; Yasar, E.; Cuglan, B.; Kaplan, O.; Gozubuyuk, G. 2014: Ivabradine improves heart rate variability in patients with nonischemic dilated cardiomyopathy. Arquivos Brasileiros de Cardiologia 103(4): 308-314
Rienzo, M.; Melka, J.; Bizé, A.; Sambin, L.; Jozwiak, M.; Su, J.B.; Hittinger, L.; Berdeaux, A.; Ghaleh, B. 2015: Ivabradine improves left ventricular function during chronic hypertension in conscious pigs. Hypertension 65(1): 122-129
Riccioni, G.; Masciocco, L.; Benvenuto, A.; Saracino, P.; De Viti, D.; Massari, F.; Meliota, G.; Buta, F.; Speziale, G. 2013: Ivabradine improves quality of life in subjects with chronic heart failure compared to treatment with β-blockers: results of a multicentric observational APULIA study. Pharmacology 92(5-6): 276-280
Tereshchenko, S.N.; Uskach, T.M.; Kositsyna, I.V. 2014: Ivabradine in acute myocardial infarction. Kardiologiia 54(3): 78-81
Müller-Werdan, U.; Stöckl, G.; Ebelt, H.; Nuding, S.; Höpfner, F.; Werdan, K.; Abdel-Quader, M.; Antar, R.; Aubele, R.; Bock, S.; Borchert, P.; Brunke, M.C.; Busaker, J.; Djatschuk, S.; Durak, M.; Erdmann, M.; Götze, D.; Hammerl, P.; Jasinski, S.; Jung, N.; Jung, T.; Kahn, O.; König, F.; Köstering, M.; Kornadt, T.; Kreye, K.; Kubbutat, R.; Lange, R.; Leischik, R.; Littwitz, H.; Mittnacht, S.; Papachrysanthou, P.; Patten, M.; Pohl-Wegener, S.; Pyriki, P.; Qagisch, G.J.; Reifenberg, H.; Richter, I.; Richter, F.; Schaubert, E.; Scheuermann, O.; Scholl, T.; Schulz, D.; Sobejko, A.; Steindorf, J.; Stroh, R.; Stühn-Pfeiffer, H.J.; Vogel, S.; Walter, T.; Weber, H.G.; Wilke, A.; Zeydabadinejad, M. 2014: Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study. Experimental Gerontology 59: 34-41
Koester, R.; Kaehler, J.; Ebelt, H.; Soeffker, G.; Werdan, K.; Meinertz, T. 2010: Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice. Clinical Research in Cardiology: Official Journal of the German Cardiac Society 99(10): 665-672
Pathak, A.; Berdeaux, A.; Mulder, P.; Thuillez, C. 2010: Ivabradine in coronary heart disease: experimental and clinical pharmacology. Therapie 65(5): 483-489
Teerlink, J.R. 2010: Ivabradine in heart failure--no paradigm SHIFT…yet. Lancet 376(9744): 847-849
Deedwania, P.C. 2012: Ivabradine in heart failure: hope or hype?. American Journal of Cardiovascular Drugs: Drugs Devices and other Interventions 12(6): 357-359
Schuster, A.; Tang, W.H.W. 2011: Ivabradine in heart failure: to SHIFT or not to SHIFT. Current Heart Failure Reports 8(1): 1-3
Gorman, S.; Boos, C. 2008: Ivabradine in heart failure: what about digoxin?. Lancet 372(9656): 2113; Author Reply 2113-4
Zellerhoff, S.; Hinterseer, M.; Felix Krull, B.; Schulze-Bahr, E.; Fabritz, L.; Breithardt, Günter.; Kirchhof, P.; Kääb, S. 2010: Ivabradine in patients with inappropriate sinus tachycardia. Naunyn-Schmiedeberg's Archives of Pharmacology 382(5-6): 483-486
Filipovský, J. 2009: Ivabradine in patients with stable ischemic heart disease and left ventricular systolic dysfunction: the results of the BEAUTIFUL study. Vnitrni Lekarstvi 55(5): 513-516
Correale, M.; Montrone, D.; Ieva, R.; Di Biase, M.; Brunetti, N.D. 2013: Ivabradine in pulmonary arterial hypertension: can we delay the need for parenteral prostanoid therapy?. Clinical Research in Cardiology: Official Journal of the German Cardiac Society 102(5): 391-393
Fox, K.; Ford, I.; Steg, P.Gabriel.; Tardif, J-Claude.; Tendera, M.; Ferrari, R.; Fox, K.; Ferrari, R.; Ford, I.; Steg, P.G.; Tardif, J-C.; Tendera, M.; Ferrari, R.; Iglesias, R.; Zelveian, P.A.; Freedman, B.; Huber, K.; Vanoverschelde, J.L.; Machado Cesar, L.A.; Gotcheva, N.; L'Allier, P.; Hu, D.Y.; Lau, C.P.; Bergovec, M.; Hradec, J.; Clemmensen, P.; Hildebrandt, P.; Eha, J.; Laine, M.; Danchin, N.; Kedev, S.; Chumburidze, V.; Münzel, T.; Vardas, P.; Borbola, J.; Kasliwal, R.; Crean, P.; Tavazzi, L.; Seisembekov, T.Z.; Seung, K.B.; Erglis, A.; Laucevicius, A.; Ali, R.; Alexanderson, E.; Atar, D.; Sy, R.; Rynkiewicz, A.; Gomes, R..Seabra.; Macarie, C.; Mareev, V.Y.; Karpov, Y.A.; Ostojic, M.C.; Koh, T.H.; Murin, J 2014: Ivabradine in stable coronary artery disease without clinical heart failure. New England Journal of Medicine 371(12): 1091-1099
Correale, M.; Montrone, D.; Ieva, R.; Di Biase, M.; Brunetti, N.D. 2012: Ivabradine in systemic sclerosis related pulmonary arterial hypertension. European Journal of Internal Medicine 23(8): E210-E211
Sutton, R.; Salukhe, T. 2011: Ivabradine in the treatment of orthostatic intolerance. Europace: European Pacing Arrhythmias and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing Arrhythmias and Cardiac Cellular Electrophysiology of the European Society of Cardiology 13(3): 306-307
Lopatin, I.M. 2010: Ivabradine in the treatment of patients with angina pectoris: lessons of the BEAUTIFUL trial. Kardiologiia 50(1): 78-83
Sutton, R.; Salukhe, T.V.; Franzen-McManus, A.-C.; Collins, A.; Lim, P.B.; Francis, D.P. 2014: Ivabradine in treatment of sinus tachycardia mediated vasovagal syncope. Europace: European Pacing Arrhythmias and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing Arrhythmias and Cardiac Cellular Electrophysiology of the European Society of Cardiology 16(2): 284-288
Vaillant, F.; Timour, Q.; Descotes, J.; Manati, W.; Belhani, D.; Bui-Xuan, B.; Tabib, A.; Bricca, G.; Chevalier, P. 2008: Ivabradine induces an increase in ventricular fibrillation threshold during acute myocardial ischemia: an experimental study. Journal of Cardiovascular Pharmacology 52(6): 548-554
Chia, P.-L.; Foo, D. 2013: Ivabradine is BEAUTIFUL in concurrent acute coronary syndrome and stroke. International Journal of Cardiology 163(2): E21-E22
Morris, S.; Hunter, R. 2014: Ivabradine is cost-effective in the treatment of chronic heart failure. Heart 100(13): 991-992
Dominguez-Rodriguez, A.; Abreu-Gonzalez, P.; Consuegra-Sanchez, L.; Avanzas, P. 2014: Ivabradine might improve exercise capacity in dilated cardiomyopathy in comparison with bisoprolol: assessment with the ergospirometry test. Revista Espanola de Cardiologia 67(5): 413-414
Zulkarneev, R.; Zagidullin, N.; Abdrahmanova, G.; Hoppe, U.C.; Zagidullin, S. 2012: Ivabradine prevents heart rate acceleration in patients with chronic obstructive pulmonary disease and coronary heart disease after salbutamol inhalation. Pharmaceuticals 5(4): 398-404
Mackiewicz, U.; Gerges, J.Y.; Chu, S.; Duda, M.; Dobrzynski, H.; Lewartowski, B.; Mączewski, M.ł 2014: Ivabradine protects against ventricular arrhythmias in acute myocardial infarction in the rat. Journal of Cellular Physiology 229(6): 813-823
Suzer, K.; Omay, O.; Ozker, E.; Indelen, C.; Gumus, B. 2009: Coronary artery bypass grafting and concomitant descending aorta-to-bifemoral artery bypass via sternotomy. Cardiovascular Journal of Africa 20(5): 300-302
Walcher, T.; Bernhardt, P.; Vasic, D.; Bach, H.; Durst, R.; Rottbauer, W.; Walcher, D. 2010: Ivabradine reduces chemokine-induced CD4-positive lymphocyte migration. Mediators of Inflammation 2010: 751313
Lauzier, B.; Vaillant, F.; Gélinas, R.; Bouchard, B.; Brownsey, R.; Thorin, E.; Tardif, J.-C.; Des Rosiers, C. 2011: Ivabradine reduces heart rate while preserving metabolic fluxes and energy status of healthy normoxic working hearts. American Journal of Physiology. Heart and Circulatory Physiology 300(3): H845-H852
Aalbers, J. 2012: Ivabradine reduces total hospital burden in heart failure. Cardiovascular Journal of Africa 23(9): 528
Peng, L.; Yan, B.; Song, A.; Li, L.; Zeng, L.; Wang, G. 2013: Ivabradine significantly improves cardiac function in patients with ischemic heart disease: a meta-analysis of randomized controlled trials. International Journal of Cardiology 168(3): 3007-3010
Fischer-Rasokat, U.; Honold, J.ör.; Lochmann, D.; Liebetrau, C.; Leick, J.ür.; Hamm, C.; Fichtlscherer, S.; Möllmann, H.; Spyridopoulos, I. 2014: Ivabradine therapy to unmask heart rate-independent effects of β-blockers on pulse wave reflections. Clinical Research in Cardiology: Official Journal of the German Cardiac Society 103(6): 487-494
Capulzini, L.; Sarkozy, A.; Semeraro, O.; Paparella, G.; Chierchia, G.B.; DE Asmundis, C.; Roos, M.; Yazaki, Y.; Muller-Burri, A.; Sorgente, A.; Brugada, P. 2010: Ivabradine to treat inappropriate sinus tachycardia after the fast pathway ablation in a patient with severe pectus excavatum. Pacing and Clinical Electrophysiology: Pace 33(3): E32-E35
Zugck, C.; Martinka, P.; Stöckl, G. 2014: Ivabradine treatment in a chronic heart failure patient cohort: symptom reduction and improvement in quality of life in clinical practice. Advances in Therapy 31(9): 961-974
Cavusoglu, Y.; Mert, U.; Nadir, A.; Mutlu, F.; Morrad, B.; Ulus, T. 2015: Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure. Journal of Cardiovascular Medicine 16(9): 603-609
Ripa, C.; Germano, G.; Caparra, A.; Capparuccia, C.A.; Antonicelli, R. 2009: Ivabradine use in refractory unstable angina: a case report. International Journal of Immunopathology and Pharmacology 22(3): 849-852
Fazio, G.; Sarulo, F.; Licata, P.; D'Angelo, L.; Passantino, S.; Visconti, C.; Zarcone, P.; Spanò, C.; Novo, G.; Novo, S. 2010: Ivabradine versus bisoprolol. Minerva Cardioangiologica 58(2): 281-282
Pichler, P.; Pichler-Cetin, E.; Vertesich, M.; Mendel, H.; Sochor, H.; Dock, W.; Syeda, B. 2012: Ivabradine versus metoprolol for heart rate reduction before coronary computed tomography angiography. American Journal of Cardiology 109(2): 169-173
Rayan, M.; Tawfik, M.; Alabd, A.; Gamal, A. 2011: Ivabradine, a novel heart rate slower: is it a sword of double blades in patients with idiopathic dilated cardiomyopathy?. Anadolu Kardiyoloji Dergisi: Akd 11(5): 402-406
Lally, J.; Brook, J.; Dixon, T.; Gaughran, F.; Shergill, S.; Melikian, N.; MacCabe, J.H. 2014: Ivabradine, a novel treatment for clozapine-induced sinus tachycardia: a case series. Therapeutic Advances in Psychopharmacology 4(3): 117-122
Mach, F. 2009: Ivabradine, an I(f) current inhibitor--new treatment options in coronary heart disease. Revue Medicale Suisse 5(205): 1168-1170; 1172-1173
Scicchitano, P.; Cortese, F.; Ricci, G.; Carbonara, S.; Moncelli, M.; Iacoviello, M.; Cecere, A.; Gesualdo, M.; Zito, A.; Caldarola, P.; Scrutinio, D.; Lagioia, R.; Riccioni, G.; Ciccone, M.M. 2014: Ivabradine, coronary artery disease, and heart failure: beyond rhythm control. Drug Design Development and Therapy 8: 689-700
Stulc, T.áš; Ceška, R. 2014: Ivabradine, coronary heart disease, and heart failure: time for reappraisal. Current Atherosclerosis Reports 16(12): 463
Rushworth, G.F.; Lambrakis, P.; Leslie, S.J. 2011: Ivabradine: a new rate-limiting therapy for coronary artery disease and heart failure. Therapeutic Advances in Drug Safety 2(1): 19-28
Menown, I.B.A. 2007: Ivabradine: a new strategy for management of stable angina. British Journal of Hospital Medicine 68(6): 321-325
De Santis, V.; Frati, G.; Greco, E.; Tritapepe, L. 2014: Ivabradine: a preliminary observation for a new terapeutic role in patients with multiple organ dysfunction syndrome. Clinical Research in Cardiology: Official Journal of the German Cardiac Society 103(10): 831-834
Lattuca, B.; Roubille, Fçois. 2015: Ivabradine: a promising drug in cardiogenic shock to prevent the undesirable sinus tachycardia induced by dobutamine?. International Journal of Cardiology 178: 308-310
Wellnhofer, E.; Agewall, S. 2011: Ivabradine: an hypothesis generating study--an important link between bench and bedside. Atherosclerosis 215(1): 32-33
Riccioni, G. 2012: Ivabradine: an intelligent drug for the treatment of ischemic heart disease. Molecules 17(11): 13592-13604
Kumar, S.; Vohra, J. 2010: Ivabradine: appropriate treatment for inappropriate sinus tachycardia. Heart Rhythm 7(9): 1324-1325
Riccioni, G.; Vitulano, N.; D'Orazio, N. 2009: Ivabradine: beyond heart rate control. Advances in Therapy 26(1): 12-24
Rognoni, A.; Bertolazzi, M.; Macciò, S.; Rognoni, G. 2009: Ivabradine: cardiovascular effects. Recent Patents on Cardiovascular Drug Discovery 4(1): 61-66
Riccioni, G. 2010: Ivabradine: from molecular basis to clinical effectiveness. Advances in Therapy 27(3): 160-167
Ferrari, R. 2014: Ivabradine: heart rate and left ventricular function. Cardiology 128(2): 226-230
Bruhn, C. 2012: Ivabradine: heart rate reduction in coronary heart disease and chronic heart failure. Medizinische Monatsschrift für Pharmazeuten 35(6): 202-208
Perry, C.M. 2012: Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction. American Journal of Cardiovascular Drugs: Drugs Devices and other Interventions 12(6): 415-426
Anonymous 2007: Ivabradine: new drug. Best avoided in stable angina. Prescrire International 16(88): 53-56
Stieber, J. 2008: Ivabradine: pharmacodynamic aspects of its clinical use. Methods and Findings in Experimental and Clinical Pharmacology 30(8): 633-641
Riccioni, G. 2011: Ivabradine: recent and potential applications in clinical practice. Expert Opinion on PharmacoTherapy 12(3): 443-450
Marquis-Gravel, G.; Tardif, J.-C. 2008: Ivabradine: the evidence of its therapeutic impact in angina. Core Evidence 3(1): 1-12
Riccioni, G. 2013: Ivabradine: the hope for a good treatment of ischemic heart disease. Current Medicinal Chemistry 20(14): 1817-1823
Malakar, C.C.; Sudheendran, K.; Imrich, H.-G.; Mika, S.; Beifuss, U. 2012: Cu(I)-catalyzed annulation for the synthesis of substituted naphthalenes using o-bromobenzaldehydes and β-ketoesters as substrates. Organic and Biomolecular Chemistry 10(19): 3899-3905
Vreede, C.L.; Berkhout, M.C.; Sprij, A.J.; Fokkens, W.J.; Heijerman, H.G.M. 2015: Ivacaftor and sinonasal pathology in a cystic fibrosis patient with genotype deltaF508/S1215N. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society 14(3): 412-413
Wainwright, C.E. 2014: Ivacaftor for patients with cystic fibrosis. Expert Review of Respiratory Medicine 8(5): 533-538
Whiting, P.; Al, M.; Burgers, L.; Westwood, M.; Ryder, S.; Hoogendoorn, M.; Armstrong, N.; Allen, A.; Severens, H.; Kleijnen, J. 2014: Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis. Health Technology Assessment 18(18): 1-106
Hoare, S.; McEvoy, S.; McCarthy, C.J.; Kilcoyne, A.; Brady, D.; Gibney, B.; Gallagher, C.G.; McKone, E.F.; Dodd, J.D. 2014: Ivacaftor imaging response in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine 189(4): 484
Sheikh, S.I.; Long, F.R.; McCoy, K.S.; Johnson, T.; Ryan-Wenger, N.A.; Hayes, D. 2015: Ivacaftor improves appearance of sinus disease on computerised tomography in cystic fibrosis patients with G551D mutation. Clinical Otolaryngology: Official Journal of Ent-Uk ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology and Cervico-Facial Surgery 40(1): 16-21
Harrison, M.J.; Murphy, D.M.; Plant, B.J. 2013: Ivacaftor in a G551D homozygote with cystic fibrosis. New England Journal of Medicine 369(13): 1280-1282
Flume, P.A.; Liou, T.G.; Borowitz, D.S.; Li, H.; Yen, K.; Ordoñez, C.L.; Geller, D.E. 2012: Ivacaftor in subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation. Chest 142(3): 718-724
Kotha, K.; Clancy, J.P. 2013: Ivacaftor treatment of cystic fibrosis patients with the G551D mutation: a review of the evidence. Therapeutic Advances in Respiratory Disease 7(5): 288-296
Hussar, D.A.; Eckel, S.P. 2012: Ivacaftor, vismodegib, and ingenol mebutate. Journal of the American Pharmacists Association: Japha 52(3): 418-422
Anonymous 2013: Ivacaftor. Uncertain harm-benefit balance. Prescrire international 22(142): 229-231
Condren, M.E.; Bradshaw, M.D. 2013: Ivacaftor: a novel gene-based therapeutic approach for cystic fibrosis. Journal of Pediatric Pharmacology and Therapeutics: Jppt: the Official Journal of Ppag 18(1): 8-13
Deeks, E.D. 2013: Ivacaftor: a review of its use in patients with cystic fibrosis. Drugs 73(14): 1595-1604
Molloy, K.; McElvaney, N.G. 2014: Ivacaftor: from bench to bedside... and back again. American Journal of Respiratory and Critical Care Medicine 190(2): 128-129
McPhail, G.L.; Clancy, J.P. 2013: Ivacaftor: the first therapy acting on the primary cause of cystic fibrosis. Drugs of Today 49(4): 253-260
Stalheim, O.H. 1986: Ivadm. Canadian Veterinary Journal 27(11): 422
Calne, R.Y. 1966: Ivalon wrap operation for rectal prolapse. Proceedings of the Royal Society of Medicine 59(2): 127-128
Borodulin, V.I.; Paren'kova, O.R.; Tashkov, K.A.; Topolianskiĭ, A.V.; Chernogorov, I.Alekseevich. 2013: Ivan Alekseevich Chernogorov--the professor-cardiologist of the Moscow Stomatologic Institute. Problemy Sotsial'noi Gigieny Zdravookhraneniia i Istorii Meditsiny 2013(2): 46-47
Dikic, I.; Dikic, I. 2012: Ivan Dikic was trained as a medical doctor at the University of Zagreb, Croatia. Current biology: CB 22(3): R76-R77
Andjus, P.R.; Stojilkovic, S.S.; Cvijic, G.; Djaja, I. 2011: Ivan Djaja (Jean Giaja) and the Belgrade School of Physiology. Physiological Research 60(Suppl. 1): S1-13
Rufanov, I.G. 1959: Ivan Gur'evich Rufanov on his 75th birthday. Antibiotiki 4(2): 115-117
Davies, R.; Illich, I. 2012: Ivan Illich on medical nemesis. Nurse Education Today 32(1): 5-6
Färdow, J.; Illich, I. 2011: Ivan Illich, critic of health care, forgotten by his followers. Lakartidningen 108(39): 1917-1918
Michaelides, B.; Nurick, I.James. 2014: Ivan James Nurick. South African Medical Journal 104(4): 270
Gavrilov, Y.V.; Valko, P.O.; Sechenov, I.M. 2015: Ivan M. Sechenov (1829-1905). Journal of neurology 262(2): 495-497
Bilej, M. 2010: Ivan Málek and the Institute of Microbiology. Journal of Industrial Microbiology and Biotechnology 37(12): 1225-1226
Beran, A.; Pavlov, I.Petrovic. 2007: Ivan Petrovic Pavlov (1849-1936). Casopis Lekaru Ceskych 146(2): 179
Zagrina, N.A.; Pavlov, I.Petrovich. 2009: Ivan Petrovich Pavlov and the authorities. Neuroscience and Behavioral Physiology 39(4): 383-385
Zaĭtsev, E.I.; Kolesnikov, I.Stapanovich. 2008: Ivan Stepanovich Kolesnikov (1901-1985). Vestnik khirurgii imeni I. I. Grekova 167(5): 9-10
Gorczynski, R.M.; Erin, N.; Maqbool, T.; Gorczynski, C.P.; Gorczynski, L.Y. 2018: Characterization of an in vitro model system to explore control of tumor invasion of EMT6 and 4THM breast tumors by CD200:CD200R interactions. Breast Cancer 25(5): 547-559
Todd, M.C. 1976: Ivan illich disputed. Western Journal of Medicine 125(2): 168
Bause, G.S. 2011: Ivan the terrible anesthetist. Anesthesiology 115(2): 413
Tsagareli, M.G.; Beritashvili, I. 2007: Ivane Beritashvili: founder of physiology and neuroscience in Georgia. Journal of the History of the Neurosciences 16(3): 288-306
Tsagareli, M.G.; Doty, R.W.; Beritashvili, I.S. 2009: Ivane S. Beritashvili (1884-1974): from spinal cord reflexes to image-driven behavior. Neuroscience 163(3): 848-856
Bertini, I. 2012: Ivano Bertini (1940-2012). Journal of biological inorganic chemistry: JBIC: a publication of the Society of Biological Inorganic Chemistry 17(7): 989-990
Halldin, J.; Lo-Johansson, I. 2010: Ivar Lo-Johansson's freedom was constantly threatened by disease. Lakartidningen 107(48): 3075-3077
Jaggar, D.H. 1986: Ivas. Canadian Veterinary Journal 27(10): 358
Zhu, Z.-R.; Liu, Y.-H.; Ji, W.-G.; Duan, J.-H.; Hu, S.-J. 2013: Modulation of action potential trains in rabbit saphenous nerve unmyelinated fibers. Neuro-Signals 21(3-4): 213-228
Houston, D.M. 1987: Ivermectin Dosage: a correction. Canadian Veterinary Journal 28(7): 399
Strycharz, J.P.; Berge, N.M.; Alves, A.-M.; Clark, J.M. 2011: Ivermectin acts as a posteclosion nymphicide by reducing blood feeding of human head lice (Anoplura: Pediculidae) that hatched from treated eggs. Journal of Medical Entomology 48(6): 1174-1182
Snyder, D.E.; Wiseman, S.; Cruthers, L.R.; Slone, R.L. 2011: Ivermectin and milbemycin oxime in experimental adult heartworm (Dirofilaria immitis) infection of dogs. Journal of Veterinary Internal Medicine 25(1): 61-64
Almeida, G.D.; Feliz, D.C.; Heckler, R.P.; Borges, D.G.L.; Onizuka, M.K.V.; Tavares, L.E.R.; Paiva, F.; Borges, F.A. 2013: Ivermectin and moxidectin resistance characterization by larval migration inhibition test in field isolates of Cooperia spp. in beef cattle, Mato Grosso do Sul, Brazil. Veterinary Parasitology 191(1-2): 59-65
Asatryan, L.; Popova, M.; Perkins, D.; Trudell, J.R.; Alkana, R.L.; Davies, D.L. 2010: Ivermectin antagonizes ethanol inhibition in purinergic P2X4 receptors. Journal of Pharmacology and Experimental Therapeutics 334(3): 720-728
Steketee, R.W.; Ter Kuile, F.O. 2015: Ivermectin as a complementary strategy to kill mosquitoes and stop malaria transmission?. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 60(3): 366-368
Diazgranados-Sánchez, J.A.; Barrios-Arrázola, G.; Costa, J.L.; Burbano-Pabon, J.; Pinzón-Bedoya, J. 2008: Ivermectin as a therapeutic alternative in neurocysticercosis that is resistant to conventional pharmacological treatment. Revista de Neurologia 46(11): 671-674
Moreno, Y.; Nabhan, J.F.; Solomon, J.; Mackenzie, C.D.; Geary, T.G. 2010: Ivermectin disrupts the function of the excretory-secretory apparatus in microfilariae of Brugia malayi. Proceedings of the National Academy of Sciences of the United States of America 107(46): 20120-20125
Trailovic, S.M.; Ivanovic, S.R.; Varagić, V.M. 2011: Ivermectin effects on motor coordination and contractions of isolated rat diaphragm. Research in Veterinary Science 91(3): 426-433
Albérich, M.él.; Ménez, C.éc.; Sutra, J.-F.ço.; Lespine, A. 2014: Ivermectin exposure leads to up-regulation of detoxification genes in vitro and in vivo in mice. European Journal of Pharmacology 740: 428-435
Ejere, H.O.D.; Schwartz, E.; Wormald, R.; Evans, J.R. 2012: Ivermectin for onchocercal eye disease (river blindness). Cochrane Database of Systematic Reviews 8: Cd002219
Lowenthal, M.N. 2013: Ivermectin for scabies and headlice: veterinary use only. Israel Medical Association Journal: Imaj 15(5): 262
Bernardi, M.M.; Kirsten, T.B.; Spinosa, H.S.; Manzano, H. 2011: Ivermectin impairs sexual behavior in sexually naïve, but not sexually experienced male rats. Research in Veterinary Science 91(1): 77-81
Hashimoto, H.; Messerli, S.M.; Sudo, T.; Maruta, H. 2009: Ivermectin inactivates the kinase PAK1 and blocks the PAK1-dependent growth of human ovarian cancer and NF2 tumor cell lines. Drug Discoveries and Therapeutics 3(6): 243-246
Ménez, C.éc.; Mselli-Lakhal, L.ïl.; Foucaud-Vignault, M.; Balaguer, P.; Alvinerie, M.; Lespine, A. 2012: Ivermectin induces P-glycoprotein expression and function through mRNA stabilization in murine hepatocyte cell line. Biochemical Pharmacology 83(2): 269-278
Zhang, X.; Song, Y.; Ci, X.; An, N.; Ju, Y.; Li, H.; Wang, X.; Han, C.; Cui, J.; Deng, X. 2008: Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice. Inflammation Research: Official Journal of the European Histamine Research Society . 57(11): 524-529
Pettengill, M.A.; Lam, V.W.; Ollawa, I.; Marques-da-Silva, C.; Ojcius, D.M. 2012: Ivermectin inhibits growth of Chlamydia trachomatis in epithelial cells. Plos one 7(10): E48456
Jani, M.ár.; Makai, I.ó; Kis, E.; Szabó, P.ál.; Nagy, T.ün.; Krajcsi, P.ét.; Lespine, A. 2011: Ivermectin interacts with human ABCG2. Journal of Pharmaceutical Sciences 100(1): 94-97
Pimenta, P.Henrique.Cotrim.; Silva, C.Lucia.Martins.; Noël, Fçois. 2010: Ivermectin is a nonselective inhibitor of mammalian P-type ATPases. Naunyn-Schmiedeberg's Archives of Pharmacology 381(2): 147-152
Wagstaff, K.M.; Sivakumaran, H.; Heaton, S.M.; Harrich, D.; Jans, D.A. 2012: Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus. Biochemical Journal 443(3): 851-856
Muhammed Ameen, S.; Drancourt, M. 2013: Ivermectin lacks antituberculous activity. Journal of Antimicrobial ChemoTherapy 68(8): 1936-1937
Early, J.; MacNaughton, H. 2014: Ivermectin lotion (sklice) for head lice. American Family Physician 89(12): 984-986
Kobylinski, K.C.; Sylla, M.; Chapman, P.L.; Sarr, M.D.; Foy, B.D. 2011: Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages. American Journal of Tropical Medicine and Hygiene 85(1): 3-5
Yardley, M.M.; Wyatt, L.; Khoja, S.; Asatryan, L.; Ramaker, M.J.; Finn, D.A.; Alkana, R.L.; Huynh, N.; Louie, S.G.; Petasis, N.A.; Bortolato, M.; Davies, D.L. 2012: Ivermectin reduces alcohol intake and preference in mice. Neuropharmacology 63(2): 190-201
Moreira, N.; Bernardi, M.M.; Spinosa, H.S. 2014: Ivermectin reduces sexual behavior in female rats. Neurotoxicology and Teratology 43: 33-38
Bennett, D.C.; Cheng, K.M. 2012: Ivermectin residues in squab. Poultry Science 91(11): 2808-2811
Prichard, R.K. 2007: Ivermectin resistance and overview of the Consortium for Anthelmintic Resistance SNPs. Expert Opinion on Drug Discovery 2(S1): S41-S52
Puniamoorthy, N.; Schäfer, M.A.; Römbke, J.ör.; Meier, R.; Blanckenhorn, W.U. 2014: Ivermectin sensitivity is an ancient trait affecting all ecdysozoa but shows phylogenetic clustering among sepsid flies. Evolutionary Applications 7(5): 548-554
Tousignant, D. 1991: Ivermectin sur les chatons. Canadian Veterinary Journal 32(8): 454
Smith, R.E. 1987: Ivermectin toxicity in dogs and cats. Canadian Veterinary Journal 28(6): 299-302
Bauck, S. 1987: Ivermectin toxicity in small animals. Canadian Veterinary Journal 28(9): 563-564
Merola, V.; Khan, S.; Gwaltney-Brant, S. 2009: Ivermectin toxicosis in dogs: a retrospective study. Journal of the American Animal Hospital Association 45(3): 106-111
Puthran, N.; Hegde, V.; Anupama, B.; Andrew, S. 2012: Ivermectin treatment for massive orbital myiasis in an empty socket with concomitant scalp pediculosis. Indian Journal of Ophthalmology 60(3): 225-227
Ly, F.; Caumes, E.; Ndaw, C.A.T.; Ndiaye, B.; Mahé, A. 2009: Ivermectin versus benzyl benzoate applied once or twice to treat human scabies in Dakar, Senegal: a randomized controlled trial. Bulletin of the World Health Organization 87(6): 424-430
Rutman, H. 2010: Ivermectin versus malathion for head lice. New England Journal of Medicine 362(25): 2426-2427; Author Reply 2427
Goldust, M.; Rezaee, E.; Raghifar, R.; Naghavi-Behzad, M. 2013: Ivermectin vs. lindane in the treatment of scabies. Annals of Parasitology 59(1): 37-41
Steer, A.C.; Kearns, T.; Andrews, R.M.; McCarthy, J.S.; Carapetis, J.R.; Currie, B.J. 2009: Ivermectin worthy of further investigation. Bulletin of the World Health Organization 87(10): A; Author Reply B
Crump, A.; Ōmura, S. 2011: Ivermectin, 'wonder drug' from Japan: the human use perspective. Proceedings of the Japan Academy. Series B Physical and Biological Sciences 87(2): 13-28
Chaurasia, R.C. 2007: Ivermectin--antiscabies chemotherapeutic agent used in masses. Journal of the Indian Medical Association 105(2): 99
Vatta, A.F.; Dzimianski, M.; Storey, B.E.; Camus, M.S.; Moorhead, A.R.; Kaplan, R.M.; Wolstenholme, A.J. 2014: Ivermectin-dependent attachment of neutrophils and peripheral blood mononuclear cells to Dirofilaria immitis microfilariae in vitro. Veterinary Parasitology 206(1-2): 38-42
Seil, M.èl.; El Ouaaliti, M.; Fontanils, U.; Etxebarria, I.G.; Pochet, S.ép.; Dal Moro, G.; Marino, A.; Dehaye, J.-P. 2010: Ivermectin-dependent release of IL-1beta in response to ATP by peritoneal macrophages from P2X(7)-KO mice. Purinergic Signalling 6(4): 405-416
Epstein, S.E.; Hollingsworth, S.R. 2013: Ivermectin-induced blindness treated with intravenous lipid therapy in a dog. Journal of Veterinary Emergency and Critical Care 23(1): 58-62
Camargo, J.A.; Sapin, A.; Daloz, D.; Maincent, P. 2010: Ivermectin-loaded microparticles for parenteral sustained release: in vitro characterization and effect of some formulation variables. Journal of Microencapsulation 27(7): 609-617
Krolewiecki, A.J.; Cajal, S.P.; Villalpando, C.; Gil, Jé.F. 2011: Ivermectin-related adverse clinical events in patients treated for Mansonella ozzardi infections. Revista Argentina de Microbiologia 43(1): 48-50
Omura, S.; Crump, A. 2014: Ivermectin: panacea for resource-poor communities?. Trends in Parasitology 30(9): 445-455
Hanner, T.L.; Hanner, T.L. 2009: Iverson Bell Award. Who can mentor minorities?. Journal of veterinary medical education 36(4): 348-350
Anonymous 2012: Ivoclar Vivadent composites ensure patient benefits. Compendium of Continuing Education in Dentistry 33(4): 298
Anonymous 2014: Ivoclar Vivadent's Adhese® Universal with VivaPen®: effective delivery for all etching methods. Compendium of Continuing Education in Dentistry 35(4): 282
Anonymous 2010: Ivoclar Vivadent's bluephase 20i curing light. All the convenience of LED with all the versatility of halogen. Dentistry Today 29(4): 42
Anonymous 2012: Ivoclar Vivadent's bluephase style offers clinicians convenience, comfort. Compendium of Continuing Education in Dentistry 33(6): 448
Anonymous 2013: Ivoclar Vivadent's "all-ceramic, all-options" philosophy gives clinicians flexibility. Compendium of Continuing Education in Dentistry 34(6): 462
Anonymous 2013: Ivoclar Vivadent: a pioneer in dental composite development. Compendium of Continuing Education in Dentistry 34(5): 378
Wolff, C.S.; Castillo, S.F.; Larson, D.R.; O'Byrne, M.M.; Fredericksen, M.; Deschamps, C.; Allen, M.S.; Zais, T.G.; Romero, Y. 2008: Ivor Lewis approach is superior to transhiatal approach in retrieval of lymph nodes at esophagectomy. Diseases of the Esophagus: Official Journal of the International Society for Diseases of the Esophagus 21(4): 328-333
Martín-Malagón, A.; Bravo, A.; Arteaga, I.án.; Rodríguez, L.; Estévez, F.; Alarcó, A. 2008: Ivor Lewis esophagectomy in a patient with enlarged azygos vein: a lesson to learn. Annals of Thoracic Surgery 85(1): 326-328
Cadière, G.B.; Dapri, G.; Himpens, J.; Fodderie, L.; Rajan, A. 2010: Ivor Lewis esophagectomy with manual esogastric anastomosis by thoracoscopy in prone position and laparoscopy. Surgical Endoscopy 24(6): 1482-1485
Wu, J.; Chai, Y.; Zhou, X.-M.; Chen, Q.-X.; Yan, F.-L. 2008: Ivor Lewis subtotal esophagectomy with two-field lymphadenectomy for squamous cell carcinoma of the lower thoracic esophagus. World Journal of Gastroenterology 14(32): 5084-5089
Xie, S.-P.; Kang, G.-J.; Fan, G.-H.; Geng, Q.; Huang, J. 2014: Ivor-Lewis esophagectomy for esophageal cancer after distal gastrectomy. Journal of Thoracic Disease 6(2): E22-E26
Schröder, W.; Hölscher, A.H.; Bludau, M.; Vallböhmer, D.; Bollschweiler, E.; Gutschow, C. 2010: Ivor-Lewis esophagectomy with and without laparoscopic conditioning of the gastric conduit. World Journal of Surgery 34(4): 738-743
Zhang, B.; Wang, Y.; Yang, S.-P.; Zhou, Y.; Wu, W.-B.; Tang, W.; Zuo, J.-P.; Li, Y.; Yue, J.-M. 2012: Ivorenolide A, an unprecedented immunosuppressive macrolide from Khaya ivorensis: structural elucidation and bioinspired total synthesis. Journal of the American Chemical Society 134(51): 20605-20608
Wang, Y.; Liu, Q-Fang.; Xue, J-Jun.; Zhou, Y.; Yu, H-Chao.; Yang, S-Ping.; Zhang, B.; Zuo, J-Ping.; Li, Y.; Yue, J-Min. 2014: Ivorenolide B, an immunosuppressive 17-membered macrolide from Khaya ivorensis: structural determination and total synthesis. Organic Letters 16(7): 2062-2065
Courtin, F.; Jamonneau, V.; Kambiré, R.; Solano, P. 2010: Ivory Coast uprising and returning Burkinabe immigrants: evaluation of the risk for reemergence of sleeping sickness in Burkina Faso. Medecine Tropicale: Revue du Corps de Sante Colonial 70(5-6): 490-496
Handley, W.S. 1912: Ivory Exostosis of the Frontal Sinus. Proceedings of the Royal Society of Medicine 5(Clin Sect): 52-54
Coleman, F. 1926: Ivory Exostosis of the Mandible Simulating a Tooth. Proceedings of the Royal Society of Medicine 19(Odontol Sect): 37-39
Bullough, P.G. 1965: Ivory Exostosis of the Skull. Postgraduate Medical Journal 41(475): 277-281
Lang, W.; Armour, D. 1919: Ivory Exostosis, growing from the Roof of the Frontal Sinus into the Orbital and Cranial Cavities, removed through an Osteoplastic Opening in the Cranium by Mr. Donald Armour. Proceedings of the Royal Society of Medicine 12(Sect Ophthalmol): 16-19
Anonymous 1889: Ivory Varnish. Science 13(326): 332
Calif, E.; Vlodavsky, E.; Stahl, S. 2007: Ivory fingers: monostotic Paget's disease of the phalanges. Journal of Clinical Endocrinology and Metabolism 92(5): 1590-1591
Lee, J.C.-I.; Hsieh, H.-M.; Huang, L.-H.; Kuo, Y.-C.; Wu, J.-H.; Chin, S.-C.; Lee, A.-H.; Linacre, A.; Tsai, L.-C. 2009: Ivory identification by DNA profiling of cytochrome b gene. International Journal of Legal Medicine 123(2): 117-121
Culotta, E. 1995: Ivory identity crisis still unsolved. Science 267(5202): 1264
Johnson, K.A. 2014: Ivory trade orphans. Veterinary and Comparative Orthopaedics and Traumatology: V.C.O.T 27(2): V-Vi
Blanco, J.F.; De Pedro, J.A.; Paniagua, J.C.; Montilla, C. 2007: Ivory vertebra and palmoplantar pustulosis. Journal of Rheumatology 34(4): 896-899
Bellinger, S.; Hatamimoslehabadi, M.; Borg, R.E.; La, J.; Catsoulis, P.; Mithila, F.; Yelleswarapu, C.; Rochford, J. 2018: Characterization of a NIR absorbing thienyl curcumin contrast agent for photoacoustic imaging. Chemical Communications 54(49): 6352-6355
Aide, N.; Costo, S.; Lheureux, S.ép.; Allouache, N.; Bardet, S.ép. 2008: Ivory vertebra appearing photopenic on Tc-99m MDP bone scan: demonstration by SPECT/CT. Clinical Nuclear Medicine 33(7): 479-481
Meltzer, S.L. 1947: Ivory vertebra associated with lipoma of the spinal cord; case report. American Journal of Roentgenology and Radium Therapy 57(6): 741-743
Oldan, J.D.; Kuzminski, S.; James, O. 2014: Ivory vertebra on 18F-sodium fluoride scan: an old sign in a new modality. Clinical Nuclear Medicine 39(11): 972-974
Trepte, H.H. 1978: Ivory: a recessive white-eyed tryptophan metabolism mutant with intermediate F2 - and R 1 - progenies in the flesh fly Sarcophaga barbata. Tag. Theoretical and Applied Genetics. Theoretische und Angewandte Genetik 51(4): 185-191
Krook-Magnuson, E.; Luu, L.; Lee, S.-H.; Varga, C.; Soltesz, I. 2011: Ivy and neurogliaform interneurons are a major target of μ-opioid receptor modulation. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 31(42): 14861-14870
Bunkrongcheap, R.; Hutadilok-Towatana, N.; Noipha, K.; Wattanapiromsakul, C.; Inafuku, M.; Oku, H. 2014: Ivy gourd (Coccinia grandis L. Voigt) root suppresses adipocyte differentiation in 3T3-L1 cells. Lipids in Health and Disease 13: 88
El Beltagi, A.H.; El-Sheikh, A.; El-Saif, R.; Norbash, A. 2014: Ivy sign in mildly symptomatic β-thalassemia intermedia, with development of moyamoya disease. Neuroradiology Journal 27(1): 23-28
Vuignier, S.; Ito, M.; Kurisu, K.; Kazumata, K.; Nakayama, N.; Shichinohe, H.; Shiga, T.; Kiss, J.Z.; Tamaki, N.; Houkin, K. 2013: Ivy sign, misery perfusion, and asymptomatic moyamoya disease: FLAIR imaging and (15)O-gas positron emission tomography. Acta Neurochirurgica 155(11): 2097-2104
Ideguchi, R.; Morikawa, M.; Enokizono, M.; Ogawa, Y.; Nagata, I.; Uetani, M. 2011: Ivy signs on FLAIR images before and after STA-MCA anastomosis in patients with Moyamoya disease. Acta Radiologica 52(3): 291-296
Mulkijanyan, K.; Novikova, Z.; Sulakvelidze, M.; Getia, M.; Mshvildadze, V.; Dekanosidze, G. 2013: Ivy water extracts as gastric ulcer preventive agents. Georgian Medical News 2013(224): 63-66
Babb, J. 2014: Iwbda 2013. Acs Synthetic Biology 3(8): 506
Stojanowski, C.M. 2014: Iwo Eleru's place among Late Pleistocene and Early Holocene populations of North and East Africa. Journal of Human Evolution 75: 80-89
Esberg, A.; Moqtaderi, Z.; Fan, X.; Lu, J.; Struhl, K.; Byström, A. 2011: Iwr1 protein is important for preinitiation complex formation by all three nuclear RNA polymerases in Saccharomyces cerevisiae. Plos one 6(6): E20829
West, C.J. 1933: Ix. Research Information Service. Science 78(2019): 203-206
Wolfenden, H.H. 1940: Ix. the Costs of Health Services-(I) the Significance and Limitations of Statistics. Canadian Medical Association Journal 43(1): 72-75
Stein, A. 2010: Ixabepilone. Clinical Journal of Oncology Nursing 14(1): 65-71
Luczyński, W.ło.; Krawczuk-Rybak, M.; Stasiak-Barmuta, A. 2008: Myeloid-derived suppressor cells - the new mechanism of immunosuppression in cancer. Postepy Higieny i Medycyny Doswiadczalnej 62(1278): 18-22
Egerton, N. 2008: Ixabepilone (ixempra), a therapeutic option for locally advanced or metastatic breast cancer. P and T: a Peer-Reviewed Journal for Formulary Management 33(9): 523-531
Fountzilas, G.; Kotoula, V.; Pectasides, D.; Kouvatseas, G.; Timotheadou, E.; Bobos, M.; Mavropoulou, X.; Papadimitriou, C.; Vrettou, E.; Raptou, G.; Koutras, A.; Razis, E.; Bafaloukos, D.; Samantas, E.; Pentheroudakis, G.; Skarlos, D.V. 2013: Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase Ii trial. Plos one 8(7): E69256
Trédan, O.; Campone, M.; Jassem, J.; Vyzula, R.; Coudert, B.; Pacilio, C.; Prausova, J.; Hardy-Bessard, A.-C.; Arance, A.; Mukhopadhyay, P.; Aloe, A.; Roché, H. 2015: Ixabepilone alone or with cetuximab as first-line treatment for advanced/metastatic triple-negative breast cancer. Clinical Breast Cancer 15(1): 8-15
Morris, P.G.; Fornier, M.N. 2009: Ixabepilone and other epothilones: microtubule-targeting agents for metastatic breast cancer. Clinical Advances in Hematology and Oncology: H&o 7(2): 115-122
Gianni, L. 2007: Ixabepilone and the narrow path to developing new cytotoxic drugs. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 25(23): 3389-3391
Bertino, E.M.; Ramaswamy, B. 2010: Ixabepilone as monotherapy or in combination for the treatment of advanced breast cancer. Breast Cancer 2: 13-23
Rak Tkaczuk, K.H. 2011: Ixabepilone as monotherapy or in combination with capecitabine for the treatment of advanced breast cancer. Breast Cancer: Basic and Clinical Research 5: 1-14
Ibrahim, N.K. 2010: Ixabepilone development across the breast cancer continuum: a paradigm shift. Cancer Management and Research 2: 169-179
Alvarez, R.H.; Valero, V.; Hortobagyi, G.N. 2011: Ixabepilone for the treatment of breast cancer. Annals of Medicine 43(6): 477-486
Denduluri, N.; Swain, S.M. 2008: Ixabepilone for the treatment of solid tumors: a review of clinical data. Expert Opinion on Investigational Drugs 17(3): 423-435
Moulder, S.L. 2008: Ixabepilone for the treatment of taxane-refractory breast cancer. Future Oncology 4(3): 333-340
Lechleider, R.J.; Kaminskas, E.; Jiang, X.; Aziz, R.; Bullock, J.; Kasliwal, R.; Harapanhalli, R.; Pope, S.; Sridhara, R.; Leighton, J.; Booth, B.; Dagher, R.; Justice, R.; Pazdur, R. 2008: Ixabepilone in combination with capecitabine and as monotherapy for treatment of advanced breast cancer refractory to previous chemotherapies. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14(14): 4378-4384
Tan, A.R.; Toppmeyer, D.L. 2008: Ixabepilone in metastatic breast cancer: complement or alternative to taxanes?. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14(21): 6725-6729
Wang, J.; Fan, Y.; Xu, B. 2010: Ixabepilone plus capecitabine for Chinese patients with metastatic breast cancer progressing after anthracycline and taxane treatment. Cancer ChemoTherapy and Pharmacology 66(3): 597-603
Fornier, M. 2010: Ixabepilone plus capecitabine for breast cancer patients with an early metastatic relapse after adjuvant chemotherapy: two clinical trials. Clinical Breast Cancer 10(5): 352-358
Thomas, E.S. 2008: Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 26(13): 2223
Jassem, J.; Fein, L.; Karwal, M.; Campone, M.; Peck, R.; Poulart, V.; Vahdat, L. 2012: Ixabepilone plus capecitabine in advanced breast cancer patients with early relapse after adjuvant anthracyclines and taxanes: a pooled subset analysis of two phase III studies. Breast 21(1): 89-94
Roché, H.; Conte, P.; Perez, E.A.; Sparano, J.A.; Xu, B.; Jassem, J.; Peck, R.; Kelleher, T.; Hortobagyi, G.N. 2011: Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies. Breast Cancer Research and Treatment 125(3): 755-765
Li, L.; Li, J.; Yang, K.; Tian, J.; Sun, T.; Jia, W.; Zhang, P.; Yi, K. 2010: Ixabepilone plus capecitabine with capecitabine alone for metastatic breast cancer. Future Oncology 6(2): 201-207
Toppmeyer, D.L.; Goodin, S. 2010: Ixabepilone, a new treatment option for metastatic breast cancer. American Journal of Clinical Oncology 33(5): 516-521
Pivot, X.; Villanueva, C.; Chaigneau, L.ïc.; Nguyen, T.; Demarchi, M.; Maurina, T.; Stein, U.; Borg, C. 2008: Ixabepilone, a novel epothilone analog in the treatment of breast cancer. Expert Opinion on Investigational Drugs 17(4): 593-599
Fornier, M.N. 2007: Ixabepilone, first in a new class of antineoplastic agents: the natural epothilones and their analogues. Clinical Breast Cancer 7(10): 757-763
Harzstark, A.L.; Rosenberg, J.E.; Weinberg, V.K.; Sharib, J.; Ryan, C.J.; Smith, D.C.; Pagliaro, L.C.; Beer, T.M.; Liu, G.; Small, E.J. 2011: Ixabepilone, mitoxantrone, and prednisone for metastatic castration-resistant prostate cancer after docetaxel-based therapy: a phase 2 study of the Department Of Defense Prostate Cancer Clinical Trials Consortium. Cancer 117(11): 2419-2425
Villanueva, C.; Vuillemin, A.T.; Demarchi, M.; Bazan, F.; Chaigneau, L.ïc.; Pivot, X. 2009: Ixabepilone: a new active chemotherapy in the treatment of breast cancer. Women's Health 5(2): 115-121
Bhushan, S.; Walko, C.M. 2008: Ixabepilone: a new antimitotic for the treatment of metastatic breast cancer. Annals of PharmacoTherapy 42(9): 1252-1261
Puhalla, S.; Brufsky, A. 2008: Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer. Biologics: Targets and Therapy 2(3): 505-515
Higa, G.M.; Abraham, J. 2008: Ixabepilone: a new microtubule-targeting agent for breast cancer. Expert Review of Anticancer Therapy 8(5): 671-681
Cobham, M.Vallee.; Donovan, D. 2009: Ixabepilone: a new treatment option for the management of taxane-resistant metastatic breast cancer. Cancer Management and Research 1: 69-77
Vahdat, L. 2008: Ixabepilone: a novel antineoplastic agent with low susceptibility to multiple tumor resistance mechanisms. Oncologist 13(3): 214-221
Steinberg, M. 2008: Ixabepilone: a novel microtubule inhibitor for the treatment of locally advanced or metastatic breast cancer. Clinical Therapeutics 30(9): 1590-1617
Goodin, S. 2008: Ixabepilone: a novel microtubule-stabilizing agent for the treatment of metastatic breast cancer. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 65(21): 2017-2026
Denduluri, N.; Swain, S. 2011: Ixabepilone: clinical role in metastatic breast cancer. Clinical Breast Cancer 11(3): 139-145
Moen, M.D. 2009: Ixabepilone: in locally advanced or metastatic breast cancer. Drugs 69(11): 1471-1481
Anonymous 2009: Ixabepilone: new drug. Similar to taxanes, but no better. Prescrire International 18(102): 160
Dumontet, C.; Jordan, M.Ann.; Lee, F.F.Y. 2009: Ixabepilone: targeting betaIII-tubulin expression in taxane-resistant malignancies. Molecular Cancer Therapeutics 8(1): 17-25
Nakamura, K.; Chung, S-Wen.; Kono, Y.; Ho, M-Jung.; Hsu, T-Chuan.; Peng, C-I. 2014: Ixeridium calcicola (Compositae), a new limestone endemic from Taiwan, with notes on its atypical basic chromosome number, phylogenetic affinities, and a limestone refugium hypothesis. Plos one 9(10): E109797
Kim, D-Seung.; Ko, J-Ho.; Jeon, Y-Deok.; Han, Y-Han.; Kim, H-Ju.; Poudel, A.; Jung, H-Ju.; Ku, S-Kwang.; Kim, S-Jin.; Park, S-Hyun.; Park, J-Han.; Choi, B-Min.; Park, S-Joo.; Um, J-Young.; Hong, S-Heon. 2013: Ixeris dentata NAKAI Reduces Clinical Score and HIF-1 Expression in Experimental Colitis in Mice. Evidence-Based Complementary and Alternative Medicine: Ecam 2013: 671281
Lee, M.-R.; Lee, H.-Y.; Lee, G.-H.; Kim, H.-K.; Kim, N.-Y.; Kim, S.H.; Kim, H.-R.; Chae, H.-J. 2014: Ixeris dentata decreases ER stress and hepatic lipid accumulation through regulation of ApoB secretion. American Journal of Chinese Medicine 42(3): 639-649
Lee, H.-Y.; Lee, G.-H.; Kim, H.-K.; Kim, S.H.; Park, K.p.; Chae, H.-J.; Kim, H.-R. 2013: Ixeris dentata-induced regulation of amylase synthesis and secretion in glucose-treated human salivary gland cells. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 62: 739-749
Lin, Y.-C.; Hu, S.-J.; Xu, D.-L.; Zheng, G.-S. 2007: Ixeris sonchifolia induced vasoconstriction effect and its mechanism in rat thoracic aorta. Zhongguo Zhong Yao Za Zhi 32(23): 2504-2508
Jelinek, T. 2009: Ixiaro: a new vaccine against Japanese encephalitis. Expert Review of Vaccines 8(11): 1501-1511
Ledford, K.J.; Zeigler, F.; Bartel, R.L. 2013: Ixmyelocel-T, an expanded multicellular therapy, contains a unique population of M2-like macrophages. Stem Cell Research and Therapy 4(6): 134
Nadolny, R.M.; Wright, C.L.; Hynes, W.L.; Sonenshine, D.E.; Gaff, H.D. 2011: Ixodes affinis (Acari: Ixodidae) in southeastern Virginia and implications for the spread of Borrelia burgdorferi, the agent of Lyme disease. Journal of Vector Ecology: Journal of the Society for Vector Ecology 36(2): 464-467
Nowak-Chmura, M. 2012: Ixodes eldaricus Djaparidze, 1950 (Ixodidae) on migrating birds--reported first time in Poland. Veterinary Parasitology 186(3-4): 399-402
Banyard, M. 2013: Ixodes holocyclus in cooler climate regions. Australian Veterinary Journal 91(8): N26
Munderloh, U.G.; Silverman, D.J.; MacNamara, K.C.; Ahlstrand, G.G.; Chatterjee, M.; Winslow, G.M. 2009: Ixodes ovatus Ehrlichia exhibits unique ultrastructural characteristics in mammalian endothelial and tick-derived cells. Annals of the new York Academy of Sciences 1166: 112-119
Kurlovs, A.H.; Li, J.; Cheng, D.; Zhong, J. 2014: Ixodes pacificus ticks maintain embryogenesis and egg hatching after antibiotic treatment of Rickettsia endosymbiont. Plos one 9(8): E104815
Pangrácová, L.; Derdáková, M.ét.; Pekárik, L.; Hviščová, I.; Víchová, B.; Stanko, M.; Hlavatá, H.; Peťko, B. 2013: Ixodes ricinus abundance and its infection with the tick-borne pathogens in urban and suburban areas of Eastern Slovakia. Parasites and Vectors 6(1): 238
Hvidsten, D.; Stuen, S.; Jenkins, A.; Dienus, O.; Olsen, R.S.; Kristiansen, B.ør.-E.; Mehl, R.; Matussek, A. 2014: Ixodes ricinus and Borrelia prevalence at the Arctic Circle in Norway. Ticks and Tick-Borne Diseases 5(2): 107-112
Burri, C.; Moran Cadenas, F.; Douet, V.; Moret, J.; Gern, L. 2007: Ixodes ricinus density and infection prevalence of Borrelia burgdorferi sensu lato along a North-facing altitudinal gradient in the Rhône Valley (Switzerland). Vector Borne and Zoonotic Diseases 7(1): 50-58
Handeland, K.; Qviller, L.; Vikøren, T.; Viljugrein, H.; Lillehaug, A.; Davidson, R.K. 2013: Ixodes ricinus infestation in free-ranging cervids in Norway--a study based upon ear examinations of hunted animals. Veterinary Parasitology 195(1-2): 142-149
Harrison, A.; Bown, K.J.; Montgomery, W.I.; Birtles, R.J. 2012: Ixodes ricinus is not an epidemiologically relevant vector of Bartonella species in the wood mouse (Apodemus sylvaticus). Vector Borne and Zoonotic Diseases 12(5): 366-371
Beaufays, J.ér.ôm.; Adam, B.ît.; Decrem, Y.; Prévôt, P.-P.; Santini, S.éb.; Brasseur, R.; Brossard, M.; Lins, L.; Vanhamme, L.; Godfroid, E. 2008: Ixodes ricinus tick lipocalins: identification, cloning, phylogenetic analysis and biochemical characterization. Plos one 3(12): E3941
Fialová, A.; Cimburek, Z.; Iezzi, G.; Kopecký, J. 2010: Ixodes ricinus tick saliva modulates tick-borne encephalitis virus infection of dendritic cells. Microbes and Infection 12(7): 580-585
Kiewra, D.; Stańczak, J.; Richter, M. 2014: Ixodes ricinus ticks (Acari, Ixodidae) as a vector of Borrelia burgdorferi sensu lato and Borrelia miyamotoi in Lower Silesia, Poland--preliminary study. Ticks and Tick-Borne Diseases 5(6): 892-897
Coipan, E.C.; Vladimirescu, A.F. 2011: Ixodes ricinus ticks (Acari: Ixodidae): vectors for Lyme disease spirochetes in Romania. Experimental and Applied Acarology 54(3): 293-300
Sprong, H.; Wielinga, P.R.; Fonville, M.; Reusken, C.; Brandenburg, A.H.; Borgsteede, F.; Gaasenbeek, C.; van der Giessen, J.W. 2009: Ixodes ricinus ticks are reservoir hosts for Rickettsia helvetica and potentially carry flea-borne Rickettsia species. Parasites and Vectors 2(1): 41
Wilhelmsson, P.; Lindblom, P.; Fryland, L.; Nyman, D.; Jaenson, T.G.T.; Forsberg, P.; Lindgren, P.-E. 2013: Ixodes ricinus ticks removed from humans in Northern Europe: seasonal pattern of infestation, attachment sites and duration of feeding. Parasites and Vectors 6: 362
Criado, P.R.; Criado, R.F.J. 2010: Ixodiasis disclosed by epiluminescence microscopy without skin contact. Anais Brasileiros de Dermatologia 85(3): 389-390
Kwak, Y.S.; Kim, T.Y.; Nam, S.-H.; Lee, I.-Y.; Kim, H.-P.; Mduma, S.; Keyyu, J.; Fyumagwa, R.; Yong, T.-S. 2014: Ixodid tick infestation in cattle and wild animals in Maswa and Iringa, Tanzania. Korean Journal of Parasitology 52(5): 565-568
Hajnická, V.; Vančová-Štibrániová, I.; Slovák, M.; Kocáková, P.ín.; Nuttall, P.A. 2011: Ixodid tick salivary gland products target host wound healing growth factors. International Journal for Parasitology 41(2): 213-223
Bursali, A.; Tekin, S.; Orhan, M.; Keskin, A.; Ozkan, M. 2010: Ixodid ticks (Acari: Ixodidae) infesting humans in Tokat Province of Turkey: species diversity and seasonal activity. Journal of Vector Ecology: Journal of the Society for Vector Ecology 35(1): 180-186
Sanders, D.M.; Schuster, A.L.; McCardle, P.W.; Strey, O.F.; Blankenship, T.L.; Teel, P.D. 2013: Ixodid ticks associated with feral swine in Texas. Journal of Vector Ecology: Journal of the Society for Vector Ecology 38(2): 361-373
Omeragic, J. 2011: Ixodid ticks in Bosnia and Herzegovina. Experimental and Applied Acarology 53(3): 301-309
Hove, T.; Mukandi, R.; Bere, M.; Horak, I.G.; Latif, A.A. 2008: Ixodid ticks infesting domestic goats in communal land areas of Zimbabwe. Journal of the South African Veterinary Association 79(3): 116-120
Matthee, S.; Lovely, C.; Gaugler, A.; Beeker, R.; Venter, H.R.; Horak, I.G. 2010: Ixodid ticks on domestic dogs in the Northern Cape Province of South Africa and in Namibia. Journal of the South African Veterinary Association 81(2): 126-128
Kumsa, B.E.; Mekonnen, S. 2011: Ixodid ticks, fleas and lice infesting dogs and cats in Hawassa, southern Ethiopia. Onderstepoort Journal of Veterinary Research 78(1): 326
Mirzaei, M.; Khedri, J. 2014: Ixodidae ticks in cattle and sheep in Sistan and Baluchestan Province (Iran). Veterinaria Italiana 50(1): 65-68
Carneiro-Lobo, T.C.; Konig, S.; Machado, D.E.; Nasciutti, L.E.; Forni, M.F.; Francischetti, I.M.B.; Sogayar, M.C.; Monteiro, R.Q. 2009: Ixolaris, a tissue factor inhibitor, blocks primary tumor growth and angiogenesis in a glioblastoma model. Journal of Thrombosis and Haemostasis: Jth 7(11): 1855-1864
Upadhyay, A.; Chattopadhyay, P.; Goyary, D.; Mitra Mazumder, P.; Veer, V. 2014: Ixora coccinea Enhances Cutaneous Wound Healing by Upregulating the Expression of Collagen and Basic Fibroblast Growth Factor. Isrn Pharmacology 2014: 751824
Baliga, M.S.; Kurian, P.J. 2012: Ixora coccinea Linn.: traditional uses, phytochemistry and pharmacology. Chinese Journal of Integrative Medicine 18(1): 72-79
Wen, K-Ching.; Fan, P-Ching.; Tsai, S-Yuan.; Shih, I-Chen.; Chiang, H-Mei. 2012: Ixora parviflora Protects against UVB-Induced Photoaging by Inhibiting the Expression of MMPs, MAP Kinases, and COX-2 and by Promoting Type I Procollagen Synthesis. Evidence-BasedComplementaryandAlternativeMedicine:Ecam 2012: 417346
Lee, C.-L.; Liao, Y.-C.; Hwang, T.-L.; Wu, C.-C.; Chang, F.-R.; Wu, Y.-C. 2010: Ixorapeptide i and ixorapeptide II, bioactive peptides isolated from Ixora coccinea. Bioorganic and Medicinal Chemistry Letters 20(24): 7354-7357
Versiani, M.A.; Ikram, A.; Khalid, S.; Faizi, S.; Tahiri, I.A. 2012: Ixoroid: a new triterpenoid from the flowers of Ixora coccinea. Natural Product Communications 7(7): 831-834
Tsaponina, O.; Barsoum, E.; Aström, S.U.; Chabes, A. 2011: Ixr1 is required for the expression of the ribonucleotide reductase Rnr1 and maintenance of dNTP pools. Plos Genetics 7(5): E1002061
Vizoso-Vázquez, A.; Lamas-Maceiras, Mónica.; Becerra, M.; González-Siso, M.Isabel.; Rodríguez-Belmonte, E.; Cerdán, M.Esperanza. 2012: Ixr1p and the control of the Saccharomyces cerevisiae hypoxic response. Applied Microbiology and Biotechnology 94(1): 173-184
Castro-Prego, R.; Lamas-Maceiras, M.ón.; Soengas, P.; Fernández-Leiro, R.; Carneiro, I.; Becerra, M.; González-Siso, M.ía.I.; Cerdán, M.ía.E. 2010: Ixr1p regulates oxygen-dependent HEM13 transcription. Fems Yeast Research 10(3): 309-321
Cohen, D.L.; Bloedon, L.T.; Rothman, R.L.; Farrar, J.T.; Galantino, M.Lou.; Volger, S.; Mayor, C.; Szapary, P.O.; Townsend, R.R. 2011: Iyengar Yoga versus Enhanced Usual Care on Blood Pressure in Patients with Prehypertension to Stage I Hypertension: a Randomized Controlled Trial. Evidence-BasedComplementaryandAlternativeMedicine:Ecam 2011: 546428
Evans, S.; Sternlieb, B.; Zeltzer, L.; Tsao, J. 2013: Iyengar yoga and the use of props for pediatric chronic pain: a case study. Alternative Therapies in Health and Medicine 19(5): 66-70
Evans, S.; Lung, K.C.; Seidman, L.C.; Sternlieb, B.; Zeltzer, L.K.; Tsao, J.C.I. 2014: Iyengar yoga for adolescents and young adults with irritable bowel syndrome. Journal of Pediatric Gastroenterology and Nutrition 59(2): 244-253
Michalsen, A.; Jeitler, M.; Brunnhuber, S.; Lüdtke, R.; Büssing, A.; Musial, F.; Dobos, G.; Kessler, C. 2012: Iyengar yoga for distressed women: a 3-armed randomized controlled trial. Evidence-Based Complementary and Alternative Medicine: Ecam 2012: 408727
Evans, S.; Moieni, M.; Taub, R.; Subramanian, S.K.; Tsao, J.C.I.; Sternlieb, B.; Zeltzer, L.K. 2010: Iyengar yoga for young adults with rheumatoid arthritis: results from a mixed-methods pilot study. Journal of Pain and Symptom Management 39(5): 904-913
Khattab, K.; Khattab, A.A.; Ortak, J.; Richardt, G.; Bonnemeier, H. 2007: Iyengar yoga increases cardiac parasympathetic nervous modulation among healthy yoga practitioners. Evidence-Based Complementary and Alternative Medicine: Ecam 4(4): 511-517
Ribeiro, S. 2014: Iyengar yoga therapy as an intervention for cramp management in individuals with amyotrophic lateral sclerosis: three case reports. Journal of Alternative and Complementary Medicine 20(4): 322-326
Dos Santos, I.; dos Santos, I. 2007: Izabel dos Santos: a history inside Brazilian nursing history. Revista da Escola de Enfermagem da U S P 41(Special Issue): 853-858
Yuan, Y.; Tan, Y.-F.; Xu, P.; Li, H.; Li, Y.-H.; Chen, W.-Y.; Zhang, J.-Q.; Chen, F.; Huang, G.-J. 2014: Izalpinin from fruits of Alpinia oxyphylla with antagonistic activity against the rat bladder contractility. African Journal of Traditional Complementary and Alternative Medicines: Ajtcam 11(4): 120-125
Binbay, T.; Elbi, H.; Alptekin, K.ök.; Aksu Tanık, F.; Drukker, M.; Onay, H.üs.; Özkınay, F.; Zağlı, N.; Van Os, J. 2011: Izmir mental health survey for gene-environment interaction in psychoses (TürkSch): objectives and methodology. Turk Psikiyatri Dergisi 22(2): 65-76
Abdelfattah, M.S.; Toume, K.; Ishibashi, M. 2011: Izumiphenazine D, a new phenazoquinoline N-oxide from Streptomyces sp. IFM 11204. Chemical and Pharmaceutical Bulletin 59(4): 508-510
Abdelfattah, M.S.; Kazufumi, T.; Ishibashi, M. 2010: Izumiphenazines A-C: isolation and structure elucidation of phenazine derivatives from Streptomyces sp. IFM 11204. Journal of Natural Products 73(12): 1999-2002
Ellerman, D.A.; Pei, J.; Gupta, S.; Snell, W.J.; Myles, D.; Primakoff, P. 2009: Izumo is part of a multiprotein family whose members form large complexes on mammalian sperm. Molecular Reproduction and Development 76(12): 1188-1199
Bianchi, E.; Wright, G.J. 2014: Izumo meets Juno: preventing polyspermy in fertilization. Cell Cycle 13(13): 2019-2020
Kierzek, A.; Kuciel-Lewandowska, J.; Pozowski, A.; Paprocka-Borowicz, Młgorzata.; Rej, M.; Nahumowicz, I. 2010: Izydor Nahumowicz (1800-1842) and his work on the salt springs of Druskininkai. Annales Academiae Medicae Stetinensis 56(3): 144-150
Cheng, A.; Guo, J.; Henderson-Jackson, E.; Kim, D.; Malafa, M.; Coppola, D. 2011: IκB Kinase ε expression in pancreatic ductal adenocarcinoma. American Journal of Clinical Pathology 136(1): 60-66
Peschke, K.; Weitzmann, A.; Heger, K.; Behrendt, R.; Schubert, N.; Scholten, J.; Voehringer, D.; Hartmann, K.; Dudeck, A.; Schmidt-Supprian, M.; Roers, A. 2014: IκB kinase 2 is essential for IgE-induced mast cell de novo cytokine production but not for degranulation. Cell Reports 8(5): 1300-1307
Roget, K.; Ben-Addi, A.; Mambole-Dema, A.; Gantke, T.; Yang, H.-T.; Janzen, J.; Morrice, N.; Abbott, D.; Ley, S.C. 2012: IκB kinase 2 regulates TPL-2 activation of extracellular signal-regulated kinases 1 and 2 by direct phosphorylation of TPL-2 serine 400. Molecular and Cellular Biology 32(22): 4684-4690
Stouch, A.N.; Zaynagetdinov, R.; Barham, W.J.; Stinnett, A.M.; Slaughter, J.C.; Yull, F.E.; Hoffman, H.M.; Blackwell, T.S.; Prince, L.S. 2014: IκB kinase activity drives fetal lung macrophage maturation along a non-M1/M2 paradigm. Journal of Immunology 193(3): 1184-1193
Liu, S.; Chen, Z.; Zhu, F.; Hu, Y. 2012: IκB kinase alpha and cancer. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 32(4): 152-158
Chen, N.; Debnath, J. 2013: IκB kinase complex (IKK) triggers detachment-induced autophagy in mammary epithelial cells independently of the PI3K-AKT-MTORC1 pathway. Autophagy 9(8): 1214-1227
Ng, S.-L.; Friedman, B.A.; Schmid, S.; Gertz, J.; Myers, R.M.; Tenoever, B.R.; Maniatis, T. 2011: IκB kinase epsilon (IKK(epsilon)) regulates the balance between type i and type Ii interferon responses. Proceedings of the National Academy of Sciences of the United States of America 108(52): 21170-21175
Sanada, Y.; Kumoto, T.; Suehiro, H.; Yamamoto, T.; Nishimura, F.; Kato, N.; Yanaka, N. 2014: IκB kinase epsilon expression in adipocytes is upregulated by interaction with macrophages. Bioscience Biotechnology and Biochemistry 78(8): 1357-1362
Chapuis, N.; Park, S.; Leotoing, L.; Tamburini, J.; Verdier, F.; Bardet, V.; Green, A.S.; Willems, L.; Agou, F.; Ifrah, N.; Dreyfus, F.ço.; Bismuth, G.; Baud, V.; Lacombe, C.; Mayeux, P.; Bouscary, D. 2010: IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia. Blood 116(20): 4240-4250
Karim, Z.A.; Zhang, J.; Banerjee, M.; Chicka, M.C.; Al Hawas, R.; Hamilton, T.R.; Roche, P.A.; Whiteheart, S.W. 2013: IκB kinase phosphorylation of SNAP-23 controls platelet secretion. Blood 121(22): 4567-4574
Christoffel, D.J.; Golden, S.A.; Dumitriu, D.; Robison, A.J.; Janssen, W.G.; Ahn, H.F.; Krishnan, V.; Reyes, C.M.; Han, M.-H.; Ables, J.L.; Eisch, A.J.; Dietz, D.M.; Ferguson, D.; Neve, R.L.; Greengard, P.; Kim, Y.; Morrison, J.H.; Russo, S.J. 2011: IκB kinase regulates social defeat stress-induced synaptic and behavioral plasticity. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 31(1): 314-321
Marinis, J.M.; Hutti, J.E.; Homer, C.R.; Cobb, B.A.; Cantley, L.C.; McDonald, C.; Abbott, D.W. 2012: IκB kinase α phosphorylation of TRAF4 downregulates innate immune signaling. Molecular and Cellular Biology 32(13): 2479-2489
Kai, X.; Chellappa, V.; Donado, C.; Reyon, D.; Sekigami, Y.; Ataca, D.; Louissaint, A.; Mattoo, H.; Joung, J.K.; Pillai, S. 2014: IκB kinase β (IKBKB) mutations in lymphomas that constitutively activate canonical nuclear factor κB (NFκB) signaling. Journal of Biological Chemistry 289(39): 26960-26972
Lancaster, G.I.; Skiba, B.; Yang, C.; Nicholls, H.T.; Langley, K.G.; Chan, M.H.Stanley.; Bruce, C.R.; Rewcastle, G.W.; Shepherd, P.R.; Karin, M.; Febbraio, M.A. 2012: IκB kinase β (IKKβ) does not mediate feedback inhibition of the insulin signalling cascade. Biochemical Journal 442(3): 723-732
Liao, J.-M.; Zhang, Y.; Liao, W.; Zeng, S.X.; Su, X.; Flores, E.R.; Lu, H. 2013: IκB kinase β (IKKβ) inhibits p63 isoform γ (TAp63γ) transcriptional activity. Journal of Biological Chemistry 288(25): 18184-18193
Ogawa, H.; Azuma, M.; Muto, S.; Nishioka, Y.; Honjo, A.; Tezuka, T.; Uehara, H.; Izumi, K.; Itai, A.; Sone, S. 2011: IκB kinase β inhibitor IMD-0354 suppresses airway remodelling in a Dermatophagoides pteronyssinus-sensitized mouse model of chronic asthma. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 41(1): 104-115
Lupino, E.; Ramondetti, C.; Piccinini, M. 2012: IκB kinase β is required for activation of NF-κB and AP-1 in CD3/CD28-stimulated primary CD4(+) T cells. Journal of Immunology 188(6): 2545-2555
Chen, L.; Meng, Q.; Kao, W.; Xia, Y. 2011: IκB kinase β regulates epithelium migration during corneal wound healing. Plos one 6(1): E16132
Kim, H.-J.; Kim, J.-G.; Moon, M.-Y.; Park, S.-H.; Park, J.-B. 2014: IκB kinase γ/nuclear factor-κB-essential modulator (IKKγ/NEMO) facilitates RhoA GTPase activation, which, in turn, activates Rho-associated KINASE (ROCK) to phosphorylate IKKβ in response to transforming growth factor (TGF)-β1. Journal of Biological Chemistry 289(3): 1429-1440
Verhelst, K.; Verstrepen, L.; Carpentier, I.; Beyaert, R. 2013: IκB kinase ε (IKKε): a therapeutic target in inflammation and cancer. Biochemical Pharmacology 85(7): 873-880
Shen, R.R.; Zhou, A.Y.; Kim, E.; Lim, E.; Habelhah, H.; Hahn, W.C. 2012: IκB kinase ε phosphorylates TRAF2 to promote mammary epithelial cell transformation. Molecular and Cellular Biology 32(23): 4756-4768
Sgarbanti, M.; Marsili, G.; Remoli, A.L.; Stellacci, E.; Mai, A.; Rotili, D.; Perrotti, E.; Acchioni, C.; Orsatti, R.; Iraci, N.; Ferrari, M.; Borsetti, A.; Hiscott, J.; Battistini, A. 2014: IκB kinase ε targets interferon regulatory factor 1 in activated T lymphocytes. Molecular and Cellular Biology 34(6): 1054-1065
Nakhaei, P.; Sun, Q.; Solis, M.; Mesplede, T.; Bonneil, E.; Paz, S.; Lin, R.; Hiscott, J. 2012: IκB kinase ε-dependent phosphorylation and degradation of X-linked inhibitor of apoptosis sensitizes cells to virus-induced apoptosis. Journal of Virology 86(2): 726-737
Wei, J.; Shi, M.; Wu, W.-Q.; Xu, H.; Wang, T.; Wang, N.; Ma, J.-L.; Wang, Y.-G. 2011: IκB kinase-beta inhibitor attenuates hepatic fibrosis in mice. World Journal of Gastroenterology 17(47): 5203-5213
Ben-Addi, A.; Mambole-Dema, A.; Brender, C.; Martin, S.R.; Janzen, J.; Kjaer, S.; Smerdon, S.J.; Ley, S.C. 2014: IκB kinase-induced interaction of TPL-2 kinase with 14-3-3 is essential for Toll-like receptor activation of ERK-1 and -2 MAP kinases. Proceedings of the National Academy of Sciences of the United States of America 111(23): E2394-E2403
Lennikov, A.; Hiraoka, M.; Abe, A.; Ohno, S.; Fujikawa, T.; Itai, A.; Ohguro, H. 2014: IκB kinase-β inhibitor IMD-0354 beneficially suppresses retinal vascular permeability in streptozotocin-induced diabetic mice. Investigative Ophthalmology and Visual Science 55(10): 6365-6373
Schmeisser, M.J.; Baumann, B.; Johannsen, S.; Vindedal, G.F.; Jensen, V.; Hvalby, Øi.C.; Sprengel, R.; Seither, J.; Maqbool, A.; Magnutzki, A.; Lattke, M.; Oswald, F.; Boeckers, T.M.; Wirth, T. 2012: IκB kinase/nuclear factor κB-dependent insulin-like growth factor 2 (Igf2) expression regulates synapse formation and spine maturation via Igf2 receptor signaling. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 32(16): 5688-5703
Yeh, P.-Y.; Lu, Y.-S.; Ou, D.-L.; Cheng, A.-L. 2011: IκB kinases increase Myc protein stability and enhance progression of breast cancer cells. Molecular Cancer 10: 53
Jain, G.; Voogdt, C.; Tobias, A.; Spindler, K.-D.; Möller, P.; Cronauer, M.V.; Marienfeld, R.B. 2012: IκB kinases modulate the activity of the androgen receptor in prostate carcinoma cell lines. Neoplasia 14(3): 178-189
Péant, B.; Forest, V.ér.; Trudeau, V.; Latour, M.; Mes-Masson, A.-M.; Saad, F. 2011: IκB-Kinase-ε (IKKε/IKKi/IκBKε) expression and localization in prostate cancer tissues. Prostate 71(10): 1131-1138
Nogai, H.; Wenzel, S.ör.-S.; Hailfinger, S.; Grau, M.; Kaergel, E.; Seitz, V.; Wollert-Wulf, B.; Pfeifer, M.; Wolf, A.; Frick, M.; Dietze, K.; Madle, H.; Tzankov, A.; Hummel, M.; Dörken, B.; Scheidereit, C.; Janz, M.; Lenz, P.; Thome, M.; Lenz, G. 2013: IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL. Blood 122(13): 2242-2250
Brendecke, S.M.; Prinz, M. 2013: IκB-ζ deficiency leaves epithelial cells high and dry. Immunity 38(3): 404-406
Seufert, B.L.; Poole, E.M.; Whitton, J.; Xiao, L.; Makar, K.W.; Campbell, P.T.; Kulmacz, R.J.; Baron, J.A.; Newcomb, P.A.; Slattery, M.L.; Potter, J.D.; Ulrich, C.M. 2013: IκBKβ and NFκB1, NSAID use and risk of colorectal cancer in the Colon Cancer Family Registry. Carcinogenesis 34(1): 79-85
Niida, T.; Isoda, K.; Kitagaki, M.; Ishigami, N.; Adachi, T.; Matsubara, O.; Takeda, K.; Kishimoto, T.; Ohsuzu, F. 2012: IκBNS regulates interleukin-6 production and inhibits neointimal formation after vascular injury in mice. Cardiovascular Research 93(2): 371-379
Mulero, M.C.; Bigas, A.; Espinosa, L.ís. 2013: IκBα beyond the NF-kB dogma. Oncotarget 4(10): 1550-1551
Lian, H.; Shim, D.J.; Gaddam, S.S.K.; Rodriguez-Rivera, J.; Bitner, B.R.; Pautler, R.G.; Robertson, C.S.; Zheng, H. 2012: IκBα deficiency in brain leads to elevated basal neuroinflammation and attenuated response following traumatic brain injury: implications for functional recovery. Molecular Neurodegeneration 7: 47
Hain, B.A.; Dodd, S.L.; Judge, A.R. 2011: IκBα degradation is necessary for skeletal muscle atrophy associated with contractile claudication. American Journal of Physiology. Regulatory Integrative and Comparative Physiology 300(3): R595-R604
Seidel, P.; Roth, M.; Ge, Q.; Merfort, I.; S'ng, C.T.; Ammit, A.J. 2011: IκBα glutathionylation and reduced histone H3 phosphorylation inhibit eotaxin and RANTES. European Respiratory Journal 38(6): 1444-1452
Buffington, S.A.; Sobotzik, J.ür.M.; Schultz, C.; Rasband, M.N. 2012: IκBα is not required for axon initial segment assembly. Molecular and Cellular Neurosciences 50(1): 1-9
Wang, S.; Zhang, M.; Zeng, Z.; Tian, L.; Wu, K.; Chu, J.; Fan, D.; Hu, P.; Sung, J.J.Y.; Yu, J. 2011: IκBα polymorphisms were associated with increased risk of gastric cancer in a southern Chinese population: a case-control study. Life Sciences 88(17-18): 792-797
Xu, S.; Zhi, H.; Hou, X.; Cohen, R.A.; Jiang, B. 2011: IκBβ attenuates angiotensin II-induced cardiovascular inflammation and fibrosis in mice. Hypertension 58(2): 310-316
Michaelis, K.A.; Agboke, F.; Liu, T.; Han, K.; Muthu, M.; Galambos, C.; Yang, G.; Dennery, P.A.; Wright, C.J. 2014: IκBβ-mediated NF-κB activation confers protection against hyperoxic lung injury. American Journal of Respiratory Cell and Molecular Biology 50(2): 429-438
Alves, B.N.; Tsui, R.; Almaden, J.; Shokhirev, M.N.; Davis-Turak, J.; Fujimoto, J.; Birnbaum, H.; Ponomarenko, J.; Hoffmann, A. 2014: IκBε is a key regulator of B cell expansion by providing negative feedback on cRel and RelA in a stimulus-specific manner. Journal of Immunology 192(7): 3121-3132
Kannan, Y.; Yu, J.; Raices, R.M.; Seshadri, S.; Wei, M.; Caligiuri, M.A.; Wewers, M.D. 2011: IκBζ augments IL-12- and IL-18-mediated IFN-γ production in human NK cells. Blood 117(10): 2855-2863
Alexander, E.; Hildebrand, D.G.; Kriebs, A.; Obermayer, K.; Manz, M.; Rothfuss, O.; Schulze-Osthoff, K.; Essmann, F. 2013: IκBζ is a regulator of the senescence-associated secretory phenotype in DNA damage- and oncogene-induced senescence. Journal of Cell Science 126(Part 16): 3738-3745
Hildebrand, D.G.; Alexander, E.; Hörber, S.; Lehle, S.; Obermayer, K.; Münck, N.-A.; Rothfuss, O.; Frick, J.-S.; Morimatsu, M.; Schmitz, I.; Roth, J.; Ehrchen, J.M.; Essmann, F.; Schulze-Osthoff, K. 2013: IκBζ is a transcriptional key regulator of CCL2/MCP-1. Journal of Immunology 190(9): 4812-4820
Miyake, T.; Satoh, T.; Kato, H.; Matsushita, K.; Kumagai, Y.; Vandenbon, A.; Tani, T.; Muta, T.; Akira, S.; Takeuchi, O. 2010: IκBζ is essential for natural killer cell activation in response to IL-12 and IL-18. Proceedings of the National Academy of Sciences of the United States of America 107(41): 17680-17685
Pazarentzos, E.; Mahul-Mellier, A-Laure.; Datler, C.; Chaisaklert, W.; Hwang, M-Shih.; Kroon, J.; Qize, D.; Osborne, F.; Al-Rubaish, A.; Al-Ali, A.; Mazarakis, N.D.; Aboagye, E.O.; Grimm, S. 2014: IκΒα inhibits apoptosis at the outer mitochondrial membrane independently of NF-κB retention. EMBO Journal 33(23): 2814-2828
Yuan, J.; Ma, X.; Yi, H.; Liu, C.; Lei, A. 2014: I₂-catalyzed oxidative C(sp³)-H/S-H coupling: utilizing alkanes and mercaptans as the nucleophiles. Chemical Communications 50(92): 14386-14389
White, C.C. 1950: J and L Transformer. Canadian Medical Association Journal 62(2): 203
Faccioli, P.; Lourenço, C.; Seixas, J.ão.; Wöhri, H.K. 2009: J / psi polarization from fixed-target to collider energies. Physical Review Letters 102(15): 151802
Vucković-Dekić, L.; Radulović, S. 2007: J BUON and important biomedical databases. Journal of BUON: Official Journal of the Balkan Union of Oncology 12(1): 133
Gopikrishna, V. 2012: J Conserv Dent: BI-MONTHLY from 2013. Journal of Conservative Dentistry: Jcd 15(4): 309
Pandey, S.K.; Sharma, V.; O'Day, D.M.; Billson, F.A.; Gass, J.D.M. 2011: J Donald M Gass MD: father of macular diseases, and one of the ten most influential ophthalmologists of the 20th century. Clinical and Experimental Ophthalmology 39(8): 828-831
Mueen, A.K. 2011: J Young Pharm. 2011: what are we aiming at?. Journal of Young Pharmacists: Jyp 3(1): 1-3
Gopikrishna, V. 2011: J conserv dent - citius, altius, fortius…. Journal of Conservative Dentistry: Jcd 14(2): 97
Slany, J. 2013: J curve: when lowering blood pressure becomes a hazard?. Der Internist 54(3): 376-382
Sentürk, T.; Ozbek, C.; Tolga, D.; Kazazoğlu, A.R. 2013: J deflections on ECG in severe hypothermia and hypokalaemia: a case report. Netherlands Heart Journal: Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 21(2): 106-108
Vembar, S.S.; Jonikas, M.C.; Hendershot, L.M.; Weissman, J.S.; Brodsky, J.L. 2010: J domain co-chaperone specificity defines the role of BiP during protein translocation. Journal of Biological Chemistry 285(29): 22484-22494
Matoshvili, Z.; Petriashvili, S.; Archvadze, A.; Azaladze, I. 2014: J point elevation as a predictor of premature ventricular beats. Georgian Medical News 226: 16-18
Koutras, C.; Braun, J.E.A. 2014: J protein mutations and resulting proteostasis collapse. Frontiers in Cellular Neuroscience 8: 191
Clavijo-Alvarez, J.A.; Hurwitz, D.J. 2012: J torsoplasty: a novel approach to avoid circumferential scars of the upper body lift. Plastic and Reconstructive Surgery 130(2): 382e-383e
Shimizu, M.; Nishizaki, M.; Yamawake, N.; Fujii, H.; Sakurada, H.; Isobe, M.; Hiraoka, M. 2014: J wave and fragmented QRS formation during the hyperacute phase in Takotsubo cardiomyopathy. Circulation Journal: Official Journal of the Japanese Circulation Society 78(4): 943-949
Sacher, F.; Derval, N.; Horlitz, M.; Haïssaguerre, M. 2014: J wave elevation to monitor quinidine efficacy in early repolarization syndrome. Journal of Electrocardiology 47(2): 223-225
Pasquier, M.; Pasquier, J.; Vallotton, L. 2011: J wave in hypothermia. Journal of Trauma 71(4): E99
Fukushima Kusano, K. 2014: J wave monitoring and drug efficacy in Brugada syndrome. Internal Medicine 53(14): 1459-1460
Yong, C.M.; Zarafshar, S.; Froelicher, V. 2013: J wave patterns and ST elevation in women. Journal of Electrocardiology 46(5): 417-423
Perez, M.V.; Froelicher, V. 2013: J wave patterns and their prognostic value in African Americans. Journal of Electrocardiology 46(5): 442-445
Macfarlane, P.W.; Clark, E.N.; Heng, J.S. 2013: J wave patterns--morphology, prevalence and nomenclature. Journal of Electrocardiology 46(6): 505-509
Antzelevitch, C. 2013: J wave syndromes: molecular and cellular mechanisms. Journal of Electrocardiology 46(6): 510-518
Cappato, R.; Furlanello, F.; Giovinazzo, V.; Infusino, T.; Lupo, P.; Pittalis, M.; Foresti, S.; De Ambroggi, G.; Ali, H.; Bianco, E.; Riccamboni, R.; Butera, G.; Ricci, C.; Ranucci, M.; Pelliccia, A.; De Ambroggi, L. 2010: J wave, QRS slurring, and ST elevation in athletes with cardiac arrest in the absence of heart disease: marker of risk or innocent bystander?. CIRCULATION. Arrhythmia and Electrophysiology 3(4): 305-311
Rosso, R.; Halkin, A.; Viskin, S. 2012: J waves and early repolarization: do not confuse me with the facts!. Heart Rhythm 9(10): 1603-1604
Higuchi, S.; Takahashi, T.; Kabeya, Y.; Hasegawa, T.; Nakagawa, S.; Mitamura, H. 2014: J waves in accidental hypothermia. Circulation Journal: Official Journal of the Japanese Circulation Society 78(1): 128-134
Edelman, E.R.; Joynt, K.; Osborne, J. 2010: J waves of Osborn revisited. Journal of the American College of Cardiology 55(20): 2287
Weber, M. 2014: J&J partners with Yale to share trial data. Cancer Discovery 4(4): 384
Lott, P.F. 1983: Serendipity in analytical chemistry. Analytical Chemistry 55(2): 245a-248a
Czerski, I.; Kamieńska-Trela, K.; Koźmiński, W.; Ratajczyk, T.; Szymański, S.; Wójcik, J. 2007: J(F,H), J(C,H) and J(H,H) couplings involving the individual methyl group protons in 1,2,3,4-tetrachloro-5,6,7,8-tetrafluoro-9-methyltriptycene. Evidence of blue-shifting hydrogen bond. Magnetic Resonance in Chemistry: Mrc 45(12): 1040-1044
Zhao, L.; Ma, R.; Li, J.; Li, Y.; An, Y.; Shi, L. 2008: J- and H-aggregates of 5,10,15,20-tetrakis-(4-sulfonatophenyl)-porphyrin and interconversion in PEG-b-P4VP micelles. Biomacromolecules 9(10): 2601-2608
Markova, L.I.; Malinovskii, V.L.; Patsenker, L.D.; Häner, R. 2013: J- vs. H-type assembly: pentamethine cyanine (Cy5) as a near-IR chiroptical reporter. Chemical Communications 49(46): 5298-5300
Lapchak, P.A.; Bombien, R.; Rajput, P.S. 2013: J-147 a Novel Hydrazide Lead Compound to Treat Neurodegeneration: CeeTox™ Safety and Genotoxicity Analysis. Journal of Neurology and Neurophysiology 4(3)
Li, H.; Wu, J.; Ying, G.; Chen, L.; Lai, L.; Liu, Z.; Zhang, N.; Guo, H. 2012: J-4: a novel and typical preclinical anticancer drug targeting protein kinase C ζ. Anti-Cancer Drugs 23(7): 691-697
Iwatsubo, T. 2012: J-ADNi and very early treatment of Alzheimer's disease. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 49(3): 300-302
Patwardhan, B. 2010: J-AIM - a Renaissance for Ayurveda. Journal of Ayurveda and Integrative Medicine 1(1): 1-2
Joshi, V.R. 2010: J-AIM fulfills important need. Journal of Ayurveda and Integrative Medicine 1(2): 88-89
Patwardhan, B. 2010: J-AIM receives warm welcome. Journal of Ayurveda and Integrative Medicine 1(2): 85-86
Deodhar, N.S. 2010: J-AIM: A welcome step. Journal of Ayurveda and Integrative Medicine 1(2): 87-88
Iwatsubo, T. 2010: J-Adni. Rinsho Shinkeigaku 50(11): 935
Tian, Y.; Chen, L.; Niks, D.; Kaiser, J.M.; Lai, J.; Rienstra, C.M.; Dunn, M.F.; Mueller, L.J. 2009: J-Based 3D sidechain correlation in solid-state proteins. Physical Chemistry Chemical Physics: Pccp 11(32): 7078-7086
Okamoto, H.; Kitabatake, A.; Tsutsui, H. 2007: J-CHF Study. Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 4): 537-542
Yamamoto, K.; Hori, M. 2007: J-DHF Study (Japanese Diastolic Heart Failure Study). Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 4): 498-501
Ito, H. 2013: J-EDIT: aim, method and effects of intervention. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 50(1): 49-52
Yamamoto, K.; Hori, M. 2007: J-ELAN study (effect of losartan and amlodipine on left ventricular diastolic function in patients with mild-to-moderate hypertension). Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 4): 513-515
Kameoka, M.; Sasaki, T. 2013: J-GRID and SATREPS programs in Thailand. Uirusu 63(1): 51-58
Taylor, P.R.; Koski, G.K.; Paustian, C.C.; Bailey, E.; Cohen, P.A.; Moore, F.B.-G.; Zimmerman, D.H.; Rosenthal, K.S. 2010: J-LEAPS vaccines initiate murine Th1 responses by activating dendritic cells. Vaccine 28(34): 5533-5542
Yoshino, G. 2006: J-MIND study: effect of nifedipine on renal function in Japanese hypertensive patients with diabetes mellitus. Drugs 66(Special Issue 1): 22-24
Klages, J.; Kessler, H.; Glaser, S.J.; Luy, B. 2007: J-ONLY-TOCSY: efficient suppression of RDC-induced transfer in homonuclear TOCSY experiments using JESTER-1-derived multiple pulse sequences. Journal of Magnetic Resonance 189(2): 217-227
Yasaka, M. 2012: J-ROCKET AF trial increased expectation of lower-dose rivaroxaban made for Japan. Circulation Journal: Official Journal of the Japanese Circulation Society 76(9): 2086-2087
Kohriyama, T.; Nomura, E.; Matsumoto, M.; Ohtsuki, T. 2006: J-STARS (Japan statin treatment against recurrent stroke). Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 7): 511-518
Pileio, G.; Levitt, M.H. 2007: J-Stabilization of singlet states in the solution NMR of multiple-spin systems. Journal of Magnetic Resonance 187(1): 141-145
Wu, J.-J.; Li, N.; Li, K.-A.; Liu, F. 2008: J-aggregates of diprotonated tetrakis(4-sulfonatophenyl)porphyrin induced by ionic liquid 1-butyl-3-methylimidazolium tetrafluoroborate. Journal of Physical Chemistry. B 112(27): 8134-8138
Song, X.; Gong, H.; Liu, T.; Cheng, L.; Wang, C.; Sun, X.; Liang, C.; Liu, Z. 2014: J-aggregates of organic dye molecules complexed with iron oxide nanoparticles for imaging-guided photothermal therapy under 915-nm light. Small 10(21): 4362-4370
Würthner, F.; Kaiser, T.E.; Saha-Möller, C.R. 2011: J-aggregates: from serendipitous discovery to supramolecular engineering of functional dye materials. Angewandte Chemie 50(15): 3376-3410
Yang, C.-H.; Lee, J.-Y.; Shin, H.-K.; Kim, G.-C.; Kwon, Y.-S. 2009: J-aggregation characteristics of merocyanine dye with arachidic acid LB films by heat treatment. Journal of Nanoscience and Nanotechnology 9(12): 6979-6982
Shin, J.; Kang, N.S.; Kim, K.H.; Lee, T.W.; Jin, J.-I.; Kim, M.; Lee, K.; Ju, B.K.; Hong, J.-M.; Choi, D.H. 2012: J-aggregation induced low bandgap anthracene-based conjugated molecule for solution-processed solar cells. Chemical Communications 48(68): 8490-8492
De Miguel, G.; Hosomizu, K.; Umeyama, T.; Matano, Y.; Imahori, H.; Pérez-Morales, M.; Martín-Romero, M.ía.T.; Camacho, L. 2011: J-aggregation of a sulfonated amphiphilic porphyrin at the air-water interface as a function of pH. Journal of Colloid and Interface Science 356(2): 775-782
Slavnova, T.D.; Görner, H.; Chibisov, A.K. 2007: J-aggregation of anionic ethyl meso-thiacarbocyanine dyes induced by binding to proteins. Journal of Physical Chemistry. B 111(33): 10023-10031
Steiger, R.; Pugin, R.ël.; Heier, J. 2009: J-aggregation of cyanine dyes by self-assembly. Colloids and Surfaces. B Biointerfaces 74(2): 484-491
Ali, M.; Kumar, V.; Baker, S.N.; Baker, G.A.; Pandey, S. 2010: J-aggregation of ionic liquid solutions of meso-tetrakis(4-sulfonatophenyl)porphyrin. Physical Chemistry Chemical Physics: Pccp 12(8): 1886-1894
Arai, Y.; Segawa, H. 2010: J-aggregation of protonated meso-tetrakis(sulfonatothienyl)porphyrin isomers: morphological selection of self-assembled nanostructures from structurally similar zwitterionic porphyrins. Chemical Communications 46(24): 4279-4281
Chen, L.; Kaiser, J.M.; Lai, J.; Polenova, T.; Yang, J.; Rienstra, C.M.; Mueller, L.J. 2007: J-based 2D homonuclear and heteronuclear correlation in solid-state proteins. Magnetic Resonance in Chemistry: Mrc 45(Suppl 1): S84-S92
Ataç, M.S.; Kilinç, Y. 2014: J-bone graft for the reconstruction of the jaws. Journal of Craniofacial Surgery 25(4): 1468-1469
Torres, A.M.; Zheng, G.; Price, W.S. 2010: J-compensated PGSE: an improved NMR diffusion experiment with fewer phase distortions. Magnetic Resonance in Chemistry: Mrc 48(2): 129-133
Salvador, P.; Tsai, I.-H.M.; Dannenberg, J.J. 2011: J-coupling constants for a trialanine peptide as a function of dihedral angles calculated by density functional theory over the full Ramachandran space. Physical Chemistry Chemical Physics: Pccp 13(39): 17484-17493
Okumiya, K.; Sakamoto, R.; Kimura, Y.; Ishimoto, Y.; Fukutomi, E.; Kasahara, Y.; Chen, W-Ling.; Ishine, M.; Wada, T.; Fujisawa, M.; Imai, H.; Ishikawa, M.; Yamamoto, N.; Otsuka, K.; Matsubayashi, K. 2012: J-curve association between economic status and diabetes independent of functional disability in Japanese elderly. Geriatrics and Gerontology International 12(4): 755-756
Kotsis, V.; Grassi, G. 2011: J-curve for DBP and cardiovascular mortality in coronary artery disease patients: myth or reality. Journal of Hypertension 29(10): 1854-1856
Andrikou, E.; Bafakis, I.; Grassos, C.; Papaspyropoulos, A.; Kranidis, A. 2012: J-curve phenomenon: a matter of debate. Hellenic Journal of Cardiology: Hjc 53(5): 357-366
Bangalore, S.; Messerli, F.H.; Wun, C-Chuan.; Zuckerman, A.L.; DeMicco, D.; Kostis, J.B.; LaRosa, J.C. 2010: J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial. European Heart Journal 31(23): 2897-2908
Thompson, P.L. 2013: J-curve revisited: cardiovascular benefits of moderate alcohol use cannot be dismissed. Medical Journal of Australia 198(8): 419-422
Scholz, I.; Jehle, S.; Schmieder, P.; Hiller, M.; Eisenmenger, F.; Oschkinat, H.; van Rossum, B.-J. 2007: J-deconvolution using maximum entropy reconstruction applied to 13C-13C solid-state cross-polarization magic-angle-spinning NMR of proteins. Journal of the American Chemical Society 129(21): 6682-6683
Near, J.; Evans, C.J.; Puts, N.A.J.; Barker, P.B.; Edden, R.A.E. 2013: J-difference editing of gamma-aminobutyric acid (GABA): simulated and experimental multiplet patterns. Magnetic Resonance in Medicine 70(5): 1183-1191
Smith, M.A.; Koutcher, J.A.; Zakian, K.L. 2008: J-difference lactate editing at 3.0 Tesla in the presence of strong lipids. Journal of Magnetic Resonance Imaging: Jmri 28(6): 1492-1498
Gospodinova, N.; Tomšík, E.; Omelchenko, O. 2014: J-like liquid-crystalline and crystalline states of polyaniline revealed by thin, highly crystalline, and strongly oriented films. Journal of Physical Chemistry. B 118(29): 8901-8904
Thiele, C.M.; Bermel, W. 2007: J-modulated ADEQUATE experiments using different kinds of refocusing pulses. Magnetic Resonance in Chemistry: Mrc 45(10): 889-894
Botana, A.; Aguilar, J.A.; Nilsson, M.; Morris, G.A. 2011: J-modulation effects in DOSY experiments and their suppression: the Oneshot45 experiment. Journal of Magnetic Resonance 208(2): 270-278
Rosso, R.; Kogan, E.; Belhassen, B.; Rozovski, U.; Scheinman, M.M.; Zeltser, D.; Halkin, A.; Steinvil, A.; Heller, K.; Glikson, M.; Katz, A.; Viskin, S. 2008: J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance. Journal of the American College of Cardiology 52(15): 1231-1238
Yoshino, T.; Hayashi, H.; Nakae, I.; Horie, M. 2012: J-point elevation induced by double master two-step test. Internal Medicine 51(14): 1941
Chen, X.; Boesiger, P.; Henning, A. 2013: J-refocused 1H PRESS DEPT for localized 13C MR spectroscopy. Nmr in Biomedicine 26(9): 1113-1124
Pan, J.W.; Avdievich, N.; Hetherington, H.P. 2010: J-refocused coherence transfer spectroscopic imaging at 7 T in human brain. Magnetic Resonance in Medicine 64(5): 1237-1246
von Gunten, E.; Braun, J.; Bopp, M.; Keller, U.; Faeh, D. 2013: J-shaped association between plasma glucose concentration and cardiovascular disease mortality over a follow-up of 32years. Preventive Medicine 57(5): 623-628
Ntaios, G.; Egli, M.; Faouzi, M.; Michel, P. 2010: J-shaped association between serum glucose and functional outcome in acute ischemic stroke. Stroke 41(10): 2366-2370
Kuzuya, M.; Enoki, H.; Iwata, M.; Hasegawa, J.; Hirakawa, Y. 2008: J-shaped relationship between resting pulse rate and all-cause mortality in community-dwelling older people with disabilities. Journal of the American Geriatrics Society 56(2): 367-368
Sakurai, M.; Miura, K.; Takamura, T.; Ishizaki, M.; Morikawa, Y.; Nakamura, K.; Yoshita, K.; Kido, T.; Naruse, Y.; Kaneko, S.; Nakagawa, H. 2009: J-shaped relationship between waist circumference and subsequent risk for Type 2 diabetes: an 8-year follow-up of relatively lean Japanese individuals. Diabetic Medicine: a Journal of the British Diabetic Association 26(8): 753-759
Yilmaz, A.; Sjatskig, J.; van Boven, W.J.; Waanders, F.G.; Kelder, J.C.; Sonker, U.; Kloppenburg, G.T.L. 2011: J-shaped versus median sternotomy for aortic valve replacement with minimal extracorporeal circuit. Scandinavian Cardiovascular Journal: Scj 45(6): 379-384
Cao, S.; Moineddin, R.; Urquia, M.L.; Razak, F.; Ray, J.G. 2014: J-shapedness: an often missed, often miscalculated relation: the example of weight and mortality. Journal of Epidemiology and Community Health 68(7): 683-690
Ritterman, S.A.; Daniels, A.H.; Kane, P.M.; Eberson, C.P.; Born, C.T. 2014: J-splint use for temporizing management of pediatric femur fractures: a review of 18 cases. Pediatric Emergency Care 30(8): 516-520
Kim, H.S.; Lee, B.K.; Jung, J.-W.; Lee, J.K.; Byun, S.-S.; Lee, S.E.; Jeong, C.W. 2014: J-tube technique for double-j stent insertion during laparoscopic upper urinary tract surgical procedures. Journal of Endourology 28(11): 1278-1281
Jastrzebski, M.; Kukla, P.; Bacior, B.ła. 2008: J-wave associated idiopathic ventricular fibrillation--a new arrhythmogenic syndrome?. Kardiologia Polska 66(4): 447-449; Discussion: 449-450
Sorgente, A.; Sarkozy, A.; Brugada, P. 2010: J-wave disappearance immediately after an episode of ventricular fibrillation in a patient with resuscitated sudden cardiac death and Brugada syndrome. Journal of Cardiovascular Electrophysiology 21(12): 1413-1415
Milewska, A.; Guzik, P.; Rudzka, M.; Baranowski, R.; Jankowski, R.; Nowak, S.; Wysocki, H. 2009: J-wave formation in patients with acute intracranial hypertension. Journal of Electrocardiology 42(5): 420-423
Ito, S.; Inage, T.; Fukumoto, Y. 2015: J-wave syndrome with giant negative T-wave in severely activated arrhythmogenicity on 12-lead electrocardiography. Europace: European Pacing Arrhythmias and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing Arrhythmias and Cardiac Cellular Electrophysiology of the European Society of Cardiology 17(6): 937
Borggrefe, M.; Schimpf, R. 2010: J-wave syndromes caused by repolarization or depolarization mechanisms a debated issue among experimental and clinical electrophysiologists. Journal of the American College of Cardiology 55(8): 798-800
Antzelevitch, C.; Yan, G.-X. 2011: J-wave syndromes. from cell to bedside. Journal of Electrocardiology 44(6): 656-661
Sullivan, B.T.; Li, L.; Dawson, P.H. 2014: J. A. Dobrowolski (1931-2013): in memoriam. Applied optics 53(4): A1-A7
Anonymous 1931: J. A. Lindsay, M.A., M.D., F.R.C.P. British medical journal 2(3703): 1201-1202
Anonymous 1928: J. A. MACDONALD, M.D., M.Ch., LL.D. British Medical Journal 1(3513): 781-785
Anonymous 1933: J. A. Mitchell, M.B., D.P.H. British medical journal 2(3783): 81
Griffiths, W.L. 1934: J. A. RAWLINGS, M.R.C.P.Ed. British Medical Journal 1(3809): 40-41
Dronamraju, K.; Haldane, J.B.S. 2010: J. B. S. Haldane's last years: his life and work in India (1957-1964). Genetics 185(1): 5-10
Rao, V.; Nanjundiah, V.; Haldane, J.B.S.; Mayr, E. 2011: J. B. S. Haldane, Ernst Mayr and the Beanbag genetics dispute. Journal of the History of Biology 44(2): 233-281
Blacker, C.P. 1952: J. B. S. haldane on eugenics. Eugenics Review 44(3): 146-151
Ohno, Y.; Otsuka, Y.; Nohara, M.; Furihata, T.; Kuse, Y.; Itoh, Y.; Hara, H.; Anzai, N. 2017: Characterization of an L-Carnitine Transport System in Murine Photoreceptor Cell Line. Biological and Pharmaceutical Bulletin 40(12): 2110-2116
Anonymous 1927: J. C. Uhthoff, M.D., F.R.C.S. British medical journal 1(3448): 264-265
Anonymous 1954: J. C. Wainright. Canadian journal of comparative medicine and veterinary science 18(5): 192-193
Williams, D.R.; Lees, A.J.; Wherrett, J.R.; Steele, J.C.; Richardson, C. 2008: J. Clifford Richardson and 50 years of progressive supranuclear palsy. Neurology 70(7): 566-573
Venter, J.C.; Beard, A.; Venter, J.C. 2014: J. Craig Venter the biologist who led the for-profit effort to sequence the human genome shares his thoughts on commercializing science. Harvard Business Review 92(9): 132
Shampo, M.A.; Kyle, R.A.; Venter, J.C.; Collins, F. 2011: J. Craig Venter--The Human Genome Project. Mayo Clinic Proceedings 86(4): E26-E27
Hunter, W.D. 1922: J. D. Mitchell. Science 55(1427): 469
Nelson, J.D. 2010: J. Daniel Nelson, MD. Ocular Surface 8(2): 96-98
Sen, T.K. 2012: J. Douglas Carroll (1939-2011). American psychologist 67(7): 572
Anonymous 1927: J. E. Gordon, O.B.E., M.R.C.S., L.R.C.P. British Medical Journal 2(3470): 80
Anonymous 1930: J. E. MacILWAINE, M.D., B.Sc. British Medical Journal 2(3636): 452-453
Anonymous 1936: J. F. Crombie, D.S.O., M.D. British medical journal 2(3958): 1005-1006
Anonymous 1934: J. F. Dobson, M.S., F.R.C.S. British medical journal 1(3817): 409
Anonymous 1926: J. F. Gemmill, M.A., M.D., D.Sc., F.R.S. British Medical Journal 1(3399): 352
Anonymous 1931: J. FARQUHAR CHRISTIE, M.B., F.R.C.P.Ed. British Medical Journal 1(3669): 776
Frich, J.; Lundin, K.E.A.; Os, I. 2014: J. Frich and colleagues reply. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 134(5): 496; Discussion 497
Anonymous 1932: J. G. Blackman, M.D. British medical journal 1(3712): 406
Anonymous 1940: J. G. FitzGerald, M.D. American Journal of Public Health and the Nation's Health 30(9): 1112-1113
A G N 1930: J. George Adami-A Memoir. Canadian Medical Association Journal 22(5): 693
Dobloug, J.H. 2013: J. H. Dobloug replies. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 133(11): 1164
Kulick, J.H.; Jarem, J.M.; Lindquist, R.G.; Kowel, S.T.; Friends, M.W.; Leslie, T.M. 1995: J. H. Kulick, J. M. Jarem, R. G. Lindquist, S. T. Kowel, and M. W. Friends are with the Department of Electrical and Computer Engineering, University of Alabama in Huntsville, Huntsville, Alabama 35899. Applied Optics 34(11): 1901-1922
Anonymous 1932: J. H. Reynolds, V.C., Ll.D. British medical journal 1(3715): 546
Bailey, H. 1933: The Treatment of Abscess of the Breast. British Medical Journal 1(3779): 1001-1003
Hagen, J.; Hjelmeland, H.; Knizek, B.Loa. 2014: J. Hagen and colleagues reply. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 134(6): 593-594
Halse, J. 2014: J. Halse replies. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 134(3): 272
Zuman, P. 2012: J. Heyrovský, Japan, and organic polarography. Chemical Record 12(1): 46-62
Hutson, J. 2014: J. Hutson replies. Journal of Orthopaedic Trauma 28(4): E92
Dockal, E. 2001: J. J. P. Oud as architect of the "new Munich"? A missed opportunity. Zeitschrift für Kunstgeschichte 64(1): 103-115
Anonymous 1935: J. J. R. Macleod, Ll.D., F.R.C.P., F.R.S. British medical journal 1(3872): 624
Downard, K.M.; Thomson, J.John. 2009: J. J. Thomson goes to America. Journal of the American Society for Mass Spectrometry 20(11): 1964-1973
Anonymous 1929: J. J. Waterston: A Man Born Out of his Time. Canadian Medical Association Journal 21(2): 217
Schlumberger, H.G.; Woodward, J.J. 1945: J. J. Woodward and photomicrography during the Civil War. Bulletin. International Association of Medical Museums 25: 81-86
Jortveit, J.; Grenne, Børnar.; Uchto, M.; Dahlslett, T.; Fosse, L.; Gunnes, Pål. 2014: J. Jortveit and colleagues reply. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 134(8): 813
Rao, A.V. 1995: J. Krishnamurti'S teachings - relevance to mental health. Indian Journal of Psychiatry 37(4): 155-160
Krohn, Jørgen.; Dahl, O.; Nybø, T.; Kjersem, Bård. 2014: J. Krohn and colleagues reply. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 134(8): 814
Anonymous 1934: J. L. Birley, M.D., F.R.C.P. British medical journal 1(3819): 510
Merian, M.; Glisson, R.R.; Nunley, J.A. 2011: J. Leonard Goldner Award 2010. Ligament balancing for total ankle arthroplasty: an in vitro evaluation of the elongation of the hind- and midfoot ligaments. Foot and Ankle International 32(5): S457-S472
Queen, R.M.; De Biassio, J.C.; Butler, R.J.; DeOrio, J.K.; Easley, M.E.; Nunley, J.A. 2012: J. Leonard Goldner Award 2011: changes in pain, function, and gait mechanics two years following total ankle arthroplasty performed with two modern fixed-bearing prostheses. Foot and Ankle International 33(7): 535-542
Bone, J.A.; Rolfe, D.T.; Turner, E.L. 1939: The use of Atropine and Digitalis in Certain Forms of Decompensated Heart Disease. Journal of the National Medical Association 31(1): 1-6
Anonymous 1930: J. M. DUNCAN SCOTT, M.A., M.D., Ph.D. British Medical Journal 1(3608): 420-421
Morison, J.M.WOODBURN. 1951: J. M. Woodburn Morison, M.D., F.R. C.P. (Edin.), F.F.R., D.M.R.E. Journal of the Faculty of Radiologists. Faculty of Radiologists 3(2): 78
Moir, C. 1940: J. Marion Sims and the Vesico-vaginal Fistula: Then and Now. British Medical Journal 2(4170): 773-778
Rebelein, J.G.; Lee, C.C.; Newcomb, M.; Hu, Y.; Ribbe, M.W. 2018: Characterization of an M-Cluster-Substituted Nitrogenase VFe Protein. Mbio 9(2)
Li, J.-Y.; Gao, K.; Shao, T.; Fan, D.-D.; Hu, C.-B.; Sun, C.-C.; Dong, W.-R.; Lin, A.-F.; Xiang, L.-X.; Shao, J.-Z. 2018: Characterization of an NLRP1 Inflammasome from Zebrafish Reveals a Unique Sequential Activation Mechanism Underlying Inflammatory Caspases in Ancient Vertebrates. Journal of Immunology 201(7): 1946-1966
Phadte, A.S.; Santhoshkumar, P.; Sharma, K.K. 2018: Characterization of an N-terminal mutant of αA-crystallin αA-R21Q associated with congenital cataract. Experimental Eye Research 174: 185-195
Marcucella, H.; Harrison, J.Michael. 2008: J. Michael Harrison (1915-2007): a research career well lived. Journal of the experimental analysis of behavior 90(2): 131-134
Kelly, J.; Gavel, J.M. 2007: J. Murray Gavel, DMD: bridging research and practice. Journal of the Massachusetts Dental Society 56(2): 22-24
Davies, A.G.; Collie, J.N. 2014: J. Norman Collie, the inventive chemist. Science Progress 97(Part 1): 62-71
Anonymous 1934: J. P. A. Gabb, M.D. British medical journal 2(3849): 702
Smith, W.E. 1955: J. P. Marble, Research Geochemist. Science 122(3167): 459
Stevenson, J.J. 1903: J. Peter Lesley. Science 18(444): 1-3
Anonymous 1933: J. R. DREVER, M.A., M.B., F.R.C.P.Ed. British Medical Journal 1(3772): 725-726
Parrott, L.J. 1984: J. R. Kantor's contributions to psychology and philosophy: A guide to further study. Behavior Analyst 7(2): 168-181
Peirson, R.P.; Jones, J.C.W.; Ciccone, R.J. 2007: J. Richard Ciccone, MD: a visionary leader. Journal of the American Academy of Psychiatry and the Law 35(4): 411-414
Wageman, R.; Amabile, T.M.; Hackman, J.Richard. 2014: J. Richard Hackman (1940-2013). American psychologist 69(1): 80
Hart, C.W.; Oppenheimer, J.R. 2008: J. Robert Oppenheimer: a faith development portrait. Journal of Religion and Health 47(1): 118-128
Price, D.K. 1967: J. Robert oppenheimer. Science 155(3766): 1061
Campbell, M. 1961: J. S. Haldane Centenary, 1961. British Heart Journal 23(6): 711-715
Anonymous 1934: J. STRICKLAND GOODALL, M.B., F.R.C.S.Ed., M.R.C.P. British Medical Journal 2(3856): 1020-1021
Jones, J.Stephen. 2008: J. Stephen Jones, M.D., F.A.C.S., is Chairman of the Department of Regional Urology at the Cleveland Clinic Glickman Urological and Kidney Institute. Urology 72(5): 959
Anonymous 1935: J. T. Cunningham, M.A. British medical journal 2(3887): 42
Anonymous 1933: J. T. J. Morrison, M.A., M.B., F.R.C.S. British medical journal 1(3776): 897
Anonymous 1936: J. T. Kitchin, M.D., D.P.H. British medical journal 2(3961): 1172-1173
Anonymous 1936: J. Theodore Cash, M.D., Ll.D., F.R.S. British medical journal 2(3962): 1238
Dean, J.T. 2013: J. Todd Dean on Lewis Kirshner. Journal of the American Psychoanalytic Association 61(4): Np1-Np4
Anonymous 1926: J. W. F. Rait, M.B., B.S.Lond. British Medical Journal 1(3407): 724-725
Wahl, A.C. 1957: J. W. Kennedy, Scientist, Teacher, Leader. Science 126(3263): 65-66
Anonymous 1930: J. W. L. SPENCE, L.R.C.P. and S. Ed., L.R.F.P.S. British Medical Journal 1(3611): 570-571
Anonymous 1926: J. W. Smith, M.B., C.M.Ed., F.R.C.S.Eng. British Medical Journal 1(3408): 766-767
Anonymous 1933: J. W. Springthorpe, M.D., M.R.C.P. British medical journal 2(3786): 216
Oddie, S.I. 1931: Henry Bright Weir, M.A., M.B. British Medical Journal 1(3671): 871
Meredith, J.Wayne. 2014: J. Wayne Meredith, MD, FACS, chosen as 2014 Distinguished Service Award recipient. Bulletin of the American College of Surgeons 99(10): 50-51
Streilein, J.Wayne. 2007: J. Wayne Streilein memorial issue. Ocular Immunology and Inflammation 15(3): 1 P Preceding 147 147-294
Getman, F.H. 1923: J. Willard Gibbs and his Contribution to Chemistry. Science 58(1495): 129-133
Gómez Mango, E.; Pontalis, J.B. 2014: J.-B. Pontalis, a thinker of psychoanalysis. International Journal of Psycho-Analysis 95(3): 525-532
Goetz, C.G.; Charcot, J.-M.; Mitchell, S.W. 2007: J.-M. Charcot and simulated neurologic disease: attitudes and diagnostic strategies. Neurology 69(1): 103-109
Newman, S.; Itard, J-Marc.Gaspard. 2010: J.-M. G. Itard's 1825 study: movement and the science of the human mind. History of Psychiatry 21(81 Pt 1): 67-78
Manus, J.-M. 2006: Nursing temporary work, a solution to the crisis?. Soins; la Revue de Reference Infirmiere 109(709): S2-S3
Clausen, T.; Skou, J.C. 2007: J.C. Skou identified Na+,K+-pump--a breakthrough and its significance. Ugeskrift for Laeger 169(35): 2897
Hilger, H.H.; Cole, T.C.H.; Selvi, F. 2014: J.G.C. Lehmann's 'Botanical Observations' of 1818 on Coldenia, Colsmannia, Cynoglossum, and Omphalodes (commented translation). Biodiversity Data Journal 2014(2): E1064
Laake, J.Henrik.; Nordøy, I. 2013: J.H. Laake & I. Nordøy replies. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 133(15): 1555
Berrios, G.E.; Pons, J.H. 2014: J.H. Pons on 'Sympathetic insanity': With an introduction by GE Berrios. History of Psychiatry 25(3): 364-376
Osterbrink, J.; Bonica, J.J. 2013: J.J. Bonica would have been pleased. Schmerz 27(6): 549-552
van Gijn, J.; Gijselhart, J.P.; Wertheim Salomonson, J.K. 2010: J.K.A. Wertheim Salomonson (1864-1922): nerves, currents and X-rays. Nederlands tijdschrift voor geneeskunde 154: A1705
Han, S.Hwan.; Lee, J.Woo.; Guyton, G.P.; Parks, B.G.; Courneya, J-Paul.; Schon, L.C. 2009: J.Leonard Goldner Award 2008. Effect of extracorporeal shock wave therapy on cultured tenocytes. Foot and Ankle International 30(2): 93-98
Uranues, S. 2012: J.O. Larkin, P.A. Carroll, P.H. McCormick, B.J. Mehigan: Control of splenic bleeding during splenic flexure mobilisation by devascularisation of the inferior pole of the spleen. Techniques in Coloproctology 16(6): 473; Author Reply 475
Battistuzzi, P.G.F.C.M.; Glauber, J.R. 2012: J.R. Glauber and sodium sulfate. Nederlands Tijdschrift Voor Tandheelkunde 119(9): 411
Lancellotti, P.; Habib, G.; Badano, L.; Fraser, A.; Nihoyannopoulos, P.; Pinto, F.; Zamorano, J-Luis.; Distante, A.; Founder, E.; Maurer, G.; Roelandt, J.R.T.C. 2014: J.R.T.C. Roelandt (November 12, 1938-August 31, 2014). European Heart Journal Cardiovascular Imaging 15(11): 1187
West, J.B.; Haldane, J.Scott. 2008: J.S. Haldane and some of his contributions to physiology. Advances in Experimental Medicine and Biology 605: 9-15
Anonymous 1994: J.T. Baker. Environmental Science and Technology 28(2): 51a
Rotheray, S.; Watts, D. 2012: Peer mentorship for medical students and junior doctors. Medical Teacher 34(8): 673-674
Anonymous 1983: J.T. Baker chemical co. Analytical Chemistry 55(13): 1390A
Anonymous 1983: J.T. Baker chemical co. Analytical Chemistry 55(2): 333A
Anonymous 1983: J.T. Baker research products. Analytical Chemistry 55(13): 1349A
Miao, J.; Ying, B.; Li, R.; Tollefson, A.E.; Spencer, J.F.; Wold, W.S.M.; Song, S.-H.; Kong, I.-K.; Toth, K.; Wang, Y.; Wang, Z. 2018: Characterization of an N-Terminal Non-Core Domain of RAG1 Gene Disrupted Syrian Hamster Model Generated by CRISPR Cas9. Viruses 10(5)
Marriott Jr, J.W."Bill". 2013: J.W. "Bill" Marriott, Jr. Caring: National Association for Home Care Magazine 32(9): 16-19
Mitchell, R.E.; Shepherd, M.R.; Besson, D.; Pedlar, T.K.; Cronin-Hennessy, D.; Gao, K.Y.; Hietala, J.; Kubota, Y.; Klein, T.; Lang, B.W.; Poling, R.; Scott, A.W.; Zweber, P.; Dobbs, S.; Metreveli, Z.; Seth, K.K.; Tomaradze, A.; Libby, J.; Powell, A.; Wilkinson, G.; Ecklund, K.M.; Love, W.; Savinov, V.; Lopez, A.; Mendez, H.; Ramirez, J.; Ge, J.Y.; Miller, D.H.; Shipsey, I.P.J.; Xin, B.; Adams, G.S.; Anderson, M.; Cummings, J.P.; Danko, I.; Hu, D.; Moziak, B.; Napolitano, J.; He, Q.; Insler, J.; Muramatsu, H.; Park, C.S.; Thorndike, E.H.; Yang, F.; Artuso, M.; Blusk, S.; Khalil, S.; Li, J.; Mountain, R.; Nisar, S.; Randrianarivony, K.; Sultana, N.; Skwarnicki, T.; Stone, S.; Wang, J.C.; Zhang, L.M.; Bonvicini, G.; Cinabro, D.; Dubrovin, M.;, 2009: J/psi and psi(2S) Radiative Transitions to eta_{c}. Physical Review Letters 102(1): 011801
Artoisenet, P.; Campbell, J.; Maltoni, F.; Tramontano, F. 2009: J/psi production at HERA. Physical Review Letters 102(14): 142001
Arnaldi, R.; Banicz, K.; Castor, J.; Chaurand, B.; Cicalò, C.; Colla, A.; Cortese, P.; Damjanovic, S.; David, A.; de Falco, A.; Devaux, A.; Ducroux, L.; En'yo, H.; Fargeix, J.; Ferretti, A.; Floris, M.; Förster, A.; Force, P.; Guettet, N.; Guichard, A.; Gulkanian, H.; Heuser, J.M.; Keil, M.; Kluberg, L.; Lourenço, C.; Lozano, J.; Manso, F.; Martins, P.; Masoni, A.; Neves, A.; Ohnishi, H.; Oppedisano, C.; Parracho, P.; Pillot, P.; Poghosyan, T.; Puddu, G.; Radermacher, E.; Ramalhete, P.; Rosinsky, P.; Scomparin, E.; Seixas, J.; Serci, S.; Shahoyan, R.; Sonderegger, P.; Specht, H.J.; Tieulent, R.; Usai, G.; Veenhof, R.; Wöhri, H.K. 2007: J/psi production in Indium-Indium collisions at 158 GeV/nucleon. Physical Review Letters 99(13): 132302
Adare, A.; Afanasiev, S.; Aidala, C.; Ajitanand, N.N.; Akiba, Y.; Al-Bataineh, H.; Alexander, J.; Aoki, K.; Aphecetche, L.; Armendariz, R.; Aronson, S.H.; Asai, J.; Atomssa, E.T.; Averbeck, R.; Awes, T.C.; Azmoun, B.; Babintsev, V.; Baksay, G.; Baksay, L.; Baldisseri, A.; Barish, K.N.; Barnes, P.D.; Bassalleck, B.; Bathe, S.; Batsouli, S.; Baublis, V.; Bazilevsky, A.; Belikov, S.; Bennett, R.; Berdnikov, Y.; Bickley, A.A.; Boissevain, J.G.; Borel, H.; Boyle, K.; Brooks, M.L.; Buesching, H.; Bumazhnov, V.; Bunce, G.; Butsyk, S.; Campbell, S.; Chang, B.S.; Charvet, J.-L.; Chernichenko, S.; Chiba, J.; Chi, C.Y.; Chiu, M.; Choi, I.J.; Chujo, T.; Chung, P.; Churyn, A.; Cianciolo, V.; Cleven, C.R.; Cole, B.A.; Comets, M.P.; Constantin, P.; Csaná 2008: J/psi production in sqrt s_NN=200 GeV Cu+Cu collisions. Physical Review Letters 101(12): 122301
Adare, A.; Afanasiev, S.; Aidala, C.; Ajitanand, N.N.; Akiba, Y.; Al-Bataineh, H.; Alexander, J.; Al-Jamel, A.; Aoki, K.; Aphecetche, L.; Armendariz, R.; Aronson, S.H.; Asai, J.; Atomssa, E.T.; Averbeck, R.; Awes, T.C.; Azmoun, B.; Babintsev, V.; Baksay, G.; Baksay, L.; Baldisseri, A.; Barish, K.N.; Barnes, P.D.; Bassalleck, B.; Bathe, S.; Batsouli, S.; Baublis, V.; Bauer, F.; Bazilevsky, A.; Belikov, S.; Bennett, R.; Berdnikov, Y.; Bickley, A.A.; Bjorndal, M.T.; Boissevain, J.G.; Borel, H.; Boyle, K.; Brooks, M.L.; Brown, D.S.; Bucher, D.; Buesching, H.; Bumazhnov, V.; Bunce, G.; Burward-Hoy, J.M.; Butsyk, S.; Campbell, S.; Chai, J.-S.; Chang, B.S.; Charvet, J.-L.; Chernichenko, S.; Chiba, J.; Chi, C.Y.; Chiu, M.; Choi, I.J.; Chujo, T.; Ch 2007: J/psi production versus centrality, transverse momentum, and rapidity in Au+au collisions at square root sNN=200 GeV. Physical Review Letters 98(23): 232301
Adare, A.; Afanasiev, S.; Aidala, C.; Ajitanand, N.N.; Akiba, Y.; Al-Bataineh, H.; Alexander, J.; Aoki, K.; Aphecetche, L.; Armendariz, R.; Aronson, S.H.; Asai, J.; Atomssa, E.T.; Averbeck, R.; Awes, T.C.; Azmoun, B.; Babintsev, V.; Baksay, G.; Baksay, L.; Baldisseri, A.; Barish, K.N.; Barnes, P.D.; Bassalleck, B.; Bathe, S.; Batsouli, S.; Baublis, V.; Bazilevsky, A.; Belikov, S.; Bennett, R.; Berdnikov, Y.; Bickley, A.A.; Boissevain, J.G.; Borel, H.; Boyle, K.; Brooks, M.L.; Buesching, H.; Bumazhnov, V.; Bunce, G.; Butsyk, S.; Campbell, S.; Chang, B.S.; Charvet, J.-L.; Chernichenko, S.; Chiba, J.; Chi, C.Y.; Chiu, M.; Choi, I.J.; Chujo, T.; Chung, P.; Churyn, A.; Cianciolo, V.; Cleven, C.R.; Cole, B.A.; Comets, M.P.; Constantin, P.; Csaná 2007: J/psi production versus transverse momentum and rapidity in p+p collisions at square root s=200 GeV. Physical Review Letters 98(23): 232002
Abbas, E.; Abelev, B.; Adam, J.; Adamová, D.; Adare, A.M.; Aggarwal, M.M.; Aglieri Rinella, G.; Agnello, M.; Agocs, A.G.; Agostinelli, A.; Ahammed, Z.; Ahmad, N.; Ahmad Masoodi, A.; Ahn, S.A.; Ahn, S.U.; Aimo, I.; Ajaz, M.; Akindinov, A.; Aleksandrov, D.; Alessandro, B.; Alici, A.; Alkin, A.; Almaráz Aviña, E.; Alme, J.; Alt, T.; Altini, V.; Altinpinar, S.; Altsybeev, I.; Andrei, C.; Andronic, A.; Anguelov, V.; Anielski, J.; Anson, C.; Antičić, T.; Antinori, F.; Antonioli, P.; Aphecetche, L.; Appelshäuser, H.; Arbor, N.; Arcelli, S.; Arend, A.; Armesto, N.; Arnaldi, R.; Aronsson, T.; Arsene, I.C.; Arslandok, M.; Asryan, A.; Augustinus, A.; Averbeck, R.; Awes, T.C.; Äystö, J.; Azmi, M.D.; Bach, M.; Badalà, A.; Baek, Y.W.; Bailhache, 2013: J/ψ elliptic flow in Pb-Pb collisions at √(s(NN))=2.76 TeV. Physical Review Letters 111(16): 162301
Chao, K.-T.; Ma, Y.-Q.; Shao, H.-S.; Wang, K.; Zhang, Y.-J. 2012: J/ψ polarization at hadron colliders in nonrelativistic QCD. Physical Review Letters 108(24): 242004
Butenschoen, M.; Kniehl, B.A. 2012: J/ψ polarization at the Tevatron and the LHC: nonrelativistic-QCD factorization at the crossroads. Physical Review Letters 108(17): 172002
Abelev, B.; Abrahantes Quintana, A.; Adamová, D.; Adare, A.M.; Aggarwal, M.M.; Aglieri Rinella, G.; Agocs, A.G.; Agostinelli, A.; Aguilar Salazar, S.; Ahammed, Z.; Ahmad, N.; Ahmad Masoodi, A.; Ahn, S.U.; Akindinov, A.; Aleksandrov, D.; Alessandro, B.; AlfaroMolina, R.; Alici, A.; Alkin, A.; Almaráz Aviña, E.; Alt, T.; Altini, V.; Altinpinar, S.; Altsybeev, I.; Andrei, C.; Andronic, A.; Anguelov, V.; Anson, C.; Antičić, T.; Antinori, F.; Antonioli, P.; Aphecetche, L.; Appelshäuser, H.; Arbor, N.; Arcelli, S.; Arend, A.; Armesto, N.; Arnaldi, R.; Aronsson, T.; Arsene, I.C.; Arslandok, M.; Asryan, A.; Augustinus, A.; Averbeck, R.; Awes, T.C.; Aystö, J.; Azmi, M.D.; Bach, M.; Badalà, A.; Baek, Y.W.; Bailhache, R.; Bala, R.; Baldini Fer 2012: J/ψ polarization in pp collisions at √s=7 TeV. Physical review letters 108(8): 082001
Abelev, B.; Adam, J.; Adamová, D.; Adare, A.M.; Aggarwal, M.M.; Aglieri Rinella, G.; Agocs, A.G.; Agostinelli, A.; Aguilar Salazar, S.; Ahammed, Z.; Ahmad Masoodi, A.; Ahmad, N.; Ahn, S.U.; Akindinov, A.; Aleksandrov, D.; Alessandro, B.; Alfaro Molina, R.; Alici, A.; Alkin, A.; Almaráz Aviña, E.; Alme, J.; Alt, T.; Altini, V.; Altinpinar, S.; Altsybeev, I.; Andrei, C.; Andronic, A.; Anguelov, V.; Anielski, J.; Anson, C.; Antičić, T.; Antinori, F.; Antonioli, P.; Aphecetche, L.; Appelshäuser, H.; Arbor, N.; Arcelli, S.; Arend, A.; Armesto, N.; Arnaldi, R.; Aronsson, T.; Arsene, I.C.; Arslandok, M.; Asryan, A.; Augustinus, A.; Averbeck, R.; Awes, T.C.; Aystö, J.; Azmi, M.D.; Bach, M.; Badalà, A.; Baek, Y.W.; Bailhache, R.; Bala, R.; B 2012: J/ψ suppression at forward rapidity in Pb-Pb collisions at √s(NN) = 2.76 TeV. Physical Review Letters 109(7): 072301
Arleo, F.ço.; Peigné, S.ép. 2012: J/ψ suppression in p-A collisions from parton energy loss in cold QCD matter. Physical Review Letters 109(12): 122301
Ma, Y.-Q.; Wang, K.; Chao, K.-T. 2011: J/ψ(ψ') production at the Tevatron and LHC at O(α(s)4v4) in nonrelativistic QCD. Physical Review Letters 106(4): 042002
Shuangshoti, S.; Thorner, P.S.; Ruangvejvorachai, P.; Saha, B.; Groshen, S.; Taylor, C.R.; Malhotra, S.; Imam, S.A. 2009: J1-31 protein expression in astrocytes and astrocytomas. Neuropathology: Official Journal of the Japanese Society of Neuropathology 29(5): 521-527
Xiao, H.; Zhang, H.; Yu, Z.-Y.; Zhang, L.; Yu, M.; Huang, Y.-F.; Li, S.; Shen, B.-F.; Li, Y. 2007: J2 prolongs the corneal allograft survival through inhibition of the CD4+ T cell-mediated response in vivo. Transplant Immunology 18(2): 130-137
Morón, M.J.; Luque, J.R.; Botella, A.A.; Cuberos, E.J.; Casilari, E.; Díaz-Estrella, A. 2007: J2ME and smart phones as platform for a Bluetooth body area network for patient-telemonitoring. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2007: 2791-2794
Shen, L.; Yu, H. 2011: J3 regulation of flowering time is mainly contributed by its activity in leaves. Plant Signaling and Behavior 6(4): 601-603
Melià-Seguí, J.; Garcia-Alfaro, J.; Herrera-Joancomartí, J. 2013: J3Gen: a PRNG for low-cost passive RFID. Sensors 13(3): 3816-3830
Behabadi, B.F.; Mel, B.W. 2007: J4 at sweet 16: a new wrinkle?. Neural Computation 19(11): 2865-2870
Holicka, M.; Novosad, J.; Kudlova, M.; Loudova, M.; Andrys, C.; Krejsek, J. 2010: J774 macrophage-like cell line cytokine and chemokine patterns are modulated by Francisella tularensis LVS strain infection. Folia Microbiologica 55(2): 191-200
Jin, D-dan.; Dong, H-yan.; Yan, J.; Li, L-wei.; Mao, Y-fei. 2008: J774A.1 cell apoptosis induced by Leptospira interrogans and effects of caspase-3, -6 activation on apoptosis. Zhejiang da Xue Xue Bao. Yi Xue Ban 37(6): 558-563
Vandoorn, A.; Bonaventure, G.; Rogachev, I.; Aharoni, A.; Baldwin, I.T. 2011: JA-Ile signalling in Solanum nigrum is not required for defence responses in nature. Plant Cell and Environment 34(12): 2159-2171
Jerger, J. 2011: JAAA from a geographic perspective. Journal of the American Academy of Audiology 22(9): 566
Schmid, N.; Stöckl, J.B.; Flenkenthaler, F.; Dietrich, K.-G.; Schwarzer, J.U.; Köhn, F.-M.; Drummer, C.; Fröhlich, T.; Arnold, G.J.; Behr, R.; Mayerhofer, A. 2018: Characterization of a non-human primate model for the study of testicular peritubular cells-comparison with human testicular peritubular cells. Molecular Human Reproduction 24(8): 401-410
Lynch, J.H.; Sa, N.; Saeheng, S.; Raffaelli, N.; Roje, S. 2018: Characterization of a non-nudix pyrophosphatase points to interplay between flavin and NAD(H) homeostasis in Saccharomyces cerevisiae. Plos one 13(6): E0198787
Shin, W.-S.; Lee, D.; Lee, S.J.; Chun, G.-T.; Choi, S.-S.; Kim, E.-S.; Kim, S. 2018: Characterization of a non-phosphotransferase system for cis,cis-muconic acid production in Corynebacterium glutamicum. Biochemical and Biophysical Research Communications 499(2): 279-284
Cho, C.; Chande, A.T.; Gakhar, L.; Hunt, J.; Ketterer, M.R.; Apicella, M.A. 2018: Characterization of a nontypeable Haemophilus influenzae thermonuclease. Plos one 13(5): E0197010
Zheng, L.; Wang, W.; Liu, J.; Chen, X.; Li, S.; Wang, Q.; Huo, Y.; Qin, C.; Shen, S.; Wang, M. 2018: Characterization of a Norovirus-specific monoclonal antibody that exhibits wide spectrum binding activities. Journal of Medical Virology 90(4): 671-676
Alvarez-Quinto, R.A.; Cornejo-Franco, J.F.; Quito-Avila, D.F. 2017: Characterization of a not so new potexvirus from babaco (Vasconcellea x heilbornii). Plos one 12(12): E0189519
Corbella, M.; Caltagirone, M.; Gaiarsa, S.; Mariani, B.; Sassera, D.; Bitar, I.; Muzzi, A.; Migliavacca, R.; Scudeller, L.; Stronati, M.; Cambieri, P. 2018: Characterization of an Outbreak of Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae in a Neonatal Intensive Care Unit in Italy. Microbial Drug Resistance 24(8): 1128-1136
Zhu, X.; Li, X.; Shi, H.; Zhou, J.; Tan, Z.; Yuan, M.; Yao, P.; Liu, X. 2018: Characterization of a Novel Alginate Lyase from Marine Bacterium Vibrio furnissii H1. Marine Drugs 16(1)
Tian, W.; Zhu, F.M.; Wang, W.Y.; Li, L.X.; Cai, J.H. 2018: Characterization of a novel allelic variant in HLA-B*40 lineage, HLA-B*40:298:02, by cloning and sequencing. International Journal of Immunogenetics 45(3): 143-145
Li, L.; Tian, W.; Zhu, F.; Wang, W.; Wang, F. 2018: Characterization of a novel allelic variant in HLA-B*46:01 lineage, HLA-B*46:01:25, by cloning, phasing and sequencing. International Journal of Immunogenetics 45(6): 347-350
Koseki, T.; Ichikawa, K.; Sasaki, K.; Shiono, Y. 2018: Characterization of a novel Aspergillus oryzae tannase expressed in Pichia pastoris. Journal of Bioscience and Bioengineering 126(5): 553-558
Ogawa, H.; Kajihara, M.; Nao, N.; Shigeno, A.; Fujikura, D.; Hang'ombe, B.M.; Mweene, A.S.; Mutemwa, A.; Squarre, D.; Yamada, M.; Higashi, H.; Sawa, H.; Takada, A. 2017: Characterization of a Novel Bat Adenovirus Isolated from Straw-Colored Fruit Bat (Eidolon helvum). Viruses 9(12)
Johnson, J.; Bessette, D.C.; Saunus, J.M.; Smart, C.E.; Song, S.; Johnston, R.L.; Cocciardi, S.; Rozali, E.N.; Johnstone, C.N.; Vargas, A.C.; Kazakoff, S.H.; BioBank, V.C.; Khanna, K.K.; Lakhani, S.R.; Chenevix-Trench, G.; Simpson, P.T.; Nones, K.; Waddell, N.; Al-Ejeh, F. 2018: Characterization of a novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patient. Breast Cancer Research and Treatment 170(1): 179-188
Lin, X.; Huang, M.; Yin, G.; Zhang, J.; Zhang, Z.; Lai, P.; Yan, B.; Chen, Y.; Jin, D.; Wang, L. 2018: Characterization of a Novel Calcific Achilles Tendinopathy Model in Mice: Contralateral Tendinopathy Induced by Unilateral Tenotomy. Calcified Tissue International 103(6): 698-707
Han, Z.; Shang-Guan, F.; Yang, J. 2018: Characterization of a novel cold-active xylanase from Luteimonas species. World Journal of Microbiology and Biotechnology 34(8): 123
Patiño, B.én.; Vázquez, C.; Manning, J.M.; Roncero, M.ía.I.G.; Córdoba-Cañero, D.; Di Pietro, A.; Martínez-Del-Pozo, Ál. 2018: Characterization of a novel cysteine-rich antifungal protein from Fusarium graminearum with activity against maize fungal pathogens. International Journal of Food Microbiology 283: 45-51
Wester, J.V.W.C.; Lima, C.A.C.; Machado, M.C.R.; Zampar, P.íc.V.; Tavares, S.S.; Monesi, N. 2018: Characterization of a novel Drosophila melanogaster cis-regulatory module that drives gene expression to the larval tracheal system and adult thoracic musculature. Genesis 56(8): E23222
Jiang, Y.; Deng, H.; Huang, X.; Zhang, Y.; Zhong, W. 2016: Characterization of a novel electrogenic Clostridium sporogenes isolated from forest soil. Wei Sheng Wu Xue Bao 56(5): 846-855
Sánchez-Rodríguez, D.B.én.; Ortega-López, J.; Cárdenas-Guerra, R.E.; Reséndiz-Cardiel, G.; Chávez-Munguía, B.; Lagunes-Guillen, A.; Arroyo, R. 2018: Characterization of a novel endogenous cysteine proteinase inhibitor, trichocystatin-3 (TC-3), localized on the surface of Trichomonas vaginalis. International Journal of Biochemistry and Cell Biology 102: 87-100
Yagi, H.; Fujise, A.; Itabashi, N.; Ohshiro, T. 2018: Characterization of a novel endo-type alginate lyase derived from Shewanella sp. YH1. Journal of Biochemistry 163(4): 341-350
Yang, C.; Jairam, S.; Amoroso, K.A.; Robson, M.E.; Walsh, M.F.; Zhang, L. 2018: Characterization of a novel germline BRCA1 splice variant, c.5332+4delA. Breast Cancer Research and Treatment 168(2): 543-550
Huang, Y.; Zhang, H.; Ben, P.; Duan, Y.; Lu, M.; Li, Z.; Cui, Z. 2018: Characterization of a novel GH36 α-galactosidase from Bacillus megaterium and its application in degradation of raffinose family oligosaccharides. International Journal of Biological Macromolecules 108: 98-104
Diop, K.; Diop, A.; Khelaifia, S.; Robert, C.; Pinto, F.D.; Delerce, J.ér.ém.; Raoult, D.; Fournier, P.-E.; Bretelle, F.; Fenollar, F. 2018: Characterization of a novel Gram-stain-positive anaerobic coccus isolated from the female genital tract: Genome sequence and description of Murdochiella vaginalis sp. nov. Microbiologyopen 7(3): E00570
Miao, J.; Ran, J.; Song, Y.; Liu, Y.; Gao, L.; Miao, Z.; Zhang, C.; Feng, Y.; Xia, X. 2018: Characterization of a Novel HIV-1 Circulating Recombinant Form, CRF01_AE/B'/C (CRF96_cpx), in Yunnan, China. Aids Research and Human Retroviruses 34(4): 393-397
Biagini, C.; Fornaciari, S.; Mariotti, M.L.; Scatena, F.; Curcio, M. 2018: Characterization of a novel HLA-C allele, HLA-C*04:288, in an Italian patient. Hla 2018
Balas, A.; Alenda, R.; Moreno-Hidalgo, M.A.; García-Sánchez, F.; Vicario, J.L. 2018: Characterization of a novel HLA-DRB1*07 allele, DRB1*07:83. Hla 91(4): 313-314
Isobe, K.; Kitagawa, A.; Kanamori, K.; Kashiwagi, N.; Matsui, D.; Yamaguchi, T.; Fuhshuku, K-Ichi.; Semba, H.; Asano, Y. 2018: Characterization of a novel hydroxynitrile lyase from Nandina domestica Thunb. Bioscience Biotechnology and Biochemistry 82(10): 1760-1769
De Roover, R.; Crijns, W.; Poels, K.; Peeters, R.; Draulans, C.éd.; Haustermans, K.; Depuydt, T. 2018: Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer. Medical Physics 45(5): 2205-2217
Halter, M.C.; Zahn, J.A. 2018: Characterization of a novel lytic bacteriophage from an industrial Escherichia coli fermentation process and elimination of virulence using a heterologous CRISPR-Cas9 system. Journal of Industrial Microbiology and Biotechnology 45(3): 153-163
Zhang, F.; Huang, K.; Yang, X.; Sun, L.; You, J.; Pan, X.; Cui, X.; Yang, H. 2018: Characterization of a novel lytic podovirus O4 of Pseudomonas aeruginosa. Archives of Virology 163(9): 2377-2383
Durán, D.; Imperial, J.; Palacios, J.é; Ruiz-Argüeso, T.ás.; Göttfert, M.; Zehner, S.; Rey, L. 2018: Characterization of a novel MIIA domain-containing protein (MdcE) in Bradyrhizobium spp. Fems Microbiology Letters 365(5)
Ekelöf, M.ån.; Manni, J.; Nazari, M.; Bokhart, M.; Muddiman, D.C. 2018: Characterization of a novel miniaturized burst-mode infrared laser system for IR-MALDESi mass spectrometry imaging. Analytical and Bioanalytical Chemistry 410(9): 2395-2402
Scalera, V.; Giangregorio, N.; De Leonardis, S.; Console, L.; Carulli, E.S.; Tonazzi, A. 2018: Characterization of a Novel Mitochondrial Ascorbate Transporter from Rat Liver and Potato Mitochondria. Frontiers in Molecular Biosciences 5: 58
O'Sullivan, J.A.; Wei, Y.; Carroll, D.J.; Moreno-Vinasco, L.; Cao, Y.; Zhang, F.; Lee, J.J.; Zhu, Z.; Bochner, B.S. 2018: Frontline Science: Characterization of a novel mouse strain expressing human Siglec-8 only on eosinophils. Journal of Leukocyte Biology 104(1): 11-19
Ding, Y.; Zwe, Y.H.; Chin, S.F.; Kohli, G.S.; Drautz-Moses, D.I.; Givskov, M.; Schlundt, J.; Schuster, S.C.; Yuk, H.-G.; Yang, L. 2018: Characterization of a novel multidrug resistance plasmid pSGB23 isolated from Salmonella enterica subspecies enterica serovar Saintpaul. Gut Pathogens 10: 20
Mahmoodi, M.; Hashemi, P.M.; Imani, R. 2014: Characterization of a novel nanobiomaterial fabricated from HA, TiO2 and Al2O3 powders: an in vitro study. Progress in Biomaterials 3(1): 25
Lu, Y.; Yoo, W.G.; Dai, F.; Lee, J.-Y.; Pak, J.H.; Sohn, W.-M.; Hong, S.-J. 2018: Characterization of a novel organic solute transporter homologue from Clonorchis sinensis. Plos Neglected Tropical Diseases 12(4): E0006459
Stromecki, M.; Tatari, N.; Morrison, L.Coudière.; Kaur, R.; Zagozewski, J.; Palidwor, G.; Ramaswamy, V.; Skowron, P.; Wölfl, M.; Milde, T.; Del Bigio, M.R.; Taylor, M.D.; Werbowetski-Ogilvie, T.E. 2018: Characterization of a novel OTX2-driven stem cell program in Group 3 and Group 4 medulloblastoma. Molecular Oncology 12(4): 495-513
Tharakan, A.; Dobzanski, A.; London, N.R.; Khalil, S.M.; Surya, N.; Lane, A.P.; Ramanathan, M. 2018: Characterization of a novel, papain-inducible murine model of eosinophilic rhinosinusitis. International Forum of Allergy and Rhinology 8(4): 513-521
Peng, Q.; Yuan, Y. 2018: Characterization of a novel phage infecting the pathogenic multidrug-resistant Bacillus cereus and functional analysis of its endolysin. Applied Microbiology and Biotechnology 102(18): 7901-7912
Hartmann, S.; Lopez Cruz, R.; Alameh, S.; Ho, C.-L.C.; Rabideau, A.; Pentelute, B.L.; Bradley, K.A.; Martchenko, M. 2018: Characterization of Novel Piperidine-Based Inhibitor of Cathepsin B-Dependent Bacterial Toxins and Viruses. Acs Infectious Diseases 4(8): 1235-1245
Wang, C.; Chapman, I.; Agim, N. 2013: JAAD Grand Rounds. Acral erythematous papules and dysmorphic features. Journal of the American Academy of Dermatology 69(2): 326-328
Taylor, A.; Nguyen, R.H.; Glass, D.A.; Agim, N.G. 2013: JAAD Grand Rounds. Annular plaques and craniosynostosis. Journal of the American Academy of Dermatology 68(5): 881-884
Berlin, J.M.; Cassedy, A.H.; Zoppi, K.; Strasswimmer, J.; de Guzman, M.Jean. 2013: JAAD Grand Rounds. Multiple papules on the nose. Journal of the American Academy of Dermatology 69(2): 322-324
Tucker, M.; Ramolia, P.; Wells, M.J. 2013: JAAD Grand Rounds. Neonate with extensive papulovesicles. Journal of the American Academy of Dermatology 68(5): 877-879
Mudigonda, P.; Ragland, H.P.; Murina, A. 2013: JAAD Grand Rounds. Posttreatment lesional hyperpigmentation. Journal of the American Academy of Dermatology 68(5): 879-881
Abraham, A.; Mockler, D.; Cohen, J.; Silverstein, D. 2013: JAAD Grand Rounds. Stellate-shaped ulcers and violaceous plaques. Journal of the American Academy of Dermatology 69(2): 324-326
Michelacci, V.; Maugliani, A.; Tozzoli, R.; Corteselli, G.; Chiani, P.; Minelli, F.; Gigliucci, F.; Arancia, S.; Conedera, G.; Targhetta, C.; Pierasco, A.; Collini, L.; Parisi, A.; Scavia, G.; Morabito, S. 2018: Characterization of a novel plasmid encoding F4-like fimbriae present in a Shiga-toxin producing enterotoxigenic Escherichia coli isolated during the investigation on a case of hemolytic-uremic syndrome. International Journal of Medical Microbiology: Ijmm 308(7): 947-955
Zhuang, J.; Zhang, K.; Liu, X.; Liu, W.; Lyu, Q.; Ji, A. 2018: Characterization of a Novel PolyM-Preferred Alginate Lyase from Marine Vibrio splendidus OU02. Marine Drugs 16(9)
Wang, Z.; Zhang, H.; Shen, Y.; Zhao, X.; Wang, X.; Wang, J.; Fan, K.; Zhan, X. 2018: Characterization of a novel polysaccharide from Ganoderma lucidum and its absorption mechanism in Caco-2 cells and mice model. International Journal of Biological Macromolecules 118(Part A): 320-326
Li, Y.; Chen, J.; Cao, L.; Li, L.; Wang, F.; Liao, Z.; Chen, J.; Wu, S.; Zhang, L. 2018: Characterization of a novel polysaccharide isolated from Phyllanthus emblica L. and analysis of its antioxidant activities. Journal of Food Science and Technology 55(7): 2758-2764
Jahan, M.I.; Tobe, R.; Mihara, H. 2018: Characterization of a Novel Porin-Like Protein, ExtI, from Geobacter sulfurreducens and its Implication in the Reduction of Selenite and Tellurite. International Journal of Molecular Sciences 19(3)
Asai, T.; Okamoto-Shibayama, K.; Kikuchi, Y.; Ishihara, K. 2018: Characterization of a novel potential peptide import system in Treponema denticola. Microbial Pathogenesis 123: 467-472
Cai, Z.-W.; Ge, H.-H.; Yi, Z.-W.; Zeng, R.-Y.; Zhang, G.-Y. 2018: Characterization of a novel psychrophilic and halophilic β-1, 3-xylanase from deep-sea bacterium, Flammeovirga pacifica strain WPAGA1. International Journal of Biological Macromolecules 118(Part B): 2176-2184
Weidlich, G.A.; Schneider, M.B.; Adler, J.R. 2018: Characterization of a Novel Revolving Radiation Collimator. Cureus 10(2): E2146
Lyraki, R.; Lokaj, M.; Soares, D.C.; Little, A.; Vermeren, M.; Marsh, J.A.; Wittinghofer, A.; Hurd, T. 2018: Characterization of a novel RP2-OSTF1 interaction and its implication for actin remodelling. Journal of Cell Science 131(4)
Guo, J.; Li, M.; Sun, Y.; Yu, L.; He, P.; Nie, Z.; Zhan, X.; Zhao, Y.; Luo, X.; Wang, S.; Aoyang, S.; Liu, Q.; Huang, C.; He, L.; Zhao, J. 2018: Characterization of a novel secretory spherical body protein in Babesia orientalis and Babesia orientalis-infected erythrocytes. Parasites and Vectors 11(1): 433
Solanki, D.S.; Kumar, S.; Parihar, K.; Tak, A.; Gehlot, P.; Pathak, R.; Singh, S.K. 2018: Characterization of a novel seed protein of Prosopis cineraria showing antifungal activity. International Journal of Biological Macromolecules 116: 16-22
Hu, X.; Xiao, Y.; Yu, C.; Zuo, Y.; Yang, W.; Wang, X.; Gu, B.; Li, J. 2018: Characterization of a novel selective factor Xa inhibitor, DJT06001, which reduces thrombus formation with low risk of bleeding. European Journal of Pharmacology 825: 85-91
Nogueira, K.M.V.; de Paula, R.G.; Antoniêto, A.C.C.; Dos Reis, T.F.; Carraro, C.áu.B.; Silva, A.C.; Almeida, F.; Rechia, C.G.V.; Goldman, G.H.; Silva, R.N. 2018: Characterization of a novel sugar transporter involved in sugarcane bagasse degradation in Trichoderma reesei. Biotechnology for Biofuels 11: 84
Lei, C.-W.; Chen, Y.-P.; Kang, Z.-Z.; Kong, L.-H.; Wang, H.-N. 2018: Characterization of a Novel SXT/R391 Integrative and Conjugative Element Carrying cfr, blaCTX-M-65, fosA3, and aac(6')-Ib-cr in Proteus mirabilis. Antimicrobial Agents and ChemoTherapy 62(9)
Li, Q.; Wu, T.; Qi, Z.; Zhao, L.; Pei, J.; Tang, F. 2018: Characterization of a novel thermostable and xylose-tolerant GH 39 β-xylosidase from Dictyoglomus thermophilum. Bmc Biotechnology 18(1): 29
Trappey, A.; Glorioso, S.; de la Bretonne, G. 2009: JAAD grand rounds. A 47-year-old female with ulcerated lesions. Journal of the American Academy of Dermatology 61(5): 916-917
Digiorgio, C.M.; Altmeyer, M.D.; Wang, A.R.; Boh, E.E. 2009: JAAD grand rounds. A 49-year-old man with an asymptomatic cutaneous eruption. Journal of the American Academy of Dermatology 61(5): 913-915
Kai, A.; Wujanto, L.; Teixeira, F.; Kubba, F. 2012: JAAD grand rounds. A young woman with papules on the neck and axillae. Journal of the American Academy of Dermatology 66(5): 863-865
Pfingstler, L.F.; Adams, D.R. 2012: JAAD grand rounds. Erythematous macules and crusted erosions in sun-exposed areas. Journal of the American Academy of Dermatology 66(5): 862-863
Carroll, T.; Kristjansson, A.; Murphy, M.; Sloan, S.Brett. 2009: JAAD grand rounds. Flaccid pustular eruption. Journal of the American Academy of Dermatology 61(5): 917-919
Pfingstler, L.F.; Adams, D.R. 2012: JAAD grand rounds. Increased fragility and bulla formation on the dorsal surface of the hand. Journal of the American Academy of Dermatology 66(5): 866
Morganroth, P.; Wilmot, A.Cowden.; Miller, C. 2009: JAAD online. Over-the-counter scar products for postsurgical patients: disparities between online advertised benefits and evidence regarding efficacy. Journal of the American Academy of Dermatology 61(6): E31-E47
Frymoyer, J.W. 2013: JAAOS at 20 years: the history of its founding and guiding principles. Journal of the American Academy of Orthopaedic Surgeons 21(9): 511-512
Wang, Y.; Yu, Y.-N.; Song, S.; Li, T.-J.; Xiang, J.-Y.; Zhang, H.; Lu, M.-D.; Ji, F.; Hu, L.-Q. 2014: JAB1 and phospho-Ser10 p27 expression profile determine human hepatocellular carcinoma prognosis. Journal of Cancer Research and Clinical Oncology 140(6): 969-978
Qin, J.; Wang, Z.; Wang, Y.; Ma, L.; Ni, Q.; Ke, J. 2010: JAB1 expression is associated with inverse expression of p27(kip1) in hepatocellular carcinoma. Hepato-Gastroenterology 57(99-100): 547-553
Nishimoto, A.; Kugimiya, N.; Hosoyama, T.; Enoki, T.; Li, T-Sheng.; Hamano, K. 2013: JAB1 regulates unphosphorylated STAT3 DNA-binding activity through protein-protein interaction in human colon cancer cells. Biochemical and Biophysical Research Communications 438(3): 513-518
Shackleford, T.J.; Claret, F.X. 2010: JAB1/CSN5: a new player in cell cycle control and cancer. Cell Division 5: 26
Cigada, A.; Gil, F.X.; Kirkpatrick, J.; Nicolais, L.; Tranquilli Leali, P. 2012: JABB: Moving Towards the Future. Journal of Applied Biomaterials and Functional Materials 10(1): 1
Dever, G. 2005: JABSOM's legacy in the Pacific: linking the PBMOTP and Pacific Basin AHEC Programs--a Palau perspective. Pacific Health Dialog 12(1): 6-10
Dangas, G.D.; Popma, J.J. 2009: JACC White Papers: an avenue for interventional knowledge?. JACC. Cardiovascular interventions 2(5): 472-473
Navas, L.E.; Florin-Christensen, M.ón.; Benintende, G.B.; Zandomeni, R.én.O.; Berretta, M.F. 2018: Characterization of a Novel Thermostable Enzyme from Thermus sp. 2.9 with Phospholipase and Acyltransferase Activities. Journal of Molecular Microbiology and Biotechnology 28(3): 99-106
Braunwald, E. 2008: JACC: Cardiovascular Interventions: the end of the beginning. JACC. Cardiovascular interventions 1(1): 1-2
O'Connor, C. 2013: JACC: Heart Failure fellows program: training the next generation. JACC. Heart failure 1(5): 458
O'Gara, P.T. 2014: JACC: the literature that continues to shape cardiology. Journal of the American College of Cardiology 64(1): 113-114
McGrath, E. 2013: JACIE accreditation & quality issues in HPC apheresis. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 48(2): 137
Pamphilon, D.; Apperley, J.F.; Samson, D.; Slaper-Cortenbach, I.; McGrath, E. 2009: JACIE accreditation in 2008: demonstrating excellence in stem cell transplantation. Hematology/Oncology and Stem Cell Therapy 2(2): 311-319
Donot, P.Emmanuel. 2009: JACIE: from guidelines to clinical practice and continuous quality improvement, the Léon-Bérard cancer center experience. Bulletin du Cancer 96(7): 797-804
Hassan, H.; Scheres, B.; Blilou, I. 2010: JACKDAW controls epidermal patterning in the Arabidopsis root meristem through a non-cell-autonomous mechanism. Development 137(9): 1523-1529
Rosenthal, E.Lee.; Macinko, J. 2011: JACM special issue on community health workers and community health worker practice. Journal of ambulatory care management 34(3): 208-209
Yang, J.; Waller, M.P. 2012: JACOB: a dynamic database for computational chemistry benchmarking. Journal of Chemical Information and Modeling 52(12): 3255-3262
Waller, M.P.; Dresselhaus, T.; Yang, J. 2013: JACOB: an enterprise framework for computational chemistry. Journal of Computational Chemistry 34(16): 1420-1428
Boatsman, J.; Bennett, D.Lee.; Meier, J.; Zander, D. 2012: JACR Journal Club: the University of Iowa experience. Journal of the American College of Radiology: JACR 9(2): 148-149
Mahesh, M.; Haines, G.Rebecca. 2013: JACR radiation dose optimization in CT: an online resource center for radiologists. Journal of the American College of Radiology: Jacr 10(6): 477
Amis, E.S.; Neiman, H.L. 2013: JACR: the Beginning. Journal of the American College of Radiology: Jacr 10(1): 6-8
Hawkins, C.Matthew. 2013: JACR: a necessary, valuable resource for residents and fellows. Journal of the American College of Radiology: JACR 10(11): 812-813
Anonymous 2011: JACS CME featured articles, volume 213, September 2011. Journal of the American College of Surgeons 213(3): 457-459
Hua, C.; Li, W.; Han, W.; Wang, Q.; Bi, P.; Han, C.; Zhu, L. 2018: Characterization of a novel thermostable GH7 endoglucanase from Chaetomium thermophilum capable of xylan hydrolysis. International Journal of Biological Macromolecules 117: 342-349
Kurt-Gür, G.ün.; Ordu, E. 2018: Characterization of a novel thermotolerant NAD+-dependent formate dehydrogenase from hot climate plant cotton (Gossypium hirsutum L.). 3 Biotech 8(3): 175
Grimes, J.; Uribe, C.; Celler, A. 2013: JADA: a graphical user interface for comprehensive internal dose assessment in nuclear medicine. Medical Physics 40(7): 072501
Edlinger, D.; Sauter, S.K.; Rinner, C.; Neuhofer, L.M.; Wolzt, M.; Grossmann, W.; Endel, G.; Gall, W. 2014: JADE: a tool for medical researchers to explore adverse drug events using health claims data. Applied Clinical Informatics 5(3): 621-629
Ejiri, H.; Lim, C.-K.; Isawa, H.; Fujita, R.; Murota, K.; Sato, T.; Kobayashi, D.; Kan, M.; Hattori, M.; Kimura, T.; Yamaguchi, Y.; Takayama-Ito, M.; Horiya, M.; Posadas-Herrera, G.; Minami, S.; Kuwata, R.; Shimoda, H.; Maeda, K.; Katayama, Y.; Mizutani, T.; Saijo, M.; Kaku, K.; Shinomiya, H.; Sawabe, K. 2018: Characterization of a novel thogotovirus isolated from Amblyomma testudinarium ticks in Ehime, Japan: a significant phylogenetic relationship to Bourbon virus. Virus Research 249: 57-65
Reedijk, M.; Pinnaduwage, D.; Dickson, B.C.; Mulligan, A.M.; Zhang, H.; Bull, S.B.; O'Malley, F.P.; Egan, S.E.; Andrulis, I.L. 2008: JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer. Breast Cancer Research and Treatment 111(3): 439-448
Digilio, M.C.; Luca, A.D.; Lepri, F.; Guida, V.; Ferese, R.; Dentici, M.L.; Angioni, A.; Marino, B.; Dallapiccola, B. 2013: JAG1 mutation in a patient with deletion 22q11.2 syndrome and tetralogy of Fallot. American Journal of Medical Genetics. Part a 161a (12): 3133-3136
Bureau, M.; Rast, M.I.; Illmer, J.; Simon, R.üd. 2010: Jagged Lateral Organ (Jlo) Controls Auxin Dependent Patterning during Development of the Arabidopsis Embryo and Root. Plant Molecular Biology 74(4-5): 479-491
Sauret-Güeto, S.; Schiessl, K.; Bangham, A.; Sablowski, R.; Coen, E. 2013: JAGGED controls Arabidopsis petal growth and shape by interacting with a divergent polarity field. Plos Biology 11(4): E1001550
Schiessl, K.; Kausika, S.; Southam, P.; Bush, M.; Sablowski, R. 2012: JAGGED controls growth anisotropyand coordination between cell sizeand cell cycle during plant organogenesis. Current Biology: Cb 22(19): 1739-1746
Nebel, M.E.; Wild, S.; Holzhauser, M.; Hüttenberger, L.; Reitzig, R.; Sperber, M.; Stoeck, T. 2011: JAGUC--a software package for environmental diversity analyses. Journal of Bioinformatics and Computational Biology 9(6): 749-773
Butterfield, Y.S.; Kreitzman, M.; Thiessen, N.; Corbett, R.D.; Li, Y.; Pang, J.; Ma, Y.P.; Jones, S.J.M.; Birol, İn.ç 2014: JAGuaR: junction alignments to genome for RNA-seq reads. Plos one 9(7): E102398
Kelly, S.A.; Skvortsov, T.; Magill, D.; Quinn, D.J.; McGrath, J.W.; Allen, C.C.R.; Moody, T.S.; Gilmore, B.F. 2018: Characterization of a novel ω-transaminase from a Triassic salt mine metagenome. Biochemical and Biophysical Research Communications 503(4): 2936-2942
Zúñiga-Mayo, V.M.; Marsch-Martínez, N.; de Folter, S. 2012: JAIBA, a class-Ii HD-ZIP transcription factor involved in the regulation of meristematic activity, and important for correct gynoecium and fruit development in Arabidopsis. Plant Journal: for Cell and Molecular Biology 71(2): 314-326
Günther, S.; von Eichborn, J.; May, P.; Preissner, R. 2009: JAIL: a structure-based interface library for macromolecules. Nucleic Acids Research 37(Database Issue): D338-D341
Kucine, N.; Levine, R.L. 2011: JAK Inhibitors and other Novel Agents in Myeloproliferative Neoplasms: Are We Hitting the Target?. Therapeutic Advances in Hematology 2(4): 203-211
Abdel-Magid, A.F. 2012: JAK Kinase Inhibitors as Possible Treatment for Myeloproliferative Disorders and Cancer: Patent Highlight. ACS medicinal chemistry letters 3(8): 610-611
Tefferi, A. 2008: JAK and MPL mutations in myeloid malignancies. Leukemia and Lymphoma 49(3): 388-397
O'Shea, J.J.; Plenge, R. 2012: JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 36(4): 542-550
Tundwal, K.; Alam, R. 2012: JAK and Src tyrosine kinase signaling in asthma. Frontiers in Bioscience 17: 2107-2121
Ratner, L. 2011: JAK blockade and HTLV. Blood 117(6): 1771-1772
Brosius, F.C.; He, J.Cijiang. 2015: JAK inhibition and progressive kidney disease. Current Opinion in Nephrology and Hypertension 24(1): 88-95
Vaddi, K.; Luchi, M. 2012: JAK inhibition for the treatment of rheumatoid arthritis: a new era in oral DMARD therapy. Expert Opinion on Investigational Drugs 21(7): 961-973
Arellano-Rodrigo, E.; Alvarez-Larrán, A. 2010: JAK inhibition in myelofibrosis. New England Journal of Medicine 363(25): 2464; Author Reply 2464-2465; Discussion 2465
Patel, A.M.; Lupash, D.; Chew, D.; Levesque, M.C.; Moreland, L.W. 2011: JAK inhibition in rheumatoid arthritis. Current Rheumatology Reports 13(5): 379-380
Gotlib, J. 2013: JAK inhibition in the myeloproliferative neoplasms: lessons learned from the bench and bedside. Hematology. American Society of Hematology. Education Program 2013: 529-537
Harrison, C.; Kiladjian, J-Jacques.; Al-Ali, H.Kathrin.; Gisslinger, H.; Waltzman, R.; Stalbovskaya, V.; McQuitty, M.; Hunter, D.S.; Levy, R.; Knoops, L.; Cervantes, F.; Vannucchi, A.M.; Barbui, T.; Barosi, G. 2012: JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. New England Journal of Medicine 366(9): 787-798
Tibes, R.; Bogenberger, J.M.; Mesa, R.A. 2012: JAK inhibition: the key to treating myeloproliferative neoplasm?. Expert Review of Hematology 5(6): 583-585
Yamaoka, K.; Tanaka, Y. 2013: JAK inhibitor. Nihon Rinsho. Japanese Journal of Clinical Medicine 71(7): 1243-1247
Passamonti, F.; Caramazza, D.; Maffioli, M. 2014: JAK inhibitor in CALR-mutant myelofibrosis. New England Journal of Medicine 370(12): 1168-1169
Higashi, Y. 2014: JAK inhibitors as a new generation of small-molecule immunosuppressants. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 144(4): 160-166
Kwatra, S.G.; Dabade, T.S.; Gustafson, C.J.; Feldman, S.R. 2012: JAK inhibitors in psoriasis: a promising new treatment modality. Journal of Drugs in Dermatology: Jdd 11(8): 913-918
Teshima, T. 2014: JAK inhibitors: a home run for GVHD patients?. Blood 123(24): 3691-3693
Cervantes, F.; Mesa, R.; Harrison, C. 2013: JAK inhibitors: beyond spleen and symptoms?. Haematologica 98(2): 160-162
Treliński, J.; Robak, T. 2013: JAK inhibitors: pharmacology and clinical activity in chronic myeloprolipherative neoplasms. Current Medicinal Chemistry 20(9): 1147-1161
Hsu, L.; Armstrong, A.W. 2014: JAK inhibitors: treatment efficacy and safety profile in patients with psoriasis. Journal of Immunology Research 2014: 283617
Bleiblo, F.; Michael, P.; Brabant, D.; Ramana, C.V.; Tai, T.; Saleh, M.; Parrillo, J.E.; Kumar, A.; Kumar, A. 2013: JAK kinases are required for the bacterial RNA and poly I:C induced tyrosine phosphorylation of PKR. International Journal of Clinical and Experimental Medicine 6(1): 16-25
Mullighan, C.G.; Zhang, J.; Harvey, R.C.; Collins-Underwood, J.Racquel.; Schulman, B.A.; Phillips, L.A.; Tasian, S.K.; Loh, M.L.; Su, X.; Liu, W.; Devidas, M.; Atlas, S.R.; Chen, I-Ming.; Clifford, R.J.; Gerhard, D.S.; Carroll, W.L.; Reaman, G.H.; Smith, M.; Downing, J.R.; Hunger, S.P.; Willman, C.L. 2009: JAK mutations in high-risk childhood acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of the United States of America 106(23): 9414-9418
Warsch, W.; Walz, C.; Sexl, V. 2013: JAK of all trades: JAK2-STAT5 as novel therapeutic targets in BCR-ABL1+ chronic myeloid leukemia. Blood 122(13): 2167-2175
Kurdi, M.; Booz, G.W. 2009: JAK redux: a second look at the regulation and role of JAKs in the heart. American Journal of Physiology. Heart and Circulatory Physiology 297(5): H1545-H1556
Montresor, A.; Bolomini-Vittori, M.; Toffali, L.; Rossi, B.; Constantin, G.; Laudanna, C. 2013: JAK tyrosine kinases promote hierarchical activation of Rho and Rap modules of integrin activation. Journal of Cell Biology 203(6): 1003-1019
Yoshimura, A.; Yasukawa, H. 2012: JAK's SOCS: a mechanism of inhibition. Immunity 36(2): 157-159
Hsieh, Y.-Y.; Chang, C.-C.; Hsu, C.-M.; Wan, L.; Chen, S.-Y.; Lin, W.-H.; Tsai, F.-J. 2011: JAK-1 rs2780895 C-related genotype and allele but not JAK-1 rs10789166, rs4916008, rs2780885, rs17127114, and rs3806277 are associated with higher susceptibility to asthma. Genetic Testing and Molecular Biomarkers 15(12): 841-847
Dees, C.; Tomcik, M.; Palumbo-Zerr, K.; Distler, A.; Beyer, C.; Lang, V.; Horn, A.; Zerr, P.; Zwerina, J.; Gelse, K.; Distler, O.; Schett, G.; Distler, Jörg.H.W. 2012: JAK-2 as a novel mediator of the profibrotic effects of transforming growth factor β in systemic sclerosis. Arthritis and Rheumatism 64(9): 3006-3015
Cannizzo, E.; Carulli, G.; Azzarà, A.; Galimberti, S.; Zucca, A.; Petrini, M. 2008: JAK-2V617F mutation in RARS-t: a target for Imatinib therapy?. Leukemia Research 32(10): 1636-1637
Yamada, O.; Ozaki, K.; Akiyama, M.; Kawauchi, K. 2012: JAK-STAT and JAK-PI3K-mTORC1 pathways regulate telomerase transcriptionally and posttranslationally in ATL cells. Molecular Cancer Therapeutics 11(5): 1112-1121
Li, J. 2013: JAK-STAT and bone metabolism. Jak-Stat 2(3): E23930
Ladyman, S.R.; Grattan, D.R. 2013: JAK-STAT and feeding. Jak-Stat 2(2): E23675
Heneghan, A.F.; Pierre, J.F.; Kudsk, K.A. 2013: JAK-STAT and intestinal mucosal immunology. Jak-Stat 2(4): E25530
Satou, R.; Gonzalez-Villalobos, R.A. 2012: JAK-STAT and the renin-angiotensin system: The role of the JAK-STAT pathway in blood pressure and intrarenal renin-angiotensin system regulation. Jak-Stat 1(4): 250-256
Kroon, P.; Berry, P.A.; Stower, M.J.; Rodrigues, G.; Mann, V.M.; Simms, M.; Bhasin, D.; Chettiar, S.; Li, C.; Li, P-Kai.; Maitland, N.J.; Collins, A.T. 2013: JAK-STAT blockade inhibits tumor initiation and clonogenic recovery of prostate cancer stem-like cells. Cancer Research 73(16): 5288-5298
Silver-Morse, L.; Li, W.X. 2013: JAK-STAT in heterochromatin and genome stability. Jak-Stat 2(3): E26090
Xu, D.; Yin, C.; Wang, S.; Xiao, Y. 2013: JAK-STAT in lipid metabolism of adipocytes. Jak-Stat 2(4): E27203
Liu, W.; Singh, S.Ram.; Hou, S.X. 2010: JAK-STAT is restrained by Notch to control cell proliferation of the Drosophila intestinal stem cells. Journal of Cellular Biochemistry 109(5): 992-999
Jang, Y-Na.; Baik, E.Joo. 2013: JAK-STAT pathway and myogenic differentiation. Jak-Stat 2(2): E23282
Hombría, J.Castelli-Gair.; Sotillos, S. 2013: JAK-STAT pathway in Drosophila morphogenesis: From organ selector to cell behavior regulator. Jak-Stat 2(3): E26089
Smirnova, O.V.; Ostroukhova, T.Y.; Bogorad, R.L. 2007: JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?. World Journal of Gastroenterology 13(48): 6478-6491
Issigonis, M.; Tulina, N.; de Cuevas, M.; Brawley, C.; Sandler, L.; Matunis, E. 2009: JAK-STAT signal inhibition regulates competition in the Drosophila testis stem cell niche. Science 326(5949): 153-156
Frias, M.A.; Montessuit, C. 2013: JAK-STAT signaling and myocardial glucose metabolism. Jak-Stat 2(4): E26458
Ruppert, V.; Meyer, T. 2007: JAK-STAT signaling circuits in myocarditis and dilated cardiomyopathy. Herz 32(6): 474-481
Mohri, T.; Iwakura, T.; Nakayama, H.; Fujio, Y. 2012: JAK-STAT signaling in cardiomyogenesis of cardiac stem cells. Jak-Stat 1(2): 125-130
Mair, M.; Blaas, L.; Österreicher, C.H.; Casanova, E.; Eferl, R. 2011: JAK-STAT signaling in hepatic fibrosis. Frontiers in Bioscience 16(8): 2794-2811
Stine, R.R.; Matunis, E.L. 2013: JAK-STAT signaling in stem cells. Advances in Experimental Medicine and Biology 786: 247-267
Bausek, N. 2013: JAK-STAT signaling in stem cells and their niches in Drosophila. Jak-Stat 2(3): E25686
Bäumer, D.; Trauner, J.; Hollfelder, D.; Cerny, A.; Schoppmeier, M. 2011: JAK-STAT signalling is required throughout telotrophic oogenesis and short-germ embryogenesis of the beetle Tribolium. Developmental Biology 350(1): 169-182
Tang, Y.; Tian, X.Cindy. 2013: JAK-STAT3 and somatic cell reprogramming. Jak-Stat 2(4):E24935
Tsuda, M.; Kohro, Y.; Yano, T.; Tsujikawa, T.; Kitano, J.; Tozaki-Saitoh, H.; Koyanagi, S.; Ohdo, S.; Ji, R.-R.; Salter, M.W.; Inoue, K. 2011: JAK-STAT3 pathway regulates spinal astrocyte proliferation and neuropathic pain maintenance in rats. Brain: a Journal of Neurology 134(Part 4): 1127-1139
Barry, S.P. 2012: JAK-STAT: Getting to the heart of the matter. Jak-Stat 1(2): 90-91
Levine, R.L. 2012: JAK-mutant myeloproliferative neoplasms. Current Topics in Microbiology and Immunology 355: 119-133
Träger, U.; Magnusson, A.; Lahiri Swales, N.; Wild, E.; North, J.; Lowdell, M.; Björkqvist, M. 2013: JAK/STAT Signalling in Huntington's Disease Immune Cells. Plos Currents 5
Minakhina, S.; Tan, W.; Steward, R. 2011: JAK/STAT and the GATA factor Pannier control hemocyte maturation and differentiation in Drosophila. Developmental Biology 352(2): 308-316
Borensztejn, A.; Boissoneau, E.; Fernandez, G.; Agnès, F.ço.; Pret, A.-M. 2013: JAK/STAT autocontrol of ligand-producing cell number through apoptosis. Development 140(1): 195-204
Amoyel, M.; Anderson, A.M.; Bach, E.A. 2014: JAK/STAT pathway dysregulation in tumors: a Drosophila perspective. Seminars in Cell and Developmental Biology 28: 96-103
Myllymäki, H.; Rämet, M. 2014: JAK/STAT pathway in Drosophila immunity. Scandinavian Journal of Immunology 79(6): 377-385
Trenerry, M.K.; Della Gatta, P.A.; Cameron-Smith, D. 2011: JAK/STAT signaling and human in vitro myogenesis. Bmc Physiology 11: 6
Beebe, K.; Lee, W.-C.; Micchelli, C.A. 2010: JAK/STAT signaling coordinates stem cell proliferation and multilineage differentiation in the Drosophila intestinal stem cell lineage. Developmental Biology 338(1): 28-37
Ayala-Camargo, A.; Anderson, A.M.; Amoyel, M.; Rodrigues, A.B.; Flaherty, M.S.; Bach, E.A. 2013: JAK/STAT signaling is required for hinge growth and patterning in the Drosophila wing disc. Developmental Biology 382(2): 413-426
Blätke, M.A.; Dittrich, A.; Rohr, C.; Heiner, M.; Schaper, F.; Marwan, W. 2013: JAK/STAT signalling--an executable model assembled from molecule-centred modules demonstrating a module-oriented database concept for systems and synthetic biology. Molecular Biosystems 9(6): 1290-1307
Fiocco, U.; Accordi, B.; Martini, V.; Oliviero, F.; Facco, M.; Cabrelle, A.; Piva, L.; Molena, B.; Caso, F.; Costa, L.; Scanu, A.; Pagnin, E.; Atteno, M.; Scarpa, R.; Basso, G.; Semenzato, G.; Punzi, L.; Doria, A.; Dayer, J.-M. 2014: JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis. Immunologic Research 58(1): 61-69
Lu, B.; Antoine, D.J.; Kwan, K.; Lundbäck, P.; Wähämaa, H.; Schierbeck, H.; Robinson, M.; Van Zoelen, M.A.D.; Yang, H.; Li, J.; Erlandsson-Harris, H.; Chavan, S.S.; Wang, H.; Andersson, U.; Tracey, K.J. 2014: JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation. Proceedings of the National Academy of Sciences of the United States of America 111(8): 3068-3073
Liu, R.-Y.; Zeng, Y.; Lei, Z.; Wang, L.; Yang, H.; Liu, Z.; Zhao, J.; Zhang, H.-T. 2014: JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells. International Journal of Oncology 44(5): 1643-1651
Nicolas, C.él.S.; Csaba, Z.; Fafouri, A.; Javalet, C.; Gressens, P.; Dournaud, P.; Peineau, S.ép. 2012: JAK/STAT: from inflammation to memory. Medecine Sciences: M/S 28(5): 456-458
Johnson, A.N.; Mokalled, M.H.; Haden, T.N.; Olson, E.N. 2011: JAK/Stat signaling regulates heart precursor diversification in Drosophila. Development 138(21): 4627-4638
Song, L.; Rawal, B.; Nemeth, J.A.; Haura, E.B. 2011: JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling. Molecular Cancer Therapeutics 10(3): 481-494
Chen, K.; Min, H.; Wu, X.; Zhu, X.; Li, Z.; Li, H.; Liu, Y. 2012: JAK1 gene polymorphisms are associated with the outcomes of hepatitis B virus infection, but not with α interferon therapy response in a Han Chinese population. Genetic Testing and Molecular Biomarkers 16(10): 1206-1210
Porcu, M.ël.; Gielen, O.; Cools, J.; De Keersmaecker, K. 2009: JAK1 mutation analysis in T-cell acute lymphoblastic leukemia cell lines. Haematologica 94(3): 435-437
Asnafi, V.; Le Noir, S.; Lhermitte, L.; Gardin, C.; Legrand, Fézeh.; Vallantin, X.; Malfuson, J-Valère.; Ifrah, N.; Dombret, Hé.; Macintyre, E. 2010: JAK1 mutations are not frequent events in adult T-ALL: a GRAALL study. British Journal of Haematology 148(1): 178-179
Hu, K.; Hou, S.; Li, F.; Xiang, Q.; Kijlstra, A.; Yang, P. 2013: JAK1, but not JAK2 and STAT3, confers susceptibility to Vogt-Koyanagi-Harada (VKH) syndrome in a Han Chinese population. Investigative Ophthalmology and Visual Science 54(5): 3360-3365
Evrot, E.; Ebel, N.; Romanet, V.; Roelli, C.; Andraos, R.; Qian, Z.; Dölemeyer, A.; Dammassa, E.; Sterker, D.; Cozens, R.; Hofmann, F.; Murakami, M.; Baffert, F.; Radimerski, T. 2013: JAK1/2 and Pan-deacetylase inhibitor combination therapy yields improved efficacy in preclinical mouse models of JAK2V617F-driven disease. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 19(22): 6230-6241
Villani, L.; Bergamaschi, G.; Primignani, M.; Rosti, V.; Carolei, A.; Poletto, V.; Catarsi, P.; Spolverini, A.; Vannucchi, A.M.; Barosi, G. 2012: JAK2 46/1 haplotype predisposes to splanchnic vein thrombosis-associated BCR-ABL negative classic myeloproliferative neoplasms. Leukemia Research 36(1): E7-E9
Trifa, A.P.; Crişan, S.; Popp, R.A.; Cucuianu, A.; Buzoianu, A.D. 2010: JAK2 46/1 haplotype seems not to be associated with lower limb deep venous thrombosis. Blood Cells Molecules and Diseases 45(3): 199-200
Vickers, M.A. 2007: JAK2 617V>F positive polycythemia rubra vera maintained by approximately 18 stochastic stem-cell divisions per year, explaining age of onset by a single rate-limiting mutation. Blood 110(5): 1675-1680
Vannucchi, A.M.; Pieri, L.; Guglielmelli, P. 2011: JAK2 Allele Burden in the Myeloproliferative Neoplasms: Effects on Phenotype, Prognosis and Change with Treatment. Therapeutic Advances in Hematology 2(1): 21-32
Pietra, D.; Casetti, I.; Da Vià, M.C.; Elena, C.; Milanesi, C.; Rumi, E. 2012: JAK2 GGCC haplotype in MPL mutated myeloproliferative neoplasms. American Journal of Hematology 87(7): 746-747
Geetha, J.P.; Arathi, C.A.; Shalini, M.; Srinivasa Murthy, A.G. 2010: JAK2 Negative Polycythemia Vera. Journal of Laboratory Physicians 2(2): 114-116
Ho, K.; Valdez, F.; Garcia, R.; Tirado, C.A. 2010: JAK2 Translocations in hematological malignancies: Review of the literature. Journal of the Association of Genetic Technologists 36(3): 107-109
Kaeda, J.; Bonamino, M.; Ayres-Silva, J.; Solza, C.; Ringel, F.; Blau, O.; Daumas, A.; Oberender, C.; Dörken, B.; le Coutre, P.; Zalcberg, I. 2014: JAK2 V617F allele burden quantified by real time quantitative polymerase chain reaction and competitive polymerase chain reaction in patients with chronic myeloproliferative neoplasia. Leukemia and Lymphoma 55(1): 128-135
McGaffin, G.; Harper, K.; Stirling, D.; McLintock, L. 2014: JAK2 V617F and CALR mutations are not mutually exclusive; findings from retrospective analysis of a small patient cohort. British Journal of Haematology 167(2): 276-278
Kim, H.-J.; Jang, J.-H.; Yoo, E.-H.; Kim, H.-J.; Ki, C.-S.; Kim, J.-W.; Kim, S.-H. 2010: JAK2 V617F and MPL W515L/K mutations in Korean patients with essential thrombocythemia. Korean Journal of Laboratory Medicine 30(5): 474-476
Oh, S.T.; Gotlib, J. 2010: JAK2 V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms. Expert Review of Hematology 3(3): 323-337
Kim, J.T.; Cho, Y.G.; Choi, S.I.; Lee, Y.J.; Kim, H.R.; Jang, S.J.; Moon, D.S.; Park, Y.J.; Park, G. 2010: JAK2 V617F and exon 12 genetic variations in Korean patients with BCR/ABL1-negative myeloproliferative neoplasms. Korean Journal of Laboratory Medicine 30(6): 567-574
Steensma, D.P.; Tefferi, A. 2008: JAK2 V617F and ringed sideroblasts: not necessarily RARS-T. Blood 111(3): 1748
Means, R.T. 2010: JAK2 V617F and the evolving paradigm of polycythemia vera. Korean Journal of Hematology 45(2): 90-94
Dusa, A.; Mouton, C.él.; Pecquet, C.; Herman, M.; Constantinescu, S.N. 2010: JAK2 V617F constitutive activation requires JH2 residue F595: a pseudokinase domain target for specific inhibitors. Plos one 5(6): E11157
Yang, Y-Ning.; Qin, Y-Wen.; Wang, C. 2014: JAK2 V617F detected in two B-cell chronic lymphocytic leukemia patients without coexisting Philadelphia chromosome-negative myeloproliferative neoplasms: A report of two cases. Oncology Letters 8(2): 841-844
Fleischman, A.G.; Tyner, J.W. 2012: JAK2 V617F down-modulates MPL. Blood 119(20): 4579-4580
Mahfouz, R.A.R.; Hoteit, R.; Salem, Z.; Bazarbachi, A.; Mugharbel, A.; Farhat, F.; Ziyadeh, A.; Ibrahim, A.; Taher, A. 2011: JAK2 V617F gene mutation in the laboratory work-up of myeloproliferative disorders: experience of a major referral center in Lebanon. Genetic Testing and Molecular Biomarkers 15(4): 263-265
Barosi, G.; Poletto, V.; Massa, M.; Campanelli, R.; Villani, L.; Bonetti, E.; Viarengo, G.; Catarsi, P.; Klersy, C.; Rosti, V. 2013: JAK2 V617F genotype is a strong determinant of blast transformation in primary myelofibrosis. Plos one 8(3): E59791
Li, J.; Spensberger, D.; Ahn, J.S.; Anand, S.; Beer, P.A.; Ghevaert, C.; Chen, E.; Forrai, A.; Scott, L.M.; Ferreira, R.; Campbell, P.J.; Watson, S.P.; Liu, P.; Erber, W.N.; Huntly, B.J.P.; Ottersbach, K.; Green, A.R. 2010: JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia. Blood 116(9): 1528-1538
Regina, S.; Herault, O.; D'Alteroche, L.; Binet, C.; Gruel, Y. 2007: JAK2 V617F is specifically associated with idiopathic splanchnic vein thrombosis. Journal of Thrombosis and Haemostasis: Jth 5(4): 859-861
Wang, H.; Sun, G.; Zhang, P.; Zhang, J.; Gui, E.; Zu, M.; Jia, E.; Xu, H.; Xu, L.; Zhang, J.; Lu, Z. 2014: JAK2 V617F mutation and 46/1 haplotype in Chinese Budd-Chiari syndrome patients. Journal of Gastroenterology and Hepatology 29(1): 208-214
Melis, S.; Vellinga, S.; Zachée, P.; Sierens, A.C.; De Schouwer, P.J.J.C. 2009: JAK2 V617F mutation and PRV-1 overexpression: relevance in the diagnosis of polycythaemia vera and essential thrombocythaemia. Acta Clinica Belgica 64(5): 429-433
Godeneche, G.; Gaillard, N.; Roy, L.; Mania, A.; Tondeur, S.; Chomel, J.C.; Lavabre, T.; Arquizan, C.; Neau, J.P. 2010: JAK2 V617F mutation associated with cerebral venous thrombosis: a report of five cases. Cerebrovascular Diseases 29(2): 206-209
Shammaa, D.; Bazarbachi, A.; Halas, H.; Greige, L.; Mahfouz, R. 2010: JAK2 V617F mutation detection: laboratory comparison of two kits using RFLP and qPCR. Genetic Testing and Molecular Biomarkers 14(1): 13-15
Sacharow, S.J.; Dudenhausen, E.E.; Lomelino, C.L.; Rodan, L.; El Achkar, C.M.; Olson, H.E.; Genetti, C.A.; Agrawal, P.B.; McKenna, R.; Kilberg, M.S. 2018: Characterization of a novel variant in siblings with Asparagine Synthetase Deficiency. Molecular Genetics and Metabolism 123(3): 317-325
Jekarl, D.W.; Han, S.B.; Kim, M.; Lim, J.; Oh, E.-J.; Kim, Y.; Kim, H.-J.; Min, W.-S.; Han, K. 2010: JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia. Korean Journal of Hematology 45(1): 46-50
Wong, K.F.; Wong, W.S.; Siu, L.L.P.; Lau, T.C. 2009: JAK2 V617F mutation in myeloid neoplasms with 3q21 and 3q26 abnormalities in Chinese patients. Leukemia and Lymphoma 50(8): 1386-1388
Mercier, E.; Lissalde-Lavigne, Géraldine.; Gris, J-Christophe. 2007: JAK2 V617F mutation in unexplained loss of first pregnancy. New England Journal of Medicine 357(19): 1984-1985
Wong, K.F.; Wong, W.S.; Siu, L.L.P.; Lau, T.C.; Chan, N.P. 2009: JAK2 V617F mutation is associated with 5q- syndrome in Chinese. Leukemia and Lymphoma 50(8): 1333-1335
Karimi, O.; Crusius, J.B.A.; Coucoutsi, C.; Heijmans, R.; Sambuelli, A.M.; Peña, A.S.; Koutroubakis, I.E. 2008: JAK2 V617F mutation is not involved in thromboembolism in IBD. Inflammatory Bowel Diseases 14(11): 1606-1607
Yoshinaga, K.; Mori, N.; Wang, Y.-H.; Tomita, K.; Shiseki, M.; Motoji, T. 2008: JAK2 V617F mutation is rare in idiopathic erythrocytosis: a difference from polycythemia vera. International Journal of Hematology 88(1): 82-87
Lin, P.; Luthra, R.; Nussenzveig, R.H.; Medeiros, L.J. 2010: JAK2 V617F mutation is uncommon in patients with the 3q21q26 syndrome. Human Pathology 41(5): 758-762
Zito, L.; Torchio, R.; Bannout, K.; Ulisciani, S.; Guglielmo, M.; Ciacco, C.; Lodico, D. 2011: JAK2 V617F mutation negative erythrocytosis (or how to more simply perform diagnosis and treat a patient with increased hematocrit). Multidisciplinary Respiratory Medicine 6(4): 242-246
Au, W.-Y.; Wan, T.S.K.; Ma, E.S.K. 2013: JAK2 V617F mutation positive primary myelofibrosis with concomitant t(9;11;22)(q34;p15;q11.2) but no BCR/ABL fusion. International Journal of Hematology 97(3): 435-437
Da Silva, R.R.; Domingues Hatzlhofer, B.ân.L.; Machado, C.ín.G.d.F.; Lima, A.S.d.M.; de Albuquerque, D.éi.M.; dos Santos, M.N.N.; Fertrin, K.Y.; Costa, F.F.; Araújo, A.d.S.; Bezerra, M.A.C. 2012: JAK2 V617F mutation prevalence in myeloproliferative neoplasms in Pernambuco, Brazil. Genetic Testing and Molecular Biomarkers 16(7): 802-805
Payzin, K.B.; Savasoglu, K.; Alacacioglu, I.; Ozdemirkiran, F.; Mutlu, B.B.; Bener, S.; Calli, A.O.; Kucukzeybek, B.B.; Aksun, S. 2014: JAK2 V617F mutation status of 232 patients diagnosed with chronic myeloproliferative neoplasms. Clinical Lymphoma Myeloma and Leukemia 14(6): 525-533
Means, R.T. 2008: JAK2 V617F mutation testing in polycythemia vera: use and impact in an academic practice. American Journal of the Medical Sciences 336(4): 327-329
Owens, C.D. 2010: JAK2 V617F mutation, mesenteric vein thrombosis, and myeloproliferative disorders. Journal of Vascular Surgery 52(1): 205-207
De Stefano, V.; Rossi, E.; Za, T.; Ciminello, A.; Betti, S.; Luzzi, C.; Leone, G.; Chiusolo, P. 2011: JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis. American Journal of Hematology 86(6): 526-528
Kashif, A.W.; Aggarwal, S.; Verma, T.; Gupta, R.M. 2013: JAK2 V617F negative essential thrombocythemia. Medical Journal Armed Forces India 69(3): 294-296
Zhang, S.; Qiu, H.; Fischer, B.S.; Li, W.; Duan, L.; Sun, X.; Xu, W.; Li, J. 2008: JAK2 V617F patients with essential thrombocythemia present with clinical features of polycythemia vera. Leukemia and Lymphoma 49(4): 696-699
Wei, J.; Wang, C.; Qin, Y.-W.; Zhu, J.; Gao, Y.-R.; Cai, Q.; Yan, S.-K. 2012: JAK2 V617F positive essential thrombocythemia developing in a patient with CD5⁻ chronic lymphocytic leukemia. Chinese Medical Journal 125(11): 2076-2079
Berman, J.N.; Greer, W.L.; Archambeault, S.; Loh, M.L.; Riddell, C.; Morash, B.; Dumas, N.; Fernandez, C.V.; Ludman, M.D. 2008: JAK2 V617F positive polycythemia Vera in a child with neurofibromatosis type i. Pediatric Blood and Cancer 51(5): 689-691
Oku, S.; Takenaka, K.; Kuriyama, T.; Shide, K.; Kumano, T.; Kikushige, Y.; Urata, S.; Yamauchi, T.; Iwamoto, C.; Shimoda, H.K.; Miyamoto, T.; Nagafuji, K.; Kishimoto, J.; Shimoda, K.; Akashi, K. 2010: JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activation. British Journal of Haematology 150(3): 334-344
Hoteit, R.M.; Shammaa, D.M.R.; Mahfouz, R.A.R. 2012: JAK2 V617F "indeterminate" results by MutaScreen can be easily resolved using MutaQuant kits. Genetic Testing and Molecular Biomarkers 16(2): 146-149
Irino, T.; Uemura, M.; Yamane, H.; Umemura, S.; Utsumi, T.; Kakazu, N.; Shirakawa, T.; Ito, M.; Suzuki, T.; Kinoshita, K. 2011: JAK2 V617F-dependent upregulation of PU.1 expression in the peripheral blood of myeloproliferative neoplasm patients. Plos one 6(7): E22148
Girsberger, S.; Karow, A.; Lundberg, P.; Dirnhofer, S.; Lehmann, T.; Passweg, J.R.; Tichelli, Aé.; Skoda, R.; Rovó, A. 2013: JAK2 V617F-mutated myeloproliferative neoplasia developing five years after wild-type JAK2 acute myeloid leukemia: a case report. Acta Haematologica 129(1): 23-25
Yhim, H-Young.; Kim, H.Sun.; Sohn, J-Youn.; Song, M-Ju.; Lee, N-Ri.; Song, E-Kee.; Choi, S-Im.; Yim, C-Yeol.; Kwak, J-Yong. 2010: JAK2 V617F-positive essential thrombocythemia in a patient with Klinefelter syndrome: a case report. Cancer Genetics and Cytogenetics 198(2): 162-165
Allegra, A.; Alonci, A.; Penna, G.; D'Angelo, A.; Rizzotti, P.; Granata, A.; Musolino, C. 2009: JAK2 V617F-positive latent essential thrombocythemia and splanchnic vein thrombosis: the role of bone marrow biopsy for the diagnosis of myeloproliferative disease. Acta Haematologica 121(4): 218-220
Yoo, J-Ha.; Park, T.Sung.; Maeng, H-Young.; Sun, Y-Kyu.; Kim, Y-Ah.; Kie, J-Hae.; Cho, E.Hae.; Song, J.; Lee, K-A.; Suh, B.; Choi, J.Rak. 2009: JAK2 V617F/C618R mutation in a patient with polycythemia vera: a case study and review of the literature. Cancer Genetics and Cytogenetics 189(1): 43-47
Hexner, E.O. 2007: JAK2 V617F: implications for thrombosis in myeloproliferative diseases. Current Opinion in Hematology 14(5): 450-454
Siemiatkowska, A.; Bieniaszewska, M.; Hellmann, A.; Limon, J. 2010: JAK2 and MPL gene mutations in V617F-negative myeloproliferative neoplasms. Leukemia Research 34(3): 387-389
Koppikar, P.; Levine, R.L. 2008: JAK2 and MPL mutations in myeloproliferative neoplasms. Acta Haematologica 119(4): 218-225
Besancenot, R.; Roos-Weil, D.; Tonetti, C.; Abdelouahab, H.; Lacout, C.; Pasquier, F.; Willekens, C.; Rameau, P.; Lecluse, Y.; Micol, J.-B.; Constantinescu, S.N.; Vainchenker, W.; Solary, E.; Giraudier, S.ép. 2014: JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation. Blood 124(13): 2104-2115
Yu, L.; Min, W.; He, Y.; Qin, L.; Zhang, H.; Bennett, A.M.; Chen, H. 2009: JAK2 and SHP2 reciprocally regulate tyrosine phosphorylation and stability of proapoptotic protein ASK1. Journal of Biological Chemistry 284(20): 13481-13488